72956-09-3 | [3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine

Packsize	Purity	Availability	Price	Discounted Price
50mg	≥98%	in stock	$42.00	$29.00
1g	98%	in stock	$42.00	$30.00
5g	98%	in stock	$90.00	$63.00
10g	98%	in stock	$171.00	$120.00
25g	98%	in stock	$323.00	$226.00
100g	98%	in stock	$791.00	$554.00

Description

• Catalog Number: AB48248
• Chemical Name: [3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine
• CAS Number: 72956-09-3
• Molecular Formula: C24H26N2O4
• Molecular Weight: 406.4742
• MDL Number: MFCD00864692
• SMILES: COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O
• NSC Number: 758694

Computed Properties

• Complexity: 508
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 30
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 10
• Undefined Atom Stereocenter Count: 1
• XLogP3: 4.2

Literature

• Relative contribution of rat CYP isoforms responsible for stereoselective metabolism of carvedilol.

  The Journal of toxicological sciences 20180101

• Cooling down the bath salts: Carvedilol attenuation of methylone and mephedrone mediated hyperthermia.

  Toxicology letters 20161130

• Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.

  American journal of physiology. Heart and circulatory physiology 20160801

• In vitro metabolism of phenytoin in 36 CYP2C9 variants found in the Chinese population.

  Chemico-biological interactions 20160625

• Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin.

  Chemico-biological interactions 20160205

• Febuxostat ameliorates doxorubicin-induced cardiotoxicity in rats.

  Chemico-biological interactions 20150725

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Mitofusin 2 ameliorates aortic remodeling by suppressing ras/raf/ERK pathway and regulating mitochondrial function in vascular smooth muscle cells.

  International journal of cardiology 20150115

• Chromium-induced nephrotoxicity and ameliorative effect of carvedilol in rats: Involvement of oxidative stress, apoptosis and inflammation.

  Chemico-biological interactions 20141105

• β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing.

  Circulation research 20140227

• Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice.

  Chemico-biological interactions 20131025

• Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophy.

  International journal of cardiology 20130120

• Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.

  Drug development and industrial pharmacy 20121201

• A fluorescence parameter based analysis on the solubilization of carvedilol by bile salt media.

  Journal of photochemistry and photobiology. B, Biology 20121105

• Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.

  Basic & clinical pharmacology & toxicology 20121101

• A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study.

  Journal of pharmaceutical and biomedical analysis 20121101

• Evaluation of carbon nanotubes as chiral selectors for continuous-flow enantiomeric separation of carvedilol with fluorescent detection.

  Journal of pharmaceutical and biomedical analysis 20121101

• Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.

  Journal of gastroenterology and hepatology 20121101

• Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.

  Critical reviews in toxicology 20121101

• Contribution of β-adrenergic receptors to exercise-induced bronchodilatation in healthy humans.

  Respiratory physiology & neurobiology 20121015

• Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression.

  The Journal of pharmacology and experimental therapeutics 20121001

• Validation of visualized transgenic zebrafish as a high throughput model to assay bradycardia related cardio toxicity risk candidates.

  Journal of applied toxicology : JAT 20121001

• Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.

  Pharmacogenetics and genomics 20121001

• Combined use of direct renin inhibitor and carvedilol in heart failure with preserved systolic function.

  Medical hypotheses 20121001

• A case of tubulointerstitial nephritis and uveitis syndrome in an elderly patient.

  Korean journal of ophthalmology : KJO 20121001

• The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats.

  Journal of physiology and biochemistry 20120901

• Carvedilol attenuates the progression of alcohol fatty liver disease in rats.

  Alcoholism, clinical and experimental research 20120901

• Solvent effect on the vibrational spectra of Carvedilol.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120901

• Ranolazine-induced severe bladder hypotonia.

  The Annals of pharmacotherapy 20120901

• Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.

  Circulation. Heart failure 20120901

• Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective β-adrenergic blocker.

  Journal of the American Academy of Dermatology 20120901

• Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production.

  Experimental biology and medicine (Maywood, N.J.) 20120901

• The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy.

  Clinics (Sao Paulo, Brazil) 20120901

• Beta blocker use and colorectal cancer risk: population-based case-control study.

  Cancer 20120815

• Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction.

  Clinical journal of the American Society of Nephrology : CJASN 20120807

• Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

  British journal of pharmacology 20120801

• β-Blockers in heart failure: benefits of β-blockers according to varying male proportions of study patients.

  Clinical cardiology 20120801

• Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells.

  Canadian journal of physiology and pharmacology 20120801

• β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.

  American journal of hypertension 20120801

• Protective effect of carvedilol on adriamycin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia.

  Journal of cardiac failure 20120801

• Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial.

  Journal of the American College of Cardiology 20120717

• Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to chinese herbal medicine screening.

  Current pharmaceutical biotechnology 20120701

• Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats.

  Toxicology mechanisms and methods 20120701

• Characterization of agglomerated carvedilol by hot-melt processes in a fluid bed and high shear granulator.

  International journal of pharmaceutics 20120701

• A rapid UHPLC method for the simultaneous determination of drugs from different therapeutic groups in surface water and wastewater.

  Bulletin of environmental contamination and toxicology 20120701

• Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.

  Clinical pharmacology and therapeutics 20120701

• Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.

  Future cardiology 20120701

• Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.

  Colloids and surfaces. B, Biointerfaces 20120615

• New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage.

  Toxicology and applied pharmacology 20120615

• When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.

  Circulation 20120612

• Effects of carvedilol on oxygen uptake and heart rate kinetics in patients with chronic heart failure at simulated altitude.

  European journal of preventive cardiology 20120601

• Uptake and depuration of pharmaceuticals in aquatic invertebrates.

  Environmental pollution (Barking, Essex : 1987) 20120601

• Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery.

  The Journal of cardiovascular surgery 20120601

• β-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20120601

• Spontaneous cervical epidural hematoma associated with thunderclap headache.

  The journal of headache and pain 20120601

• Effect of oxidative stress on ventricular arrhythmia in rabbits with adriamycin-induced cardiomyopathy.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20120601

• Recent developments in the management of heart failure.

  The Practitioner 20120601

• Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.

  Structure (London, England : 1993) 20120509

• Stir bar sorptive extraction and high performance liquid chromatographic determination of carvedilol in human serum using two different polymeric phases and an ionic liquid as desorption solvent.

  Journal of chromatography. A 20120504

• The effects of newer beta-adrenoceptor antagonists on vascular function in cardiovascular disease.

  Current vascular pharmacology 20120501

• Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.

  Journal of gastroenterology 20120501

• Takayasu arteritis as a cause of arterial hypertension. Case report and literature review.

  European journal of pediatrics 20120501

• Application of 13C CPMAS NMR for qualitative and quantitative characterization of carvedilol and its commercial formulations.

  Journal of pharmaceutical sciences 20120501

• Annato extract and β-carotene modulate the production of reactive oxygen species/nitric oxide in neutrophils from diabetic rats.

  Journal of clinical biochemistry and nutrition 20120501

• Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer.

  The Journal of biological chemistry 20120413

• [COPD patients with heart failure: no concern about the beta blocker!].

  MMW Fortschritte der Medizin 20120405

• Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.

  Cardiovascular therapeutics 20120401

• The 'missing' link between acute hemodynamic effect and clinical response.

  Journal of cardiovascular translational research 20120401

• Aliskiren-associated acute kidney injury in a patient with pre-existing chronic kidney disease and dilated cardiomyopathy.

  Clinical and experimental nephrology 20120401

• Effects of myricetin on the bioavailability of carvedilol in rats.

  Pharmaceutical biology 20120401

• Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.

  Current medical research and opinion 20120401

• Carvedilol or propranolol in portal hypertension? A randomized comparison.

  Scandinavian journal of gastroenterology 20120401

• β-blockers in stage B: a precursor of heart failure.

  Heart failure clinics 20120401

• An assessment of the association between carvedilol exposure and severe hypersensitivity reactions, angioedema, and anaphylactic reactions: a retrospective nested case-control analysis.

  Clinical therapeutics 20120401

• Hiccup: mystery, nature and treatment.

  Journal of neurogastroenterology and motility 20120401

• Effect of an L- and T-type calcium channel blocker on 24-hour systolic blood pressure and heart rate in hypertensive patients.

  Korean circulation journal 20120401

• Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.

  Science (New York, N.Y.) 20120302

• A re-appraisal of volume status and renal function impairment in chronic heart failure: combined effects of pre-renal failure and venous congestion on renal function.

  Heart failure reviews 20120301

• Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability.

  Naunyn-Schmiedeberg's archives of pharmacology 20120301

• Terminalia gum as a directly compressible excipient for controlled drug delivery.

  AAPS PharmSciTech 20120301

• Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.

  AAPS PharmSciTech 20120301

• Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry.

  Chirality 20120301

• [Right atrial aneurysm after chest trauma: late presentation].

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20120301

• Action of molecular switches in GPCRs--theoretical and experimental studies.

  Current medicinal chemistry 20120301

• Carvedilol attenuates oxidative stress in chronic chagasic cardiomyopathy.

  Arquivos brasileiros de cardiologia 20120301

• Retrospective review of carvedilol administration in 38 dogs with preclinical chronic valvular heart disease.

  Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology 20120301

• New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility.

  Journal of cardiac failure 20120301

• Adherence and dosing frequency of common medications for cardiovascular patients.

  The American journal of managed care 20120301

• Vasodilating versus first-generation β-blockers for cardiovascular protection.

  Postgraduate medicine 20120301

• Differential expression of caveolins and myosin heavy chains in response to forced exercise in rats.

  Laboratory animal research 20120301

• Use of direct renin inhibitor in an HIV positive subject.

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20120301

• The effect of enalapril and carvedilol on left ventricular dysfunction in middle childhood and adolescent patients with muscular dystrophy.

  Korean circulation journal 20120301

• Subarachnoid hemorrhage mimicking leakage of contrast media after coronary angiography.

  Korean circulation journal 20120301

• A case of swallow syncope associated with cold beverage ingestion.

  Korean circulation journal 20120301

• Cases of hemolytic anemia with periprosthetic leaks evaluated by real-time 3-dimensional transesophageal echocardiography.

  Journal of cardiovascular ultrasound 20120301

• Revision and update on clinical practice guideline for liver cirrhosis.

  The Korean journal of hepatology 20120301

• Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly.

  International journal of cardiology 20120223

• Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.

  Biochemical pharmacology 20120215

• Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.

  Xenobiotica; the fate of foreign compounds in biological systems 20120201

• Carvedilol improves uptake-1 in patients with systolic congestive heart failure.

  Journal of cardiovascular pharmacology 20120201

• Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension.

  Journal of clinical hypertension (Greenwich, Conn.) 20120201

• [Elevated augmentation index].

  Deutsche medizinische Wochenschrift (1946) 20120201

• Thrombolytic therapy for acute stroke in a teenager.

  Pediatric emergency care 20120201

• [Effect of carvedilol on T-type calcium current in myocytes of non-infarcted area of the rabbit healed myocardial infarction].

  Yao xue xue bao = Acta pharmaceutica Sinica 20120201

• Beta-blockers for heart failure: an evidence based review answering practical therapeutic questions.

  The Medical journal of Malaysia 20120201

• Chronic social stress induces cardiomyocyte contractile dysfunction and intracellular Ca2+ derangement in rats.

  Physiology & behavior 20120118

• A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.

  Journal of the American College of Cardiology 20120103

• Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats.

  The British journal of nutrition 20120101

• Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.

  Hypertension research : official journal of the Japanese Society of Hypertension 20120101

• Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20120101

• Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations.

  Journal of microencapsulation 20120101

• In vivo evaluation of alginate microspheres of carvedilol for nasal delivery.

  Journal of biomedical materials research. Part B, Applied biomaterials 20120101

• Interdialytic ambulatory blood pressure in patients with intradialytic hypertension.

  Current opinion in nephrology and hypertension 20120101

• Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.

  Expert review of cardiovascular therapy 20120101

• Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure.

  Yonsei medical journal 20120101

• Mid-septal hypertrophy and apical ballooning; potential mechanism of ventricular tachycardia storm in patients with hypertrophic cardiomyopathy.

  Yonsei medical journal 20120101

• Presenilin is the molecular target of acidic γ-secretase modulators in living cells.

  PloS one 20120101

• Safety and tolerability of once-daily controlled-release carvedilol 10-80 mg in Japanese patients with chronic heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20120101

• Impedance responses reveal β₂-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles.

  PloS one 20120101

• Hemodynamic and central blood pressure differences between carvedilol and valsartan added to lisinopril at rest and during exercise stress.

  Journal of the American Society of Hypertension : JASH 20120101

• Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomes.

  Biological & pharmaceutical bulletin 20120101

• Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology.

  Frontiers in pharmacology 20120101

• Oxygen Kinetics and Heart Rate Response during Early Recovery from Exercise in Patients with Heart Failure.

  Cardiology research and practice 20120101

• Toxicities effects of pharmaceutical, olive mill and textile wastewaters before and after degradation by Pseudomonas putida mt-2.

  Cancer cell international 20120101

• Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.

  Cardiovascular diabetology 20120101

• Metoprolol-induced visual hallucinations: a case series.

  Journal of medical case reports 20120101

• Dilated cardiomyopathy following trastuzumab chemotherapy.

  Indian journal of pharmacology 20120101

• Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials.

  Integrated blood pressure control 20120101

• Spontaneous sinus conversion of permanent atrial fibrillation during treatment of hyperkalemia.

  Korean circulation journal 20120101

• Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease.

  Annals of clinical microbiology and antimicrobials 20120101

• The mechanism of carvedilol in experimental viral myocarditis.

  Current pharmaceutical design 20120101

• Nebivolol: impact on cardiac and endothelial function and clinical utility.

  Vascular health and risk management 20120101

• Simultaneous determination of some antiprotozoal drugs in different combined dosage forms by mean centering of ratio spectra and multivariate calibration with model updating methods.

  Chemistry Central journal 20120101

• Strain echocardiography in early detection of Doxorubicin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia.

  ISRN pediatrics 20120101

• Phenytoin in treatment of amiodarone-induced Torsades de pointes.

  Indian journal of pharmacology 20120101

• Carbon monoxide poisoning mimicking arterial gas embolism in a commercial diver.

  Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 20120101

• Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure.

  Vascular health and risk management 20120101

• A case for pharmacogenomics in management of cardiac arrhythmias.

  Indian pacing and electrophysiology journal 20120101

• An improvement in physicochemical properties of carvedilol through spherically agglomerated solid dispersions with PVP K30.

  Acta poloniae pharmaceutica 20120101

• Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

  PloS one 20120101

• The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.

  Endocrine research 20120101

• Prevention and management of gastroesophageal varices in cirrhosis.

  International journal of hepatology 20120101

• Diverse Effects of Glutathione and UPF Peptides on Antioxidant Defense System in Human Erythroleukemia Cells K562.

  International journal of peptides 20120101

• Implication of mitochondrial cytoprotection in human islet isolation and transplantation.

  Biochemistry research international 20120101

• Vitiligo, hypothyroidism and cardiomyopathy.

  Indian journal of endocrinology and metabolism 20120101

• Different cardiovascular responses to a resistance training session in hypertensive women receiving propanolol compared with normotensive controls.

  TheScientificWorldJournal 20120101

• Diverse spectrum of presentation of coronary slow flow phenomenon: a concise review of the literature.

  Cardiology research and practice 20120101

• Oxidative stress and heart failure in altered thyroid States.

  TheScientificWorldJournal 20120101

• Use of carvedilol in hypertension: an update.

  Vascular health and risk management 20120101

• PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes.

  TheScientificWorldJournal 20120101

• Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension.

  Indian journal of pharmacology 20120101

• Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.

  PloS one 20120101

• Stereoselective glucuronidation of carvedilol in human liver and intestinal microsomes.

  Pharmacology 20120101

• Carvedilol protects against apoptotic cell death induced by cisplatin in renal tubular epithelial cells.

  Journal of toxicology and environmental health. Part A 20120101

• Rac-induced left ventricular dilation in thyroxin-treated ZmRacD transgenic mice: role of cardiomyocyte apoptosis and myocardial fibrosis.

  PloS one 20120101

• Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol.

  International journal of cardiology 20111215

• Carvedilol as a potential novel agent for the treatment of Alzheimer's disease.

  Neurobiology of aging 20111201

• Sympatho-renal axis in chronic disease.

  Clinical research in cardiology : official journal of the German Cardiac Society 20111201

• Optimization of cardiac metabolism in heart failure.

  Current pharmaceutical design 20111201

• Nebivolol for the treatment of heart failure.

  Expert opinion on investigational drugs 20111201

• Childhood onset of left ventricular dysfunction in a female manifesting carrier of muscular dystrophy.

  American journal of medical genetics. Part A 20111201

• Carvedilol compared with metoprolol on left ventricular ejection fraction after coronary artery bypass graft.

  Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses 20111201

• Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: a comparison with atenolol (CENTRAL Study).

  Journal of clinical hypertension (Greenwich, Conn.) 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation.

  Korean circulation journal 20111201

• Influence of carvedilol on anticonvulsant effect of gabapentin.

  Acta neurologica Belgica 20111201

• A mechanism underlying compound-induced voltage shift in the current activation of hERG by antiarrhythmic agents.

  Biochemical and biophysical research communications 20111111

• Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction.

  Heart and vessels 20111101

• Choice of antihypertensive treatment in subjects with pre-diabetes. Is there a dream after the navigator.

  Current vascular pharmacology 20111101

• Carvedilol for the treatment of refractory facial flushing and persistent erythema of rosacea.

  Archives of dermatology 20111101

• Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

  European heart journal 20111101

• Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium.

  Journal of muscle research and cell motility 20111101

• Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.

  Drug delivery 20111101

• The effects of cyclophosphamide, melatonin and carvedilol on neural tube and skeletal system of mice fetuses in prenatal period.

  Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 20111020

• β₂ AR agonists in treatment of chronic heart failure: long path to translation.

  Journal of molecular and cellular cardiology 20111001

• Carvedilol inhibits Kir2.3 channels by interference with PIP₂-channel interaction.

  European journal of pharmacology 20111001

• Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization.

  Journal of cardiovascular pharmacology 20111001

• Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms.

  BMJ quality & safety 20111001

• Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.

  European heart journal 20111001

• Clinical trials update from the European Society of Cardiology Heart Failure meeting 2011: TEHAF, WHICH, CARVIVA, and atrial fibrillation in GISSI-HF and EMPHASIS-HF.

  European journal of heart failure 20111001

• Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure?

  Journal of cardiac failure 20111001

• Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.

  Respiratory medicine 20111001

• Ligand-induced modulation of the free-energy landscape of G protein-coupled receptors explored by adaptive biasing techniques.

  PLoS computational biology 20111001

• CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study.

  Acta cardiologica 20111001

• Critical evaluation of the optimal medical therapy in the cardiac resynchronization therapy candidates--single centre experience.

  Vnitrni lekarstvi 20111001

• Natriuretic peptides: Diagnostic and therapeutic use.

  Indian journal of endocrinology and metabolism 20111001

• A 69-year-old Woman with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery: Surgical Repair Using a Trap-door Flap.

  The Korean journal of thoracic and cardiovascular surgery 20111001

• Mild hyperkalemia and low eGFR a tedious recipe for cardiac disaster in the elderly: an unusual reversible cause of syncope and heart block.

  Heart international 20110929

• Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze.

  World journal of cardiology 20110926

• Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure.

  International journal of cardiology 20110901

• Successful bridge to recovery with VAD implantation for anthracycline-induced cardiomyopathy.

  Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 20110901

• NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies.

  Basic research in cardiology 20110901

• A randomised, placebo-controlled trial of carvedilol in early familial dilated cardiomyopathy.

  Heart, lung & circulation 20110901

• Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).

  International journal of cardiology 20110901

• CODA-RET reveals functional selectivity as a result of GPCR heteromerization.

  Nature chemical biology 20110901

• Novel design and synthesis of modified structure of carvedilol.

  Recent patents on cardiovascular drug discovery 20110901

• Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients.

  Journal of cardiac failure 20110901

• Hypertensive heart failure associated with middle aortic syndrome reversed dramatically by endovascular management.

  Journal of cardiovascular ultrasound 20110901

• Carvedilol tweaks calcium release to ease arrhythmias.

  Nature medicine 20110804

• Effects of antihypertensive treatment on endothelial function.

  Current hypertension reports 20110801

• Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20110801

• Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial.

  Journal of cardiac failure 20110801

• Beta-blockers for heart failure: why you should use them more.

  The Journal of family practice 20110801

• Ask the doctor. I had a heart attack three years ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol is 190, and my LDL is 128. Should I be taking a statin?

  Harvard heart letter : from Harvard Medical School 20110801

• Cardiac sarcoidosis: a comprehensive review.

  Archives of medical science : AMS 20110801

• Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

  Journal of medicinal chemistry 20110714

• Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.

  Nature medicine 20110710

• [Clinical and pharmacological factors related to the requirements of laser photocoagulation in patients with diabetic nephropathy due to type 2 diabetes mellitus].

  Medicina clinica 20110709

• Arrhythmogenic dilated cardiomyopathy due to a novel mutation in the desmoplakin gene.

  Indian journal of pediatrics 20110701

• Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.

  Digestive diseases and sciences 20110701

• Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma.

  The American journal of the medical sciences 20110701

• Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels.

  British journal of pharmacology 20110701

• The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.

  Naunyn-Schmiedeberg's archives of pharmacology 20110701

• Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol.

  Journal of cardiovascular pharmacology 20110701

• Up-regulation of the cardiac lipid metabolism at the onset of heart failure.

  Cardiovascular & hematological agents in medicinal chemistry 20110701

• 1-(9H-Carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol hemihydrate: a carvedilol solvatomorph.

  Acta crystallographica. Section C, Crystal structure communications 20110701

• Cardioprotective interventions for cancer patients receiving anthracyclines.

  The Cochrane database of systematic reviews 20110615

• Genetics of mechanosensation in the heart.

  Journal of cardiovascular translational research 20110601

• Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.

  European journal of heart failure 20110601

• A pharmacological primer of biased agonism.

  Endocrine, metabolic & immune disorders drug targets 20110601

• Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20110601

• Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate.

  The Journal of pharmacy and pharmacology 20110601

• Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics.

  Pharmacogenomics 20110601

• Investigation of carvedilol-evoked Ca²+ movement and death in human oral cancer cells.

  Journal of receptor and signal transduction research 20110601

• Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy.

  The American journal of pathology 20110601

• Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.

  Drugs in R&D 20110601

• Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a long-term special survey.

  Drugs in R&D 20110601

• Design of a drug delivery system with bimodal pH dependent release of a poorly soluble drug.

  Die Pharmazie 20110601

• Retraction.

  Laboratory animal research 20110601

• [Effect of carvedilol and Radix astragali on ryanodine receptor in heart failure in mice].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20110601

• Nebivolol for the treatment of heart failure.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110515

• Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices.

  European heart journal 20110501

• New perspectives for the treatment of pulmonary hypertension.

  British journal of pharmacology 20110501

• Modelling and simulation as research tools in paediatric drug development.

  European journal of clinical pharmacology 20110501

• Complications and outcomes in chronic liver disease.

  Current opinion in gastroenterology 20110501

• 1H and 13C NMR characteristics of β-blockers.

  Magnetic resonance in chemistry : MRC 20110501

• [Effects of carvedilol on cardiomyocyte apoptosis in autoimmune myocarditis in mice].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20110501

• Neuromuscular electrical stimulation in a patient with chronic heart failure due to chagas disease: a case report.

  Clinics (Sao Paulo, Brazil) 20110501

• Indications for heart transplantation in congenital heart disease.

  Current cardiology reviews 20110501

• Population-based analysis of class effect of β blockers in heart failure.

  The American journal of cardiology 20110415

• The role of Beta-blockers as first-line therapy in hypertension.

  Current atherosclerosis reports 20110401

• Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.

  The American journal of cardiology 20110401

• Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.

  Current medical research and opinion 20110401

• Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial.

  Diabetes care 20110401

• Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients.

  British journal of clinical pharmacology 20110401

• Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.

  Trends in pharmacological sciences 20110401

• Two cases of h(2)-receptor antagonist hypersensitivity and cross-reactivity.

  Allergy, asthma & immunology research 20110401

• Carvedilol dissolution improvement by preparation of solid dispersions with porous silica.

  International journal of pharmaceutics 20110315

• UHPLC method for the simultaneous determination of β-blockers, isoflavones and their metabolites in human urine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110315

• Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.

  Circulation. Heart failure 20110301

• Two-year clinical outcome after carvedilol-loaded stent implantation in patients with coronary artery disease.

  The Korean journal of internal medicine 20110301

• Modulation of metabolic activity of phagocytes by antihistamines.

  Interdisciplinary toxicology 20110301

• The new pyridoindole antioxidant SMe1EC2 and its intervention in hypoxia/hypoglycemia-induced impairment of longterm potentiation in rat hippocampus.

  Interdisciplinary toxicology 20110301

• pH sensitive alginate-chitosan hydrogel beads for carvedilol delivery.

  Pharmaceutical development and technology 20110201

• Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma.

  Journal of human hypertension 20110201

• Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors.

  Drug metabolism and disposition: the biological fate of chemicals 20110201

• Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude.

  Journal of hypertension 20110201

• Effect of renal sympathetic nerve on adrenergically and angiotensin II-induced renal vasoconstriction in normal Wistar-Kyoto rats.

  Upsala journal of medical sciences 20110201

• Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.

  American journal of physiology. Heart and circulatory physiology 20110201

• Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.

  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20110201

• Treatment of heart failure with normal ejection fraction.

  Current treatment options in cardiovascular medicine 20110201

• Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria.

  Chemico-biological interactions 20110115

• Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.

  The American journal of cardiology 20110115

• Mortality and morbidity of newly diagnosed heart failure with preserved systolic function treated with β-blockers: a propensity-adjusted case-control populational study.

  International journal of cardiology 20110107

• Effects of cAMP and β-adrenergic receptor antagonists on the function of peripheral T helper lymphocytes in patients with heart failure.

  Neuroimmunomodulation 20110101

• Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.

  Circulation. Heart failure 20110101

• Case report and mini literature review: anesthetic management for severe peripartum cardiomyopathy complicated with preeclampsia using sufetanil in combined spinal epidural anesthesia.

  Yonsei medical journal 20110101

• The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.

  Autonomic & autacoid pharmacology 20110101

• Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.

  Critical care (London, England) 20110101

• Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background.

  Cardiology research and practice 20110101

• Exercise-induced left bundle branch block and subsequent mechanical left ventricular dyssynchrony--resolved with pharmacological therapy.

  Cardiovascular ultrasound 20110101

• Cardiovascular effects in childhood cancer survivors treated with anthracyclines.

  Cardiology research and practice 20110101

• Carvedilol in the treatment of portal hypertension.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101

• [A ten-year follow-up of a 109-year-old woman with myocardial infarction].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20110101

• Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis.

  International journal of biological sciences 20110101

• Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations.

  Chemistry Central journal 20110101

• Changes in the organization of excitation-contraction coupling structures in failing human heart.

  PloS one 20110101

• Endothelial function in a cardiovascular risk population with borderline ankle-brachial index.

  Vascular health and risk management 20110101

• Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials.

  Critical care (London, England) 20110101

• Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients.

  Cardiovascular diabetology 20110101

• Effect of carvedilol on heart failure in patients with a functionally univentricular heart.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR TS.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20110101

• Right ventricular dysfunction following acute myocardial infarction in the absence of pulmonary hypertension in the mouse.

  PloS one 20110101

• Solid dispersions of carvedilol with porous silica.

  Chemical & pharmaceutical bulletin 20110101

• Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.

  Archives of pharmacal research 20110101

• Oral propranolol for circumscribed choroidal hemangioma.

  Case reports in ophthalmology 20110101

• [Effects of carvedilol and proxodolol on nitric oxide (NO) metabolism in various organs in a congestive heart failure model].

  Eksperimental'naia i klinicheskaia farmakologiia 20110101

• Isolated left ventricular noncompaction cardiomyopathy diagnosed by transesophageal echocardiography.

  Clinical Medicine Insights. Cardiology 20110101

• [Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction].

  Klinicheskaia meditsina 20110101

• β-blockade restores muscle sympathetic rhythmicity in human heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• The prognostic value of non-linear analysis of heart rate variability in patients with congestive heart failure--a pilot study of multiscale entropy.

  PloS one 20110101

• Insulin versus Lipid Emulsion in a Rabbit Model of Severe Propranolol Toxicity: A Pilot Study.

  Critical care research and practice 20110101

• Self-management in heart failure: where have we been and where should we go?

  Journal of multidisciplinary healthcare 20110101

• Giant cell myocarditis with incessant ventricular arrhythmias treated successfully with methylprednisolone and rat antithymocyte globulin.

  Cardiology research and practice 20110101

• Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.

  BMC cardiovascular disorders 20110101

• The causes, consequences, and treatment of left or right heart failure.

  Vascular health and risk management 20110101

• Preparation of mucoadhesive oral patches containing tetracycline hydrochloride and carvacrol for treatment of local mouth bacterial infections and candidiasis.

  Scientia pharmaceutica 20110101

• Double chambered right ventricle with severe calcification of the tricuspid valve in an elderly woman: a case report.

  Journal of medical case reports 20110101

• [Effect of carvedilol and metoprolol R administered with or without atorvastatin on elastic properties of vascular wall and parameters of inflammation in patients with chronic heart failure of ischemic origin].

  Kardiologiia 20110101

• The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside.

  Journal of biomedical semantics 20110101

• Centella asiatica Attenuates D-Galactose-Induced Cognitive Impairment, Oxidative and Mitochondrial Dysfunction in Mice.

  International journal of Alzheimer's disease 20110101

• Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.

  Scandinavian journal of rheumatology 20110101

• Determination of carvedilol by its quenching effect on the luminescence of terbium complex in dosage form.

  Acta poloniae pharmaceutica 20110101

• Pharmacological management of cardiorenal syndromes.

  International journal of nephrology 20110101

• Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy.

  Nutrition & metabolism 20110101

• [Efficacy and safety of the first made in Russia αβ long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree].

  Terapevticheskii arkhiv 20110101

• Additive effects of β-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Blood Loss through AV Fistula: A Case Report and Literature Review.

  International journal of nephrology 20110101

• Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.

  Current pharmaceutical design 20110101

• Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure.

  Vascular health and risk management 20110101

• Determination of trace carvedilol by solid substrate-room temperature phosphorimetry, based on its activating effect on hypochlorite-oxidizing amaranth using sodium dodecyl benzene sulphonate as sensitizer.

  Luminescence : the journal of biological and chemical luminescence 20110101

• Beta-blocker therapy for patients with acute myocardial infarction. -Implications in the post-successful PCI Era in Japan-.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Management of hypertension in high-risk ethnic minority with heart failure.

  International journal of hypertension 20110101

• Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.

  International journal of hypertension 20110101

• A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly.

  BMC medical research methodology 20110101

• Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases.

  The open cardiovascular medicine journal 20110101

• β-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis: Role of β1 Integrins.

  Journal of signal transduction 20110101

• Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).

  PloS one 20110101

• Management of Hypertension among Patients with Coronary Heart Disease.

  International journal of hypertension 20110101

• Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure.

  Clinical Medicine Insights. Cardiology 20110101

• Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI.

  BMC cancer 20110101

• δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

  Skeletal muscle 20110101

• Caloric intake, dietary lifestyles, macronutrient composition, and alzheimer' disease dementia.

  International journal of Alzheimer's disease 20110101

• Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.

  American journal of nephrology 20110101

• Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension.

  Indian journal of pharmacology 20110101

• Dissofilm: a novel approach for delivery of phenobarbital; design and characterization.

  Journal of young pharmacists : JYP 20110101

• Identification of novel functional inhibitors of acid sphingomyelinase.

  PloS one 20110101

• Hydrogen sulfide and neurogenic inflammation in polymicrobial sepsis: involvement of substance P and ERK-NF-κB signaling.

  PloS one 20110101

• Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance study.

  Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20110101

• Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system.

  Journal of pharmacy & bioallied sciences 20110101

• Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure--a randomized study.

  Cardiovascular diabetology 20110101

• Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats.

  Pharmacological reports : PR 20110101

• Challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer.

  Journal of thyroid research 20110101

• Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.

  Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20110101

• Inverse agonism and its therapeutic significance.

  Indian journal of pharmacology 20110101

• Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients.

  Journal of cardiovascular disease research 20110101

• The role of muscarinic receptors in the beneficial effects of adenosine against myocardial reperfusion injury in rats.

  PloS one 20110101

• β-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure.

  PloS one 20110101

• Carvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy.

  ISRN pharmacology 20110101

• A two-compartment model of VEGF distribution in the mouse.

  PloS one 20110101

• Low dose spinal anesthesia for peripartum cardiomyopathy.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets.

  Chemistry Central journal 20110101

• Development and evaluation of novel-trans-buccoadhesive films of Famotidine.

  Journal of advanced pharmaceutical technology & research 20110101

• Medical angioplasty - hope and expectations: an optimistic overview.

  Journal of family & community medicine 20110101

• Carvedilol induces endogenous hydrogen sulfide tissue concentration changes in various mouse organs.

  Folia biologica 20110101

• Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?

  The open cardiovascular medicine journal 20110101

• The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive.

  Vascular health and risk management 20110101

• Benefits of once-daily therapies in the treatment of hypertension.

  Vascular health and risk management 20110101

• Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.x, and Kir7.1.

  Frontiers in pharmacology 20110101

• Label-free integrative pharmacology on-target of drugs at the β(2)-adrenergic receptor.

  Scientific reports 20110101

• Effectiveness of beta blockers in primary prophylaxis of variceal bleeding in children with portal hypertension.

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20110101

• Development and validation of new discriminative dissolution method for carvedilol tablets.

  Indian journal of pharmaceutical sciences 20110101

• Beta-blockers in hypertension.

  The American journal of cardiology 20101215

• {Beta}-blocker drugs mediate calcium signaling in native central nervous system neurons by {beta}-arrestin-biased agonism.

  Proceedings of the National Academy of Sciences of the United States of America 20101207

• Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model.

  Pharmacological research 20101201

• The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.

  Journal of cardiovascular pharmacology and therapeutics 20101201

• Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles.

  Colloids and surfaces. B, Biointerfaces 20101201

• Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.

  Journal of cardiovascular translational research 20101201

• Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress.

  International journal of urology : official journal of the Japanese Urological Association 20101201

• Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.

  AAPS PharmSciTech 20101201

• Editorial comment to carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress.

  International journal of urology : official journal of the Japanese Urological Association 20101201

• Use of ß-blocker therapy to prevent primary bleeding of esophageal varices.

  Journal of the American Academy of Nurse Practitioners 20101201

• Effect of Lacidipine on Blood Pressure and Endothelial Function in Mild-to-Moderate Essential Hypertension Patients With Diabetes in Korea.

  Korean circulation journal 20101201

• Cardiomyopathy following latrodectus envenomation.

  The western journal of emergency medicine 20101201

• Oxidative stress induced by the Fe/ascorbic acid system or model ischemia in vitro: effect of carvedilol and pyridoindole antioxidant SMe1EC2 in young and adult rat brain tissue.

  Interdisciplinary toxicology 20101201

• Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

  Healthcare informatics research 20101201

• Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes.

  Diabetes therapy : research, treatment and education of diabetes and related disorders 20101201

• A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with β-blocker therapy.

  International journal of cardiology 20101105

• Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation.

  International journal of cardiology 20101105

• Current role of beta-blockers in the treatment of hypertension.

  Expert opinion on pharmacotherapy 20101101

• The effects of carvedilol administration on cardiopulmonary resuscitation in a rat model of cardiac arrest induced by airway obstruction.

  Anesthesia and analgesia 20101101

• A histamine H₂ receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade.

  Basic research in cardiology 20101101

• The foundation role of beta blockers across the cardiovascular disease spectrum: a year 2009 update.

  The American journal of medicine 20101101

• Letter by Lowenthal et al regarding article, 'BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial'.

  Circulation. Heart failure 20101101

• Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart.

  Cellular and molecular neurobiology 20101101

• Congestive heart failure in Indians: how do we improve diagnosis & management?

  The Indian journal of medical research 20101101

• (S)-(+)-4-(Oxiran-2-ylmeth-oxy)-9H-carbazole.

  Acta crystallographica. Section E, Structure reports online 20101101

• Acutely decompensated systolic heart failure: effects of frequent doses of furosemide vs a single dose plus carvedilol on clinical status, neurohormonal activation and ventricular arrhythmias.

  International journal of cardiology 20101008

• Central nervous system changes in pediatric heart failure: a volumetric study.

  Pediatric cardiology 20101001

• Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.

  Blood pressure monitoring 20101001

• Effects of carvedilol on delayed rectifier and transient inactivating potassium currents in rat hippocampal CA1 neurons.

  Clinical and experimental pharmacology & physiology 20101001

• Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats?

  Hypertension research : official journal of the Japanese Society of Hypertension 20101001

• Combined blockade of β- and α₁-adrenoceptors in left ventricular remodeling induced by hypertension: beneficial or not?

  Hypertension research : official journal of the Japanese Society of Hypertension 20101001

• Pediatric carvedilol ingestions reported to Texas poison centers, 2000 to 2008.

  Pediatric emergency care 20101001

• Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes.

  Aging 20101001

• Beneficial Effect of Efonidipine, an L- and T-Type Dual Calcium Channel Blocker, on Heart Rate and Blood Pressure in Patients With Mild-to-Moderate Essential Hypertension.

  Korean circulation journal 20101001

• Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100901

• Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.

  American journal of respiratory and critical care medicine 20100901

• BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial.

  Circulation. Heart failure 20100901

• Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.

  European journal of heart failure 20100901

• Association of physical training with beta-blockers in heart failure in mice.

  Arquivos brasileiros de cardiologia 20100901

• Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100901

• Effectiveness, safety and cost of drug substitution in hypertension.

  British journal of clinical pharmacology 20100901

• Effect of carvedilol on portal pressure estimated by hepatic vein Doppler ultrasound waveform and damping index in cirrhotic patients.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20100901

• Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.

  Journal of clinical hypertension (Greenwich, Conn.) 20100901

• Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.

  Journal of clinical hypertension (Greenwich, Conn.) 20100901

• Cheyne-stokes respiration associated with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.

  Clinics (Sao Paulo, Brazil) 20100901

• Efficacy of Carvedilol in Patients with Dilated Cardiomyopathy due to Beta-thalassemia major; a Double-blind Randomized Controlled Trial.

  Iranian journal of pediatrics 20100901

• Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.

  European journal of pharmacology 20100825

• Skeletal muscle proteins oxidation in chronic right heart failure in rats: can different beta-blockers prevent it to the same degree?

  International journal of cardiology 20100820

• Novel delivery device for monolithical solid oral dosage forms for personalized medicine.

  International journal of pharmaceutics 20100816

• The role of carvedilol in the management of portal hypertension.

  European journal of gastroenterology & hepatology 20100801

• Enantioselective quantification of carvedilol in human plasma by HPLC in heavily medicated heart failure patients.

  Journal of pharmaceutical and biomedical analysis 20100801

• Echocardiographic evaluation of children with systemic ventricular dysfunction treated with carvedilol.

  Pediatric cardiology 20100801

• Pancytopenia due to proguanil toxicity in a returning traveller with fever.

  European journal of clinical pharmacology 20100801

• Differential effects of carvedilol and metoprolol on renal function in patients with heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20100801

• Coadministration of carvedilol attenuates nitrate tolerance by preventing cytochrome p450 depletion.

  Circulation journal : official journal of the Japanese Circulation Society 20100801

• Which beta-blocker is most effective in heart failure?

  Cardiovascular drugs and therapy 20100801

• Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure.

  The American journal of cardiology 20100801

• We should not hesitate to use beta-blockers for systolic heart failure with concomitant renal dysfunction.

  Circulation journal : official journal of the Japanese Circulation Society 20100801

• Toxic epidermal necrolysis associated with carvedilol treatment.

  International journal of clinical pharmacology and therapeutics 20100801

• Overview of the methods and therapies for the primary prevention of variceal bleeding.

  Expert review of gastroenterology & hepatology 20100801

• The nonselective beta-blocker carvedilol suppresses apoptosis in human cardiac tissue: a pilot study.

  The heart surgery forum 20100801

• Heart failure in acute ischemic stroke.

  Current cardiology reviews 20100801

• Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report.

  Viruses 20100801

• Cardiac sodium channelopathies.

  Pflugers Archiv : European journal of physiology 20100701

• High-dose carvedilol therapy for mechanical circulatory assisted patients.

  Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs 20100701

• Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.

  Contemporary clinical trials 20100701

• Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review.

  Current diabetes reviews 20100701

• Replacement of carvedilol for propranolol in patients with heart failure.

  Arquivos brasileiros de cardiologia 20100701

• A study of the chemical composition of black cumin oil and its effect on penetration enhancement from transdermal formulations.

  Natural product research 20100701

• The role of vasodilating beta-blockers in patients with complicated hypertension: focus on nebivolol.

  The American journal of medicine 20100701

• One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk.

  The American journal of medicine 20100701

• Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension.

  The Journal of pharmacy and pharmacology 20100701

• [Improvement of left ventricular function during combined carvedilol, ramipril and spironolactone therapy after myocarditis in patient treated earlier by chemotherapy due to Hodgkin's lymphoma - 3-years follow-up].

  Kardiologia polska 20100701

• [Effects of carvedilol and metoprolol on expression of autoantibodies against cardiac adrenergic receptors in aged patients with chronic heart failure and ventricular arrhythmia].

  Zhonghua xin xue guan bing za zhi 20100701

• Heart rate dynamic during an exercise test in heart failure patients with different sensibilities of the carvedilol therapy: heart rate dynamic during exercise test.

  International journal of cardiology 20100625

• Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy.

  Heart international 20100623

• Proteomic profiling of cellular responses to Carvedilol enantiomers in vascular smooth muscle cells by iTRAQ-coupled 2-D LC-MS/MS.

  Journal of proteomics 20100616

• Carvedilol-induced elevation in cytosolic free Ca(2+) level and apoptosis in SIRC corneal epithelial cells.

  Human & experimental toxicology 20100601

• Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20100601

• Oxidative stress and vascular function: implications for pharmacologic treatments.

  Current hypertension reports 20100601

• Carvedilol for portal hypertension in patients with cirrhosis.

  Hepatology (Baltimore, Md.) 20100601

• Effects of beta-blockers on ventilation efficiency in heart failure.

  American heart journal 20100601

• Norepinephrine remains increased in the six-minute walking test after heart transplantation.

  Clinics (Sao Paulo, Brazil) 20100601

• Why beta-blockers should not be used as first choice in uncomplicated hypertension.

  The American journal of cardiology 20100515

• Beta-blocker pharmacogenetics in heart failure.

  Heart failure reviews 20100501

• Rapid carvedilol up-titration in hospitalized patients with left ventricular systolic dysfunction--data from the Carvedilol in Hospital: Up-titration Limits after Acute Patients Admission registry.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20100501

• Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation.

  Journal of cardiovascular pharmacology 20100501

• Mucoadhesive chitosan microspheres of carvedilol for nasal administration.

  Journal of drug targeting 20100501

• Use of cyclodextrin-modified gold nanoparticles for enantioseparations of drugs and amino acids based on pseudostationary phase-capillary electrochromatography.

  Electrophoresis 20100501

• Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.

  Journal of the American College of Cardiology 20100427

• Atrial fibrillation: adverse effects of 'pill-in-the-pocket' treatment and propafenone-carvedilol interaction.

  International journal of cardiology 20100415

• Sympathoinhibitory effect of statins in chronic heart failure.

  Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20100401

• Trend in implantable cardioverter defibrillators and relation to need.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20100401

• Carvedilol in glioma treatment alone and with imatinib in vitro.

  International journal of oncology 20100401

• Cocaine and beta-blockers: the paradigm.

  European journal of internal medicine 20100401

• Influence of the BGE composition on analyte response in CD-mediated NACE-MS.

  Electrophoresis 20100401

• Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.

  European journal of heart failure 20100401

• Inadequate control of heart rate in patients with stable angina: results from the European heart survey.

  Postgraduate medical journal 20100401

• The carvedilol's beta-blockade in heart failure and exercise training's sympathetic blockade in healthy athletes during the rest and peak effort.

  Cardiovascular therapeutics 20100401

• [Endothelial dysfunction: role of vasodilating betablockers in hypertension and chronic heart failure].

  Annales de cardiologie et d'angeiologie 20100401

• Best strategies for hypertension management in type 2 diabetes and obesity.

  Current diabetes reports 20100401

• Can we reduce the cardiovascular risk in peritoneal dialysis patients?

  Indian journal of nephrology 20100401

• The effects of beta-blockers on endothelial nitric oxide synthase immunoreactivity in the rat corpus cavernosum.

  Urology 20100301

• Takotsubo cardiomyopathy, or broken-heart syndrome.

  The Annals of pharmacotherapy 20100301

• Effect of formulation parameters on the preparation of superporous hydrogel self-nanoemulsifying drug delivery system (SNEDDS) of carvedilol.

  AAPS PharmSciTech 20100301

• Effect of beta-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction.

  Clinics (Sao Paulo, Brazil) 20100301

• Acute pericarditis and myocarditis by Toxoplasma gondii in an immunocompetent young man: a case report.

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20100301

• [The effect of carvedilol on coronary flow reserve in patients with dilated cardiomyopathy].

  Zhonghua nei ke za zhi 20100301

• Effects of short-term carvedilol on the cardiac sympathetic activity assessed by 123I-MIBG scintigraphy.

  Arquivos brasileiros de cardiologia 20100301

• Carvedilol dihydrogen phosphate propan-2-ol solvate from powder diffraction data.

  Acta crystallographica. Section E, Structure reports online 20100301

• Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.

  Circulation research 20100219

• Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20100201

• Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.

  Thrombosis research 20100201

• QT interval dispersion and cardiac sympathovagal balance shift in rats with acute ethanol withdrawal.

  Alcoholism, clinical and experimental research 20100201

• Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.

  Blood pressure 20100201

• Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases.

  Expert opinion on drug metabolism & toxicology 20100201

• Clinical trials update from the American Heart Association meeting 2009: HEAAL, FAIR-HF, J-CHF, HeartMate II, PACE and a meta-analysis of dose-ranging studies of beta-blockers in heart failure.

  European journal of heart failure 20100201

• Carvedilol versus variceal band ligation for prevention of the first variceal bleed.

  Hepatology (Baltimore, Md.) 20100201

• Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20100201

• Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.

  Pediatrics international : official journal of the Japan Pediatric Society 20100201

• Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.

  Cardiovascular drugs and therapy 20100201

• [Effect of nonselective beta-adrenoblocker carvedilol on extrasystolic and postextrasystolic contractility in the rat myocardium after experimental infarction].

  Eksperimental'naia i klinicheskaia farmakologiia 20100201

• Spontaneous rectus sheath hematoma.

  The western journal of emergency medicine 20100201

• Surgical ventricular restoration to reverse left ventricular remodeling.

  Current cardiology reviews 20100201

• Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.

  Journal of the American College of Cardiology 20100119

• Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

  Journal of the National Cancer Institute 20100106

• Caveat anicula! Beware of quiet little old ladies: demographic features, pharmacotherapy, readmissions and survival in a 10-year cohort of patients with heart failure and preserved systolic function.

  The Medical journal of Australia 20100104

• The inhibition in tumor necrosis factor-alpha-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-kappaB and reactive oxygen species.

  Journal of thrombosis and thrombolysis 20100101

• Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3.

  Journal of molecular and cellular cardiology 20100101

• Carvedilol protects against the renal mitochondrial toxicity induced by cisplatin in rats.

  Mitochondrion 20100101

• Medicinal chemistry of drugs used in diabetic cardiomyopathy.

  Current medicinal chemistry 20100101

• Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis.

  Scandinavian journal of immunology 20100101

• Protective effects of carvedilol on systemic vascular damage induced by angiotensin II: organ-specific effects independent of antihypertensive effects.

  Medical science monitor : international medical journal of experimental and clinical research 20100101

• Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100101

• Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization.

  Cardiovascular diabetology 20100101

• Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents.

  Cardiovascular therapeutics 20100101

• Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation--ischemia and apoptosis studies.

  Journal of cardiothoracic surgery 20100101

• Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure.

  PloS one 20100101

• Relation between regional and global systolic function in patients with ischemic cardiomyopathy after beta-blocker therapy or revascularization.

  Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20100101

• Reversible dilated cardiomyopathy due to subclinical hyperthyroidism.

  Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20100101

• Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.

  Lipids in health and disease 20100101

• [Structure and activity of carvedilol].

  Eksperimental'naia i klinicheskaia farmakologiia 20100101

• Prevalence and characteristics of sleep apnoea in patients with stable heart failure: Results from a heart failure clinic.

  BMC pulmonary medicine 20100101

• Behçet's Disease: an Insight from a Cardiologist's Point of View.

  The open cardiovascular medicine journal 20100101

• Inhibitory and stimulative effects of amiodarone on metabolism of carvedilol in human liver microsomes.

  Biological & pharmaceutical bulletin 20100101

• Cardiomyopathy and calciphylaxis in a patient with normal renal function: a case report.

  Congestive heart failure (Greenwich, Conn.) 20100101

• Reversible dilated cardiomyopathy in a patient with Cushing's syndrome.

  Congestive heart failure (Greenwich, Conn.) 20100101

• Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement.

  Diabetology & metabolic syndrome 20100101

• Carvedilol stability in paediatric oral liquid formulations.

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101

• An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials.

  BMJ (Clinical research ed.) 20100101

• New standards in hypertension and cardiovascular risk management: focus on telmisartan.

  Vascular health and risk management 20100101

• Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats.

  Toxicology 20100101

• [Effect of beta-adrenoblockers on remodeling of myocardium and adhesive function of endothelium in patients with ischemic heart disease, complicated with chronic heart failure and atrial fibrillation].

  Kardiologiia 20100101

• Chick embryo partial ischemia model: a new approach to study ischemia ex vivo.

  PloS one 20100101

• Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.

  Cardiovascular diabetology 20100101

• Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection.

  PloS one 20100101

• Use of remote monitoring to improve outcomes in patients with heart failure: a pilot trial.

  International journal of telemedicine and applications 20100101

• High-performance liquid chromatography determination of carvedilol in pig serum.

  Journal of chromatographic science 20100101

• Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence.

  Vascular health and risk management 20100101

• Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine.

  Vascular health and risk management 20100101

• Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

  Vascular health and risk management 20100101

• Clinical effects of home telemonitoring in the context of diabetes, asthma, heart failure and hypertension: a systematic review.

  Journal of medical Internet research 20100101

• Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease.

  Journal of Alzheimer's disease : JAD 20100101

• Combination therapy in hypertension: An update.

  Diabetology & metabolic syndrome 20100101

• Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials.

  BMC cancer 20100101

• Tako-tsubo cardiomyopathy in a patient with advanced colorectal adenocarcinoma.

  Case reports in medicine 20100101

• [Prospects for using non-invasive diagnostic techniques for assessment of cardiac rhythm variability in coronary restenosis].

  Klinicheskaia meditsina 20100101

• Use of statin therapy to reduce cardiovascular risk in older patients.

  Current gerontology and geriatrics research 20100101

• β-blockers in the treatment of dilated cardiomyopathy: which is the best?

  Current pharmaceutical design 20100101

• Beta-blocker therapy and hemophagocytic lymphohistiocytosis: a case report.

  Cardiology research and practice 20100101

• Carvedilol can prevent cardiac events in Duchenne muscular dystrophy.

  Internal medicine (Tokyo, Japan) 20100101

• [Does carvedilol minimize the requirements for laser photocoagulation in diabetic retinopathy?].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20100101

• Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope.

  The open cardiovascular medicine journal 20100101

• [Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice].

  Kardiologiia 20100101

• Unexplained Graft Dysfunction after Heart Transplantation-Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report.

  Cardiology research and practice 20100101

• Oxidative stress and mitochondrial functions in the intestinal Caco-2/15 cell line.

  PloS one 20100101

• Population pharmacokinetics of R- and S-carvedilol in Japanese patients with chronic heart failure.

  Biological & pharmaceutical bulletin 20100101

• Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review.

  PloS one 20100101

• Principal component analysis of HPLC retention data and molecular modeling structural parameters of cardiovascular system drugs in view of their pharmacological activity.

  International journal of molecular sciences 20100101

• Isolated ventricular noncompaction syndrome in a nigerian male: case report and review of the literature.

  Cardiology research and practice 20100101

• Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.

  Vascular health and risk management 20100101

• Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure.

  Vascular health and risk management 20100101

• Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection.

  Vascular health and risk management 20100101

• The importance of organizational characteristics for improving outcomes in patients with chronic disease: a systematic review of congestive heart failure.

  Implementation science : IS 20100101

• Indian research: Focus on clozapine.

  Indian journal of psychiatry 20100101

• Solid State Characterization of Domperidone: Hydroxypropyl-β-Cyclodextrin Inclusion Complex.

  Indian journal of pharmaceutical sciences 20100101

• Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

  Vascular health and risk management 20100101

• Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy.

  Journal of translational medicine 20100101

• GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.

  PloS one 20100101

• Validated HPLC determination of the two fixed dose combinations (chlordiazepoxide hydrochloride and mebeverine hydrochloride; carvedilol and hydrochlorothiazide) in their tablets.

  Journal of AOAC International 20100101

• Advances in systolic heart failure.

  F1000 medicine reports 20100101

• Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial.

  PloS one 20100101

• Therapeutic window for calcium-channel blockers in the management of dilated cardiomyopathy: a prospective, two-centre study on non-advanced disease.

  Cardiology 20100101

• A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study.

  PloS one 20100101

• Importance of blood pressure control in left ventricular mass regression.

  Journal of the American Society of Hypertension : JASH 20100101

• Effect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study.

  Critical care (London, England) 20100101

• Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

  Vascular health and risk management 20100101

• Intra-abdominal hypertension due to heparin - induced retroperitoneal hematoma in patients with ventricle assist devices: report of four cases and review of the literature.

  Journal of cardiothoracic surgery 20100101

• [Beta-adrenoblockers for the correction of arterial hypertension in postmenopausal women].

  Klinicheskaia meditsina 20100101

• [Comparative eficacy of antihypertensive therapy in patients with arterial hypertension and various sensitivity to salt].

  Kardiologiia 20100101

• Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review.

  Journal of cardiothoracic surgery 20100101

• Metabolomic profiling of cellular responses to carvedilol enantiomers in vascular smooth muscle cells.

  PloS one 20100101

• A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors.

  PloS one 20100101

• Poor tolerance of beta-blockers by elderly patients with heart failure.

  Clinical interventions in aging 20100101

• Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.

  Clinical interventions in aging 20100101

• Beta 2 antagonism in acute respiratory failure.

  Critical care (London, England) 20100101

• Bisoprolol and heart failure: new frontiers.

  Indian heart journal 20100101

• Beta-blockers and heart failure.

  Indian heart journal 20100101

• Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

  Experimental diabetes research 20100101

• Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure.

  Experimental and clinical cardiology 20100101

• Allopurinol and global left myocardial function in heart failure patients.

  Journal of cardiovascular disease research 20100101

• [Effect of carvedilol in the combination with quercetine and tiotriazoline on the nucleus density and RNA concentration in the nucleus of cardiac myocytes of spontaneous hypertensive rats].

  Likars'ka sprava 20100101

• Adrenergic receptor blockade-induced regression of pressure-overload cardiac hypertrophy is associated with inhibition of the calcineurin/NFAT3/GATA4 pathway.

  Molecular medicine reports 20100101

• Potent hepatoprotective effect in CCl(4)-induced hepatic injury in mice of phloroacetophenone from Myrcia multiflora.

  The Libyan journal of medicine 20100101

• [Impact of Gly389Arg beta1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol].

  Terapevticheskii arkhiv 20100101

• Preparation and characterization of solid dispersions of carvedilol with PVP K30.

  Research in pharmaceutical sciences 20100101

• [Efficacy of ramipril, carvedilol, and trimetazidine MR in improvement of quality of life of patients after myocardial infarction].

  Kardiologiia 20100101

• [Evolution of oral drug forms of metoprolol: advantages of long acting modified release forms with modified release].

  Kardiologiia 20100101

• Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers.

  Drug, healthcare and patient safety 20100101

• Impact of telmisartan in modifying vascular risk.

  Integrated blood pressure control 20100101

• Biomedical use of isothermal microcalorimeters.

  Sensors (Basel, Switzerland) 20100101

• Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion.

  Ecancermedicalscience 20100101

• Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

• Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

• Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol.

  European heart journal 20091201

• Reversed-phase high-performance liquid chromatographic enantioresolution of six beta-blockers using dinitrophenyl-L-Pro-N-hydroxysuccinimide ester, N-succinimidyl-(S)-2-(6-methoxynaphth-2-yl) propionate and twelve variants of Sanger's reagent as chiral derivatizing reagents.

  Biomedical chromatography : BMC 20091201

• Peak exercise responses in heart failure: back to basics.

  European heart journal 20091201

• Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxy phenoxy)ethylamino)propan-2-ol analogs and its enantiomers. Part 2.

  European journal of medicinal chemistry 20091201

• Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure.

  European heart journal 20091201

• Dose-dependent prognostic effect of carvedilol in patients with chronic heart failure--special reference to transcardiac [corrected] gradient of norepinephrine.

  Circulation journal : official journal of the Japanese Circulation Society 20091201

• Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.

  Heart failure reviews 20091201

• Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy.

  The American journal of cardiology 20091201

• Re: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20091201

• Gastrointestinal bleeding: Carvedilol-the best beta-blocker for primary prophylaxis?

  Nature reviews. Gastroenterology & hepatology 20091201

• Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats.

  The Journal of pharmacy and pharmacology 20091201

• Postoperative treatment of carvedilol following low dose landiolol has preventive effect for atrial fibrillation after coronary artery bypass grafting.

  The Thoracic and cardiovascular surgeon 20091201

• Effect of carvedilol on adrenaline-induced changes in serum electrolytes in rat.

  Bangladesh Medical Research Council bulletin 20091201

• Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer.

  The EMBO journal 20091104

• Effect of carvedilol on behavioral, mitochondrial dysfunction, and oxidative damage against D-galactose induced senescence in mice.

  Naunyn-Schmiedeberg's archives of pharmacology 20091101

• Interaction of beta-blockers with the renal uptake transporter OCT2.

  Diabetes, obesity & metabolism 20091101

• What is treatment success in cardiac resynchronization therapy?

  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20091101

• Endothelial dysfunction as a target for prevention of cardiovascular disease.

  Diabetes care 20091101

• Development and validation of an HPLC method for the simultaneous analysis of 23 selected drugs belonging to different therapeutic groups in human urine samples.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20091101

• Cardiac innervation and sudden cardiac death.

  Current cardiology reviews 20091101

• Outcome of heart failure with preserved ejection fraction: a multicentre spanish registry.

  Current cardiology reviews 20091101

• Pharmacological effects of carvedilol on T-type calcium current in murine HL-1 cells.

  European journal of pharmacology 20091025

• Nebivolol: the somewhat-different beta-adrenergic receptor blocker.

  Journal of the American College of Cardiology 20091013

• Myocardial autophagy variation during acute myocardial infarction in rats: the effects of carvedilol.

  Chinese medical journal 20091005

• Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation.

  Cardiovascular research 20091001

• Transdermal delivery of carvedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract-chitosan mixture.

  Drug development and industrial pharmacy 20091001

• Found in translation: metoprolol improves survival more than carvedilol in a mouse model of inherited dilated cardiomyopathy.

  Cardiovascular research 20091001

• Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy.

  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20091001

• 4-Hydroxy-2-nonenal induces calcium overload via the generation of reactive oxygen species in isolated rat cardiac myocytes.

  Journal of cardiac failure 20091001

• Respiratory effects of beta-blocker therapy in heart failure.

  Cardiovascular drugs and therapy 20091001

• Beta-blocker treatment of stable heart failure in primary care.

  Revista espanola de cardiologia 20091001

• Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20091001

• Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.

  Acta cardiologica 20091001

• Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090901

• Effects of carvedilol on mortality and inflammatory responses to severe hemorrhagic shock in rats.

  Shock (Augusta, Ga.) 20090901

• A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.

  Diabetes care 20090901

• Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.

  Hepatology (Baltimore, Md.) 20090901

• Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.

  European journal of heart failure 20090901

• Beta-blockers for hypertension: are they going out of style?

  Cleveland Clinic journal of medicine 20090901

• The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study.

  Circulation. Heart failure 20090901

• Prognosis and natural history of drug-related bradycardia.

  Korean circulation journal 20090901

• Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.

  Journal of physiology and biochemistry 20090901

• Assessing the matrix effects of hemolyzed samples in bioanalysis.

  Bioanalysis 20090901

• Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.

  Journal of microencapsulation 20090801

• Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

  Pharmacology & therapeutics 20090801

• Suppression of collagen production in norepinephrine stimulated cardiac fibroblasts culture: differential effect of alpha and beta-adrenoreceptor antagonism.

  Cardiovascular drugs and therapy 20090801

• Clinical trials update from the European Society of Cardiology Heart Failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF.

  European journal of heart failure 20090801

• Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.

  Pharmacotherapy 20090801

• Hydrotherapy in heart failure: a case report.

  Clinics (Sao Paulo, Brazil) 20090801

• The effects of trimetazidine on heart rate variability in patients with heart failure.

  Arquivos brasileiros de cardiologia 20090801

• Carvedilol dihydrogen phosphate hemihydrate: a powder study.

  Acta crystallographica. Section E, Structure reports online 20090801

• Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model.

  Circulation 20090728

• Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH.

  Journal of colloid and interface science 20090715

• Beta blockers for the prevention of atrial fibrillation after coronary artery bypass surgery: carvedilol versus metoprolol.

  International journal of cardiology 20090710

• Blockade of adrenoreceptors inhibits the splenic response to stroke.

  Experimental neurology 20090701

• What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?

  Current opinion in cardiology 20090701

• Delirium in a patient with toxic flecainide plasma concentrations: the role of a pharmacokinetic drug interaction with paroxetine.

  The Annals of pharmacotherapy 20090701

• Realities of newer beta-blockers for the management of hypertension.

  Journal of clinical hypertension (Greenwich, Conn.) 20090701

• [Effect of carvedilol and perindopril on Ca(2+) pump activity and Ca(2+)-release channel density in myocardial sarcoplasmic reticulum in rats with chronic heart failure following myocardial infarction].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20090701

• Acute renal failure due to amiodarone-induced hypothyroidism.

  Clinical nephrology 20090701

• [B-type natriuretic peptide (BNP) levels and the effects of carvedilol on BNP levels in juvenile rats with right heart failure].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20090701

• Occupational airborne contact dermatitis to simvastatin, carvedilol, and zolpidem.

  Contact dermatitis 20090701

• Case of the month. Idiopathic dilated cardiomyopathy.

  JAAPA : official journal of the American Academy of Physician Assistants 20090701

• Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats.

  European journal of pharmacology 20090610

• Eligibility criteria for beta-blockade might have to be taken into account.

  Archives of internal medicine 20090608

• Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers.

  Clinical research in cardiology : official journal of the German Cardiac Society 20090601

• Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20090601

• Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.

  The American journal of cardiology 20090601

• Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.

  Journal of cardiac failure 20090601

• Carvedilol ameliorates the decreases in connexin 43 and ventricular fibrillation threshold in rats with myocardial infarction.

  The Tohoku journal of experimental medicine 20090601

• Acute myocardial infarction after Kawasaki disease in an infant: treatment with coronary artery bypass grafting.

  Pediatrics international : official journal of the Japan Pediatric Society 20090601

• Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.

  Acta pharmaceutica (Zagreb, Croatia) 20090601

• Insufficient control of blood pressure and incident diabetes.

  Diabetes care 20090501

• Different inhibitory effects in rat and human carboxylesterases.

  Drug metabolism and disposition: the biological fate of chemicals 20090501

• Atrial fibrillation complicating acute myocardial infarction: how should it be interpreted and how should it be treated and prevented?

  European heart journal 20090501

• Diabetic cardiomyopathy.

  Clinical science (London, England : 1979) 20090501

• Role of carvedilol controlled-release in cardiovascular disease.

  Expert review of cardiovascular therapy 20090501

• Gln(27)-->Glubeta(2)-adrenergic receptor polymorphism in heart failure patients: differential clinical and oxidative response to carvedilol.

  Basic & clinical pharmacology & toxicology 20090501

• An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.

  Journal of cardiovascular pharmacology 20090501

• Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease.

  Heart and vessels 20090501

• Beta-blockers in the treatment of hypertension: are there clinically relevant differences?

  Postgraduate medicine 20090501

• [Influence of different type beta-adrenoblockers on functional state of liver at paracetamol induced toxic hepatitis in experiment].

  Georgian medical news 20090501

• Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure.

  Circulation. Heart failure 20090501

• New perspectives of infections in cardiovascular disease.

  Current cardiology reviews 20090501

• Arrestin times for developing antipsychotics and beta-blockers.

  Science signaling 20090414

• The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial.

  European heart journal 20090401

• Clinical profiles and outcomes for Omani children with dilated cardiomyopathy seen in a regional referral hospital.

  Cardiology in the young 20090401

• Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement.

  Journal of drug targeting 20090401

• A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.

  Journal of cardiac failure 20090401

• Comparison of different pharmacodynamic models for pharmacokinetic-pharmacodynamic (PK-PD) modeling of carvedilol.

  Yao xue xue bao = Acta pharmaceutica Sinica 20090401

• [Carvedilol therapy in pediatric patients with Takayasu's arteritis complicated with congestive heart failure: a case report].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20090401

• Changes in platelet size and spleen volume in response to selective and non-selective beta-adrenoceptor blockade in hypertensive patients.

  Clinical and experimental pharmacology & physiology 20090401

• Myocardial Infarction in a Young Man due to a Hypoplastic Coronary Artery.

  Korean circulation journal 20090401

• LC-MS/MS assay of quinapril and its metabolite quinaprilat for drug bioequivalence evaluation: prospective, concurrential and retrospective method validation.

  Bioanalysis 20090401

• Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management.

  Journal of clinical medicine research 20090401

• [A new possible strategy for prevention and preventive treatment of age-related macular degeneration resting on recent clinical and pathophysiological observations].

  Orvosi hetilap 20090315

• Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.

  Diabetes, obesity & metabolism 20090301

• Effect of carvedilol on seizure induction during electroconvulsive therapy procedure.

  The journal of ECT 20090301

• Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat.

  Pharmacology, biochemistry, and behavior 20090301

• Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study.

  European heart journal 20090301

• Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials.

  European journal of heart failure 20090301

• Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats.

  Acta physiologica (Oxford, England) 20090301

• Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study.

  AAPS PharmSciTech 20090301

• Preparation and evaluation of self-nanoemulsifying tablets of carvedilol.

  AAPS PharmSciTech 20090301

• Involvement of the CYP1A subfamily in stereoselective metabolism of carvedilol in beta-naphthoflavone-treated Caco-2 cells.

  Biological & pharmaceutical bulletin 20090301

• The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats.

  Clinics (Sao Paulo, Brazil) 20090301

• Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20090301

• Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.

  European journal of medicinal chemistry 20090201

• Carvedilol reduces the severity of central sleep apnea in chronic heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20090201

• Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20090201

• Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA.

  European journal of heart failure 20090201

• The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.

  Pacing and clinical electrophysiology : PACE 20090201

• Registry of Hospital das Clínicas of the University of São Paulo Medical School: first official solid organ and tissue transplantation report - 2008.

  Clinics (Sao Paulo, Brazil) 20090201

• Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier.

  Journal of neurology 20090201

• Effects of carvedilol, losartan and trimetazidin on functional parameters of isolated heart of rats at oxidative stress.

  Georgian medical news 20090201

• Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype.

  Acta cardiologica 20090201

• Reaction between drug substances and pharmaceutical excipients: formation of citric acid esters and amides of carvedilol in the solid state.

  Journal of pharmaceutical and biomedical analysis 20090115

• Endocardial transcatheter stimulation of the AV nodal fat pad: stabilization of rapid ventricular rate response during atrial fibrillation in left ventricular failure.

  Journal of cardiovascular electrophysiology 20090101

• The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.

  Cardiology 20090101

• Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20090101

• Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.

  Diabetes 20090101

• Is urethane-chloralose anaesthesia appropriate for pharmacokinetic-pharmacodynamic assessment? Studies with carvedilol.

  Journal of pharmacological and toxicological methods 20090101

• Successful catheter ablation to accessory atrioventricular pathway as cardiac resynchronization therapy in a patient with dilated cardiomyopathy.

  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20090101

• Metoprolol succinate therapy associated with erythema multiforme.

  Cardiology journal 20090101

• Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study.

  Drug safety 20090101

• Serum 25-hydroxyvitamin D is not related to cardiac natriuretic peptide in nulliparous and lactating women.

  BMC endocrine disorders 20090101

• Ventricular noncompaction in a female patient with nephropathic cystinosis: a case report.

  Journal of medical case reports 20090101

• Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?

  Postgraduate medicine 20090101

• Metabolic consequences and vulnerability to diet-induced obesity in male mice under chronic social stress.

  PloS one 20090101

• Hypercalcemia-leukocytosis syndrome in a patient with cavitating squamous cell carcinoma of the lung.

  Cases journal 20090101

• Single ventricle, bicuspid aorta and interatrial wall aneurysm as a rare complex adult congenital heart disease: a case report.

  Cases journal 20090101

• Carvedilol produces sustained long-term benefits: follow-up at 12 years.

  Congestive heart failure (Greenwich, Conn.) 20090101

• N-terminal pro-brain natriuretic peptide levels predict left ventricular systolic function in patients with chronic kidney disease.

  Journal of Korean medical science 20090101

• [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].

  Kardiologiia 20090101

• Spontaneous left main coronary artery dissection complicated by pseudoaneurysm formation in pregnancy: role of CT coronary angiography.

  Journal of cardiothoracic surgery 20090101

• N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.

  BMC pharmacology 20090101

• Carvedilol therapy in pediatric patients with dilated cardiomyopathy.

  The Turkish journal of pediatrics 20090101

• Candesartan cilexetil in the treatment of chronic heart failure.

  Vascular health and risk management 20090101

• Heart rate dynamics in heart transplantation patients during a treadmill cardiopulmonary exercise test: a pilot study.

  Cardiology journal 20090101

• The A's, G's, C's, and T's of health disparities.

  BMC medical genomics 20090101

• Arterial stiffness, hypertension, and rational use of nebivolol.

  Vascular health and risk management 20090101

• [Does any evidence exist to treat heart failure based on race or ethnicity?].

  Revista da Associacao Medica Brasileira (1992) 20090101

• Structured chronic primary care and health-related quality of life in chronic heart failure.

  BMC health services research 20090101

• Spontaneous coronary artery dissection: One more extrarenal manifestation of autosomal dominant polycystic kidney disease?

  Journal of nephrology 20090101

• Benefit of warm water immersion on biventricular function in patients with chronic heart failure.

  Cardiovascular ultrasound 20090101

• An analytical procedure for the determination of different therapeutic drugs in surface waters.

  Water science and technology : a journal of the International Association on Water Pollution Research 20090101

• Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.

  PloS one 20090101

• Primary care-based multifaceted, interdisciplinary medical educational intervention for patients with systolic heart failure: lessons learned from a cluster randomised controlled trial.

  Trials 20090101

• The effect of beta-blockers on the adaptive immune system in chronic heart failure.

  Cardiovascular therapeutics 20090101

• A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.

  Therapeutics and clinical risk management 20090101

• Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

  Cell communication and signaling : CCS 20090101

• Cardiac sarcoidosis culminating in severe biventricular failure.

  Case reports in medicine 20090101

• Survival among patients with left ventricular systolic dysfunction treated with atenolol.

  Congestive heart failure (Greenwich, Conn.) 20090101

• Idiopathic left ventricular aneurysm causing ventricular tachycardia with 1:1 ventriculoatrial conduction and intermittent wenckebach block.

  The open cardiovascular medicine journal 20090101

• A long-term follow-up of a girl with dilated cardiomyopathy after mitral valve replacement and septal anterior ventricular exclusion.

  Journal of cardiothoracic surgery 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Deterministic chaos and fractal complexity in the dynamics of cardiovascular behavior: perspectives on a new frontier.

  The open cardiovascular medicine journal 20090101

• Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

  Clinical pharmacokinetics 20090101

• Patient risk factors and adverse drug interactions in the treatment of acute gouty arthritis in the elderly: a case report.

  Cases journal 20090101

• Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling.

  PloS one 20090101

• Management of end-stage heart failure: a perspective on the Arab Gulf states.

  Annals of Saudi medicine 20090101

• Bench-to-bedside review: Beta-adrenergic modulation in sepsis.

  Critical care (London, England) 20090101

• Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure.

  BMC cardiovascular disorders 20090101

• A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency.

  Case reports in medicine 20090101

• Automatic implantable cardioverter defibrillator pocket infection due to Providencia rettgeri: a case report.

  Cases journal 20090101

• Distinctive effects of carvedilol in the non-infarct zone: remodelling of the ligated rat heart linked to oxidative stress.

  The Journal of international medical research 20090101

• Sudden elevation of liver enzymes in a 64-year-old patient: a case report.

  Cases journal 20090101

• Treatment of dilated cardiomyopathy with carvedilol in children.

  The Turkish journal of pediatrics 20090101

• Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles.

  PloS one 20090101

• [Provision of complex cardioprotection with the help of carvedilol in 1-2 degree arterial hypertension combined with metabolic syndrome].

  Kardiologiia 20090101

• Saw-tooth cardiomyopathy.

  Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20090101

• [Drug therapy of diastolic cardiac insufficiency in patients with type 2 diabetes and concomitant essential arterial hypertension].

  Klinicheskaia meditsina 20090101

• Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors.

  PloS one 20090101

• Familial (ATTR) amyloidosis misdiagnosed as the primary (AL) variant: a case report.

  Cases journal 20090101

• Acute pulmonary edema due to stress cardiomyopathy in a patient with aortic stenosis: a case report.

  Cases journal 20090101

• The right ventricle: biologic insights and response to disease.

  Current cardiology reviews 20090101

• Carvedilol-loaded mucoadhesive buccal tablets: influence of various mucoadhesive polymers on drug release behavior.

  PDA journal of pharmaceutical science and technology 20090101

• Long-Term Alendronate Use Not without Consequences?

  International journal of rheumatology 20090101

• Comparative effects of carvedilol and lercanidipine on ultrafiltration and solute transport in CAPD patients.

  Renal failure 20090101

• Is there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion.

  Annals of pediatric cardiology 20090101

• Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial.

  Journal of the American Society of Hypertension : JASH 20090101

• Myocarditis presenting as junctional ectopic tachycardia.

  Indian heart journal 20090101

• Improvement of Young and Elderly Patient's Knowledge of Heart Failure After an Educational Session.

  Clinical medicine. Cardiology 20090101

• Assessment of Myocardial Scar; Comparison Between F-FDG PET, CMR and Tc-Sestamibi.

  Clinical medicine. Cardiology 20090101

• Oxidative stress as a mediator of cardiovascular disease.

  Oxidative medicine and cellular longevity 20090101

• Clinical approach in treatment of resistant hypertension.

  Integrated blood pressure control 20090101

• Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.

  Archives of internal medicine 20081208

• Comparative effectiveness of beta-blockers in elderly patients with heart failure.

  Archives of internal medicine 20081208

• The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction.

  Angiology 20081201

• Attenuation of cardioprotective effect by postconditioning in coronary stenosed rat heart and its restoration by carvedilol.

  Circulation journal : official journal of the Japanese Circulation Society 20081201

• Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).

  The American journal of cardiology 20081201

• The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker.

  Journal of cardiovascular pharmacology 20081201

• Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.

  American journal of veterinary research 20081201

• The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy.

  Clinics (Sao Paulo, Brazil) 20081201

• Trends and inequities in beta-blocker prescribing for heart failure.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20081201

• Tadalafil in the treatment of erectile dysfunction.

  Therapeutics and clinical risk management 20081201

• Long-acting nifedipine in the management of the hypertensive patient.

  Vascular health and risk management 20081201

• Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.

  Vascular health and risk management 20081201

• Improvement of cardiac sympathetic nerve function in sarcoidosis.

  Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 20081201

• Multiple toxic effects of low-dose methotrexate in a patient treated for psoriasis.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081115

• American College of Endocrinology Pre-Diabetes Consensus Conference: part two.

  Diabetes care 20081101

• Anthracycline-induced cardiomyopathy.

  Postgraduate medicine 20081101

• Drug-induced sexual problems.

  Southern medical journal 20081101

• Peyronie disease in association with carvedilol: a case report.

  Southern medical journal 20081101

• Natriuretic Peptide testing in primary care.

  Current cardiology reviews 20081101

• Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.

  Bioorganic & medicinal chemistry letters 20081015

• Beta-blockade as first-line therapy in the elderly heart failure patient--the proper approach or asking for trouble?

  Cardiovascular drugs and therapy 20081001

• Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils.

  Neuro endocrinology letters 20081001

• Effect of carvedilol on the production of reactive oxygen species by HL-60 cells.

  Neuro endocrinology letters 20081001

• Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin).

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20081001

• Neuropharmacology.

  Indian journal of pharmacology 20081001

• Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation.

  Proceedings of the National Academy of Sciences of the United States of America 20080923

• HPLC analysis, isolation and identification of a new degradation product in carvedilol tablets.

  Journal of pharmaceutical and biomedical analysis 20080910

• Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.

  Clinical research in cardiology : official journal of the German Cardiac Society 20080901

• Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamster.

  Journal of cardiovascular pharmacology and therapeutics 20080901

• Influence of microalbuminuria in achieving blood pressure goals.

  Current opinion in nephrology and hypertension 20080901

• Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation.

  Drug delivery 20080901

• Severe left ventricular dysfunction in infants with ventricular preexcitation.

  Heart rhythm 20080901

• Efficacy of carvedilol for ischemia/reperfusion-induced oxidative renal injury in rats.

  Transplantation proceedings 20080901

• Pharmacological approaches to improve endothelial repair mechanisms.

  Expert review of cardiovascular therapy 20080901

• Effect of exercise training and carvedilol treatment on cardiac function and structure in mice with sympathetic hyperactivity-induced heart failure.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20080901

• Treatment of patients with cardiogenic shock in the setting of acute myocardial infarction. Case reports.

  Georgian medical news 20080901

• A randomized pilot study of atractylenolide I on gastric cancer cachexia patients.

  Evidence-based complementary and alternative medicine : eCAM 20080901

• Comparison of losartan and carvedilol on attenuating inflammatory and oxidative response and preserving energy transcription factors and left ventricular function in dilated cardiomyopathy rats.

  International heart journal 20080901

• [Preliminary study on the effect of carvedilol on children with primary endocardial fibroelastosis].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20080901

• Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.

  Journal of the American College of Cardiology 20080819

• Heart rate reduction is probably not the main beneficial mechanism by which beta blockade improves outcome in patients with systolic chronic heart failure.

  The American journal of cardiology 20080815

• Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.

  Cardiovascular drugs and therapy 20080801

• ACE-inhibitors, beta-blockers or the combination in heart failure: is it just an A-B-C ? : editorial to: effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.

  Cardiovascular drugs and therapy 20080801

• Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits.

  Nitric oxide : biology and chemistry 20080801

• Role of drug therapy for sustained ventricular tachyarrhythmias.

  Cardiology clinics 20080801

• Pharmacologic considerations in the positioning of beta-blockers in antihypertensive therapy.

  Current hypertension reports 20080801

• Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure.

  Journal of molecular and cellular cardiology 20080801

• Letter by Banach et al regarding article, 'postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting'.

  Circulation journal : official journal of the Japanese Circulation Society 20080801

• Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system?

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20080801

• Rapid carvedilol up-titration in hospitalized patients with systolic heart failure.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20080801

• Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction.

  American heart journal 20080801

• Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients.

  Clinics (Sao Paulo, Brazil) 20080801

• Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers.

  Vascular health and risk management 20080801

• Morphological and molecular changes of the myocardium after left ventricular mechanical support.

  Current cardiology reviews 20080801

• The Relationship Between HIV Infection and Cardiovascular Disease.

  Current cardiology reviews 20080801

• Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.

  European journal of pharmacology 20080728

• Pharmacological washout for the correct evaluation of the head-up tilt testing.

  International journal of cardiology 20080704

• Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.

  European heart journal 20080701

• Induction of oscillatory ventilation pattern using dynamic modulation of heart rate through a pacemaker.

  American journal of physiology. Regulatory, integrative and comparative physiology 20080701

• Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization.

  Biopharmaceutics & drug disposition 20080701

• Depression worsens outcomes in elderly patients with heart failure: an analysis of 48,117 patients in a community setting.

  European journal of heart failure 20080701

• Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080701

• Differential long-term effects of carvedilol on proinflammatory and antiinflammatory cytokines, asymmetric dimethylarginine, and left ventricular function in patients with heart failure.

  Journal of cardiovascular pharmacology 20080701

• Carvedilol overdose with quantitative confirmation.

  Basic & clinical pharmacology & toxicology 20080701

• Design and in vivo evaluation of carvedilol buccal mucoadhesive patches.

  Pakistan journal of pharmaceutical sciences 20080701

• Study on restrain stress induced changes in serum lipid profile and haemoconcentration and effect of sympathetic blocker on it.

  Mymensingh medical journal : MMJ 20080701

• Flow injection spectrofluorimetric determination of carvedilol mediated by micelles.

  Talanta 20080630

• Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy.

  Cardiovascular drugs and therapy 20080601

• Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure.

  Journal of the American Geriatrics Society 20080601

• Betablockers: is the reduction of sudden death related to pure electrophysiologic effects?

  Cardiovascular drugs and therapy 20080601

• Carvedilol: solubilization and cyclodextrin complexation: a technical note.

  AAPS PharmSciTech 20080601

• The search for medications to treat stimulant dependence.

  Addiction science & clinical practice 20080601

• Changing beta-blockers in heart failure: when is a class not a class?

  The British journal of general practice : the journal of the Royal College of General Practitioners 20080601

• Identification and guided treatment of ventricular dysfunction in general practice using blood B-type natriuretic peptide.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20080601

• Stereoselective oxidation and glucuronidation of carvedilol in human liver and intestinal microsomes.

  Biological & pharmaceutical bulletin 20080601

• Pharmacokinetic/pharmacodynamic modeling of the cardiovascular effects of beta blockers in humans.

  Archives of pharmacal research 20080601

• The influence of carvedilol on atrial connexin 40 after myocardial infarction.

  Acta cardiologica 20080601

• The effect of carvedilol therapy on coronary flow reserve in patients with idiopathic dilated cardiomyopathy.

  Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20080601

• Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.

  Neurology 20080527

• Transient syncope, left bundle branch block and first degree atrioventricular block after 'pill-in-the-pocket' administration.

  International journal of cardiology 20080507

• Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery.

  International journal of cardiology 20080507

• Protective effects of ebselen, a seleno-organic antioxidant on neurodegeneration induced by hypoxia and reperfusion in stroke-prone spontaneously hypertensive rat.

  Neuroscience 20080502

• Beta1-adrenoceptors in rat anterior pituitary may be constitutively active. Inverse agonism of CGP 20712A on basal 3',5'-cyclic adenosine 5'-monophosphate levels.

  Endocrinology 20080501

• Crystallizing thinking about the beta2-adrenergic receptor.

  Molecular pharmacology 20080501

• Therapeutic strategies to slow chronic kidney disease progression.

  Pediatric nephrology (Berlin, Germany) 20080501

• Pharmacokinetics of R- and S-carvedilol in routinely treated Japanese patients with heart failure.

  Biological & pharmaceutical bulletin 20080501

• Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease.

  Reviews on recent clinical trials 20080501

• Inpatient initiation of beta-blockade plus nurse management in vulnerable heart failure patients: a randomized study.

  Journal of cardiac failure 20080501

• Retraction of 'Xue SR. Xue Y. Xue R. Carvedilol restore cardiac calcium release channel structure and function in heart failure. Int. J Cardiology. 116(2):231-5, 2007' containing plagiarised material.

  International journal of cardiology 20080425

• Role of chemical structure in stereoselective recognition of beta-blockers by cyclodextrins in capillary zone electrophoresis.

  Journal of biochemical and biophysical methods 20080424

• Cardioprotective interventions for cancer patients receiving anthracyclines.

  The Cochrane database of systematic reviews 20080416

• Recovery of heart function in children with acute severe heart failure.

  Transplantation 20080415

• Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure.

  International journal of cardiology 20080410

• Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.

  British journal of clinical pharmacology 20080401

• Takotsubo syndrome after cardiac surgery.

  The Annals of thoracic surgery 20080401

• Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting.

  Circulation journal : official journal of the Japanese Circulation Society 20080401

• Impact of carvedilol on the serum lipid profile.

  The Annals of pharmacotherapy 20080401

• Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.

  Clinical therapeutics 20080401

• No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy.

  Archives of cardiovascular diseases 20080401

• Case 36-2007: a woman with rash, fever, and hypotension.

  The New England journal of medicine 20080327

• The significance of variation in extrusion speeds and temperatures on a PEO/PCL blend based matrix for oral drug delivery.

  International journal of pharmaceutics 20080303

• Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.

  Pediatric cardiology 20080301

• Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.

  European journal of nuclear medicine and molecular imaging 20080301

• Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.

  Journal of cardiovascular pharmacology and therapeutics 20080301

• Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications.

  American heart journal 20080301

• Comparison of the effects of carvedilol and metoprolol on exercise ventilatory efficiency in patients with congestive heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20080301

• Carvedilol is more effective than metoprolol in preventing atrial fibrillation (AF) after coronary artery bypass.

  Heart rhythm 20080301

• Beta-blockers in the treatment of hypertension: new data, new directions.

  Journal of clinical hypertension (Greenwich, Conn.) 20080301

• Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.

  International journal of clinical pharmacology and therapeutics 20080301

• Persistent left bundle branch block in a patient with dilated cardiomyopathy that improved with low dose carvedilol therapy.

  International heart journal 20080301

• Carvedilol in the treatment of elderly patients with chronic heart failure.

  Clinical interventions in aging 20080301

• Carvedilol reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel.

  Perfusion 20080301

• The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.

  European journal of haematology 20080201

• Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart.

  European journal of cancer (Oxford, England : 1990) 20080201

• Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.

  European journal of clinical pharmacology 20080201

• Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.

  Kardiologia polska 20080201

• Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells.

  Hypertension research : official journal of the Japanese Society of Hypertension 20080201

• Chronic heart failure in Japan: implications of the CHART studies.

  Vascular health and risk management 20080201

• Heart failure in sub-Saharan Africa: a literature review with emphasis on individuals with diabetes.

  Vascular health and risk management 20080201

• Carvedilol in hypertension treatment.

  Vascular health and risk management 20080201

• Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.

  Clinical research in cardiology : official journal of the German Cardiac Society 20080101

• A case of plastic bronchitis presenting 9 years after Fontan.

  Pediatric cardiology 20080101

• Carvedilol modifies antioxidant status of patients with stable angina.

  Cellular & molecular biology letters 20080101

• Cardiovascular disease in dialysis patients: do some antihypertensive drugs have specific antioxidant effects or is it just blood pressure reduction? Does antioxidant treatment reduce the risk for cardiovascular disease?

  Current opinion in nephrology and hypertension 20080101

• Carvedilol of no clear benefit for systolic heart failure in children.

  The Journal of pediatrics 20080101

• The impact of carvedilol on the defibrillation threshold.

  Heart & lung : the journal of critical care 20080101

• Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.

  Journal of cardiovascular pharmacology 20080101

• Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer.

  Current oncology (Toronto, Ont.) 20080101

• To add amiodarone or not: that is the question.

  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20080101

• Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with carvedilol therapy alone.

  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20080101

• Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues.

  Drugs & aging 20080101

• Prostacyclin among prostanoids.

  Pharmacological reports : PR 20080101

• Pharma industry in India.

  Drug news & perspectives 20080101

• Pediatric heart failure therapy with beta-adrenoceptor antagonists.

  Paediatric drugs 20080101

• The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.

  BMC medical research methodology 20080101

• Beta-blockers and coronary flow reserve: the importance of a vasodilatory action.

  Drugs 20080101

• N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol.

  Angiology 20080101

• Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug.

  PDA journal of pharmaceutical science and technology 20080101

• Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.

  Journal of diabetes and its complications 20080101

• [Effect of antihypertensive agents from various pharmacological groups on blood pressure reaction during stress-testing. Part I. Comparative characteristics of medications, exerting effect of sympathoadrenal block].

  Kardiologiia 20080101

• Beta-blocker and angiotensin-converting enzyme inhibitor may limit certain cardiac adverse effects of clozapine.

  General hospital psychiatry 20080101

• [Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation].

  Kardiologiia 20080101

• NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.

  PloS one 20080101

• [Evaluation of the effect of carvedilol in children with dilated cardiomyopathy].

  Archivos de cardiologia de Mexico 20080101

• A review of evidence-based beta-blockers in special populations with heart failure.

  Reviews in cardiovascular medicine 20080101

• Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension.

  Reviews in cardiovascular medicine 20080101

• Re: Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with carvedilol therapy alone.

  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20080101

• Drug therapy considerations in arrhythmias in children.

  Indian pacing and electrophysiology journal 20080101

• Controlled-release carvedilol.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101

• Restrictive left ventricular filling pattern and its effect on the clinical course of systolic heart failure in patients receiving carvedilol.

  Cardiology journal 20080101

• Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers.

  Pharmaceutical development and technology 20080101

• Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.

  Cardiovascular therapeutics 20080101

• [First results of open randomized clinical study of Acridilol in combination therapy of patients with arterial hypertension and obesity or type 2 diabetes (Mellitus-Open Multicenter Clinical Study ACCORD)].

  Kardiologiia 20080101

• [Heart rate variability dynamics during treatment of arterial hypertension].

  Kardiologiia 20080101

• Prolonged but successful weaning from left ventricular assist device after cardiac decompensation due to late-recognized coarctation of the aorta in a toddler.

  ASAIO journal (American Society for Artificial Internal Organs : 1992) 20080101

• Myocardial protection in sepsis.

  Critical care (London, England) 20080101

• Focal cerebral ischemia in the TNFalpha-transgenic rat.

  Journal of neuroinflammation 20080101

• Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.

  BMC medical genetics 20080101

• The ability of heart failure specialists to accurately predict NT-proBNP levels based on clinical assessment and a previous NT-proBNP measurement.

  The open cardiovascular medicine journal 20080101

• Switching to evidence-based once-daily beta-blockers for improved adherence to medication across the continuum of post-myocardial infarction left ventricular dysfunction and heart failure.

  Congestive heart failure (Greenwich, Conn.) 20080101

• Left atrioventricular remodeling in the assessment of the left ventricle diastolic function in patients with heart failure: a review of the currently studied echocardiographic variables.

  Cardiovascular ultrasound 20080101

• Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

  Journal of the cardiometabolic syndrome 20080101

• Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report.

  Cases journal 20080101

• Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats.

  Pharmacological reports : PR 20080101

• Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway.

  Mediators of inflammation 20080101

• Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report.

  Medscape journal of medicine 20080101

• [Effects of carvedilol and metoprolol on cardiac fibrosis in rats with experimental myocardial infarction].

  Zhonghua xin xue guan bing za zhi 20080101

• Letters to the editor: comments on the BEAUTIfUL study.

  Cardiovascular journal of Africa 20080101

• Echocardiography in the diagnosis left ventricular noncompaction.

  Cardiovascular ultrasound 20080101

• In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.

  PDA journal of pharmaceutical science and technology 20080101

• [Are mortality or morbidity risks appropriate endpoints for interventional studies in primary or secondary prevention with shared decision-making?].

  Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 20080101

• Congestive heart failure and renal complications.

  Boletin de la Asociacion Medica de Puerto Rico 20080101

• Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.

  PDA journal of pharmaceutical science and technology 20080101

• Effect of hydroxylpropyl-beta-cyclodextrin on Solubility of Carvedilol.

  Indian journal of pharmaceutical sciences 20080101

• The Fontan pathway: What's down the road?

  Annals of pediatric cardiology 20080101

• Hemipelvic osteomyelitis in a hemodialysis patient associated with methicillin-resistant Staphylococcus aureus bacteremia.

  International journal of nephrology and renovascular disease 20080101

• Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.

  Cardiovascular drugs and therapy 20071201

• Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome?

  The Annals of pharmacotherapy 20071201

• Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.

  Free radical biology & medicine 20071201

• Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction.

  Critical care nurse 20071201

• Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.

  Kardiologia polska 20071201

• A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.

  Vascular health and risk management 20071201

• [Efficiency of taliton in treatment of ischemic cardiomyopathy].

  Georgian medical news 20071201

• Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.

  International journal of chronic obstructive pulmonary disease 20071201

• Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience.

  International journal of cardiology 20071115

• Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.

  European journal of heart failure 20071101

• Mechanisms of carvedilol-induced [Ca2+] i rises and death in human hepatoma cells.

  Naunyn-Schmiedeberg's archives of pharmacology 20071101

• Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: a meta-analysis of randomised controlled trials.

  European journal of heart failure 20071101

• [Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension].

  Deutsche medizinische Wochenschrift (1946) 20071101

• Ethanol does not alter the pharmacokinetic profile of the controlled-release formulation of carvedilol.

  Journal of clinical pharmacology 20071101

• Stereoselective metabolism of racemic carvedilol by UGT1A1 and UGT2B7, and effects of mutation of these enzymes on glucuronidation activity.

  Biological & pharmaceutical bulletin 20071101

• Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.

  Journal of clinical hypertension (Greenwich, Conn.) 20071101

• Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?

  Cardiology clinics 20071101

• Should beta-blockers still be used as initial antihypertensive agents in uncomplicated hypertension?

  Annals of the Academy of Medicine, Singapore 20071101

• Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.

  Pharmacogenetics and genomics 20071101

• Cardioprotective effects of mast cell modulators in ischemia-reperfusion-induced injury in rats.

  Methods and findings in experimental and clinical pharmacology 20071101

• Peripartum cardiomyopathy: review of the literature.

  Yonsei medical journal 20071031

• Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm: evaluation of possible causes of aneurysm formation.

  Yonsei medical journal 20071031

• A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.

  Proceedings of the National Academy of Sciences of the United States of America 20071016

• Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.

  The international journal of cardiovascular imaging 20071001

• Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.

  AAPS PharmSciTech 20071001

• Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071001

• Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.

  Clinical and experimental pharmacology & physiology 20071001

• Simultaneous enantioseparation and sensitivity enhancement of basic drugs using large-volume sample stacking.

  Electrophoresis 20071001

• Different ventricular remodelling and autonomic modulation after long-term beta-blocker treatment in hypertensive, ischaemic and idiopathic dilated cardiomyopathy.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20071001

• Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN).

  American heart journal 20071001

• Carvedilol was more effective than metoprolol for preventing cardiovascular events in heart failure.

  Evidence-based medicine 20071001

• Stereoselective glucuronidation of carvedilol by Chinese liver microsomes.

  Journal of Zhejiang University. Science. B 20071001

• Carvedilol increases ciclosporin bioavailability by inhibiting P-glycoprotein-mediated transport.

  The Journal of pharmacy and pharmacology 20071001

• Stereoselective metabolism of carvedilol by the beta-naphthoflavone-inducible enzyme in human intestinal epithelial Caco-2 cells.

  Biological & pharmaceutical bulletin 20071001

• UGT2B7*3 did not affect the pharmacokinetics of R- and S-carvedilol in healthy Japanese.

  Drug metabolism and pharmacokinetics 20071001

• [Despite medication, overdrive pacing is required to stabilize the electrical storm associated with acute coronary syndrome: a case report].

  Journal of cardiology 20071001

• [Treating heart failure with carvedilol in private practice (initiating treatment and follow-up at one year. The KEOPS study].

  Archives des maladies du coeur et des vaisseaux 20071001

• A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus.

  Vascular health and risk management 20071001

• Nebivolol in the treatment of chronic heart failure.

  Vascular health and risk management 20071001

• Beta-adrenergic receptor antagonists and chronic heart failure in children.

  Therapeutics and clinical risk management 20071001

• Carvedilol for children and adolescents with heart failure: a randomized controlled trial.

  JAMA 20070912

• Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET.

  European journal of heart failure 20070901

• Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20070901

• The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.

  American heart journal 20070901

• Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol.

  Heart rhythm 20070901

• Does NT-proBNP remain a sensitive biomarker for chronic heart failure after administration of a beta-blocker?

  Clinical cardiology 20070901

• Should beta-blockers be used to control hypertension in people with chronic kidney disease?

  Seminars in nephrology 20070901

• Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol.

  Drug development and industrial pharmacy 20070901

• Cardiovascular disease in patients with chronic kidney disease. A clinical review.

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20070901

• Resting heart rate in cardiovascular disease.

  Journal of the American College of Cardiology 20070828

• Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.

  The American journal of cardiology 20070815

• Irradiation of rat brain reduces P-glycoprotein expression and function.

  British journal of cancer 20070806

• Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).

  Heart (British Cardiac Society) 20070801

• Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?

  European journal of heart failure 20070801

• Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates.

  Trends in pharmacological sciences 20070801

• Low-dose carvedilol reduces transmural heterogeneity of ventricular repolarization in congestive heart failure.

  Acta pharmacologica Sinica 20070801

• Carvedilol increases copper-zinc superoxide dismutase activity in patients with acute myocardial infarction.

  Basic & clinical pharmacology & toxicology 20070801

• Cutaneous vasculitis induced by carvedilol.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20070801

• The vasodilatory beta-blockers.

  Current hypertension reports 20070801

• Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.

  European journal of heart failure 20070801

• Predictors of therapeutic response to beta-blockers in patients with heart failure in Taiwan.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20070801

• Bisoprolol in the treatment of chronic heart failure.

  Vascular health and risk management 20070801

• Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results.

  Therapeutics and clinical risk management 20070801

• The Holy grail, genes and Number Needed to Treat.

  The western journal of emergency medicine 20070801

• [The optimal treatment of chronic heart failure with beta-blockers may be dependent upon the genetic background of the patient].

  Nederlands tijdschrift voor geneeskunde 20070721

• Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats.

  European journal of pharmacology 20070719

• Transient ischemic attack and electrocardiographic abnormalities revealing left ventricular noncompaction.

  International journal of cardiology 20070710

• Images in cardiovascular medicine. Mitochondrial cardiomyopathy evaluated with cardiac magnetic resonance.

  Circulation 20070710

• Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.

  Heart (British Cardiac Society) 20070701

• Chronic treatment with carvedilol improves Ca(2+)-dependent ATP consumption in triton X-skinned fiber preparations of human myocardium.

  The Journal of pharmacology and experimental therapeutics 20070701

• Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.

  Diabetic medicine : a journal of the British Diabetic Association 20070701

• Application of liquid chromatography-tandem mass spectrometry method for the analysis of new nonselective beta-adrenergic blocker 1-(1-H-indol-4-yloxy)-3-{[2-(2-methoxy phenoxy)ethylo]amino}propan-2-ol (2F109) in rat plasma.

  Chirality 20070701

• Carvedilol therapy is associated with an improvement in left atrial appendage function in patients with congestive heart failure.

  Echocardiography (Mount Kisco, N.Y.) 20070701

• Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.

  American heart journal 20070701

• Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

  American journal of hypertension 20070701

• Body weight changes with beta-blocker use: results from GEMINI.

  The American journal of medicine 20070701

• New antiarrhythmic treatment of atrial fibrillation.

  Expert review of cardiovascular therapy 20070701

• [Serum autoantibodies against the cardiac beta(1)-adrenergic receptor in patients with chronic heart failure: clinical characteristics and response to carvedilol].

  Zhonghua xin xue guan bing za zhi 20070701

• Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20070628

• Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of beta-blockers: a randomized trial.

  Circulation 20070605

• Single quadrupole mass spectrometry for pre-clinical pharmacokinetic analysis: quantitation of carvedilol in dog plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601

• The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20070601

• Development and evaluation of carvedilol transdermal patches.

  Acta pharmaceutica (Zagreb, Croatia) 20070601

• Development and in vitro evaluation of buccoadhesive carvedilol tablets.

  Acta pharmaceutica (Zagreb, Croatia) 20070601

• [Role of the drug interaction between carvedilol and dobutamine in inducing of severe hypotension in a case with acute coronary syndrome].

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20070601

• Beta-blocker dosing in community-based treatment of heart failure.

  American heart journal 20070601

• Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.

  American heart journal 20070601

• Association of beta-blocker dose with serum procollagen concentrations and cardiac response to spironolactone in patients with heart failure.

  Pharmacotherapy 20070601

• Rational pharmacoeconomics?

  The New Zealand medical journal 20070601

• Does heart failure therapy differ according to patient sex?

  Clinical cardiology 20070601

• The safety of amiodarone in patients with heart failure.

  Journal of cardiac failure 20070601

• Effects of beta-blocker therapy on high sensitivity c-reactive protein, oxidative stress, and cardiac function in patients with congestive heart failure.

  Journal of cardiac failure 20070601

• Pharmacological augmentation of endothelium-derived nitric oxide synthesis.

  Journal of managed care pharmacy : JMCP 20070601

• Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate.

  The AAPS journal 20070601

• Metoprolol succinate extended release/hydrochlorothiazide combination tablets.

  Vascular health and risk management 20070601

• Heart failure and cognitive impairment: challenges and opportunities.

  Clinical interventions in aging 20070601

• Nebivolol: more than a highly selective Beta blocker.

  Recent patents on cardiovascular drug discovery 20070601

• Carvedilol for anthracycline cardiomyopathy prevention.

  Journal of the American College of Cardiology 20070529

• [Beta blockers: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].

  Nihon rinsho. Japanese journal of clinical medicine 20070528

• [Application of beta-blockers for clinical practice].

  Nihon rinsho. Japanese journal of clinical medicine 20070528

• Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection: application in pharmacokinetic studies.

  Journal of pharmaceutical and biomedical analysis 20070509

• Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhythmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry. Method development and robustness testing by experimental design.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• Achiral-chiral LC/LC-FLD coupling for determination of carvedilol in plasma samples for bioequivalence purposes.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• Myofibrillar protein oxidation and contractile dysfunction in hyperthyroid rat diaphragm.

  Journal of applied physiology (Bethesda, Md. : 1985) 20070501

• beta-blocker use and diabetes symptom score: results from the GEMINI study.

  Diabetes, obesity & metabolism 20070501

• Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.

  Pharmacotherapy 20070501

• Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.

  The American journal of cardiology 20070501

• Ask the doctor. Does a low ejection fraction doom me to inactivity?

  Harvard heart letter : from Harvard Medical School 20070501

• Electrophysiological effects of carvedilol on rabbit heart pacemaker cells.

  International heart journal 20070501

• Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.

  Canadian journal of physiology and pharmacology 20070501

• [MUCHA(Multicenter Carvedilol Heart Failure Dose Assessment Trial)].

  Nihon rinsho. Japanese journal of clinical medicine 20070428

• [J-CHF Study].

  Nihon rinsho. Japanese journal of clinical medicine 20070428

• [COMET: metoprolol].

  Nihon rinsho. Japanese journal of clinical medicine 20070428

• [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].

  Nihon rinsho. Japanese journal of clinical medicine 20070428

• Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure.

  Journal of the American College of Cardiology 20070424

• Does beta-blocker treatment influence central sleep apnoea?

  Respiratory medicine 20070401

• Antioxidant activity of carvedilol in cardiovascular disease.

  Journal of hypertension 20070401

• A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.

  American heart journal 20070401

• Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro.

  Translational research : the journal of laboratory and clinical medicine 20070401

• Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.

  European heart journal 20070401

• Carvedilol reduces elevated B-type natriuretic peptide in dialyzed patients without heart failure: cardioprotective effect of the beta-blocker.

  Journal of cardiovascular pharmacology 20070401

• Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.

  Cardiovascular drugs and therapy 20070401

• Heart failure treatment profile at the beta blockers era.

  Arquivos brasileiros de cardiologia 20070401

• Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.

  Vascular health and risk management 20070401

• Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failure.

  Autonomic neuroscience : basic & clinical 20070330

• Carvedilol restore cardiac calcium release channel structure and function in heart failure.

  International journal of cardiology 20070320

• Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.

  Journal of the American College of Cardiology 20070306

• Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070301

• Functional derangement and cardiac innervation in the apical ballooning syndrome: a 123I-meta-iodobenzylguanidine scintigraphic and dobutamine stress echocardiographic study.

  Journal of cardiovascular medicine (Hagerstown, Md.) 20070301

• Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle.

  The American journal of cardiology 20070301

• Evaluation of effects of polymorphism for metabolic enzymes on pharmacokinetics of carvedilol by population pharmacokinetic analysis.

  Biological & pharmaceutical bulletin 20070301

• Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2 -mediated oxidative insult in H9C2 myocardial cells.

  Biochimica et biophysica acta 20070301

• Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.

  Journal of cardiac failure 20070301

• An unusual case presenting with hypertensive crisis.

  Internal and emergency medicine 20070301

• Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex.

  Journal of the American College of Cardiology 20070220

• Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardial infarction and reperfusion.

  International journal of cardiology 20070214

• The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.

  International journal of cardiology 20070207

• Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process.

  International journal of pharmaceutics 20070201

• Carvedilol improves endothelium-dependent vasodilation in patients with dilated cardiomyopathy.

  Heart (British Cardiac Society) 20070201

• Unreliability of the %VO2 reserve versus %heart rate reserve relationship for aerobic effort relative intensity assessment in chronic heart failure patients on or off beta-blocking therapy.

  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20070201

• Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.

  Calcified tissue international 20070201

• The effect of beta-blocker (carvedilol) therapy on N-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure.

  Echocardiography (Mount Kisco, N.Y.) 20070201

• [The effects of various beta-blockers on myocardial gap junction structure in rat with myocardial ischemia-reperfusion injury].

  Zhonghua xin xue guan bing za zhi 20070201

• Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction.

  Canadian journal of physiology and pharmacology 20070201

• Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.

  Vascular health and risk management 20070201

• Studies on formulation development of mouth dissolving tablets of Carvedilol.

  Hindustan antibiotics bulletin 20070201

• Effects of carvedilol on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.

  Life sciences 20070123

• Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma.

  Journal of pharmaceutical and biomedical analysis 20070117

• A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle.

  International journal of cardiology 20070108

• Beta blocker specificity: a building block toward personalized medicine.

  The Journal of clinical investigation 20070102

• Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol.

  The Journal of clinical investigation 20070102

• Carvedilol improved diabetic rat cardiac function depending on antioxidant ability.

  Diabetes research and clinical practice 20070101

• Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation.

  Journal of molecular and cellular cardiology 20070101

• In vitro effect of carvedilol on professional phagocytes.

  Pharmacology 20070101

• Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

  American heart journal 20070101

• Carvedilol: use in chronic heart failure.

  Expert review of cardiovascular therapy 20070101

• Polymer membrane electrodes for sensitive potentiometric determination of beta-blockers.

  Drug development and industrial pharmacy 20070101

• Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure.

  Chest 20070101

• Renal allograft protection with angiotensin II type 1 receptor antagonists.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070101

• Modification of cardiovascular risk in hemodialysis patients: an evidence-based review.

  Hemodialysis international. International Symposium on Home Hemodialysis 20070101

• The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients.

  Journal of cardiovascular pharmacology 20070101

• Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.

  Congestive heart failure (Greenwich, Conn.) 20070101

• Heart and renal failure in renovascular hypertension caused by giant cell arteritis--case report.

  Clinical nephrology 20070101

• Development of mucoadhesive patches for buccal administration of carvedilol.

  Current drug delivery 20070101

• Spectrophotometric determination of carvedilol in pharmaceutical formulations through charge-transfer and ion-pair complexation reactions.

  Die Pharmazie 20070101

• Beta blockers for congestive heart failure.

  Acta medica Indonesiana 20070101

• Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria.

  Renal failure 20070101

• Decline of plasma brain natriuretic peptide level after carvedilol therapy to treat dilated cardiomyopathy presenting with mechanical alternans.

  International heart journal 20070101

• [Study of carvedilol on plaque stability in carotid atherosclerotic rabbits transfected by p53 gene].

  Zhonghua xin xue guan bing za zhi 20070101

• Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.

  Texas Heart Institute journal 20070101

• Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol.

  European journal of heart failure 20070101

• Beta-blockers in 2007?

  Cardiovascular journal of Africa 20070101

• Metabolite identification by data-dependent accurate mass spectrometric analysis at resolving power of 60,000 in external calibration mode using an LTQ/Orbitrap.

  Rapid communications in mass spectrometry : RCM 20070101

• The influence of beta-blockers on delayed memory function in people with cognitive impairment.

  American journal of Alzheimer's disease and other dementias 20070101

• Chronic administration of carvedilol improves cardiac function in 6-month-old Syrian cardiomyopathic hamsters.

  Pharmacology 20070101

• Carvedilol prevents and reverses hypertrophy-induced cardiac dysfunction.

  Pharmacology 20070101

• [Are all beta-adrenoblockers equally effective? Place of carvedilol in the treatment of cardiovascular diseases].

  Terapevticheskii arkhiv 20070101

• Parvovirus B19 infection associated with dilated cardiomyopathy in patients with previous anthracycline exposure.

  Pediatric cardiology 20070101

• Evaluation of B-type natriuretic peptide for validation of a heart failure register in primary care.

  BMC cardiovascular disorders 20070101

• [The effects of beta-adrenoblocker therapy on the physical working capacity of patients with chronic heart failure of various origin].

  Klinicheskaia meditsina 20070101

• Metabolic syndrome: treatment of hypertensive patients.

  American journal of therapeutics 20070101

• World Antimalarial Resistance Network (WARN) IV: clinical pharmacology.

  Malaria journal 20070101

• Direct visualization of a significant stenosis of the right coronary artery by transthoracic echocardiography. A case report.

  Cardiovascular ultrasound 20070101

• Effects of carvedilol treatment in dogs with chronic mitral valvular disease.

  Journal of veterinary internal medicine 20070101

• Antiarrhythmics: elimination and dosage considerations in hepatic impairment.

  Clinical pharmacokinetics 20070101

• Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical framework.

  Critical care (London, England) 20070101

• Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity.

  Critical care (London, England) 20070101

• Clinical review: beyond immediate survival from resuscitation-long-term outcome considerations after cardiac arrest.

  Critical care (London, England) 20070101

• The decrease in microalbuminuria with carvedilol therapy is not enhanced by concurrent use of a statin.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101

• Carvedilol in dogs with dilated cardiomyopathy.

  Journal of veterinary internal medicine 20070101

• [Hypotensive activity and cerebroprotective properties of carvedilol in patients with arterial hypertension associated with type 2 diabetes mellitus].

  Kardiologiia 20070101

• Dilated cardiomyopathy of unknown cause in young patients: risk evaluation, possible etiologies, and treatment.

  The Libyan journal of medicine 20070101

• Anemia and heart failure: a cause of progression or only a consequence?

  Heart international 20070101

• Effects of carvedilol on M2 receptors and cholinesterase-positive nerves in adriamycin-induced rat failing heart.

  Autonomic neuroscience : basic & clinical 20061230

• Protective effects of carvedilol against anthracycline-induced cardiomyopathy.

  Journal of the American College of Cardiology 20061205

• Beta blockers in the management of chronic kidney disease.

  Kidney international 20061201

• Clinical trials of newly developed anti-cancer agents in children with acute leukemia.

  Contemporary clinical trials 20061201

• Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes.

  Scandinavian journal of gastroenterology 20061201

• Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers.

  Behavioural pharmacology 20061201

• Predictors of clinical outcomes in patients given carvedilol for heart failure.

  The American journal of cardiology 20061201

• Profile of carvedilol controlled-release: a new once-daily formulation of carvedilol.

  Expert opinion on pharmacotherapy 20061201

• On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo.

  Neuro endocrinology letters 20061201

• Effect of carvedilol on reactive oxygen species and enzymes linking innate and adaptive immunity.

  Neuro endocrinology letters 20061201

• Targeting nitric oxide with drug therapy.

  Journal of clinical hypertension (Greenwich, Conn.) 20061201

• Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.

  Journal of clinical hypertension (Greenwich, Conn.) 20061201

• Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.

  Journal of clinical pharmacy and therapeutics 20061201

• Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?

  Journal of cardiovascular pharmacology 20061201

• Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.

  Vascular health and risk management 20061201

• Carvedilol: just another Beta-blocker or a powerful cardioprotector?

  Cardiovascular & hematological disorders drug targets 20061201

• Candesartan in heart failure.

  Clinical interventions in aging 20061201

• Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial).

  International journal of cardiology 20061110

• Left ventricular assist device and drug therapy for the reversal of heart failure.

  The New England journal of medicine 20061102

• Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia.

  European journal of heart failure 20061101

• Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin.

  Pharmacoepidemiology and drug safety 20061101

• Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure.

  Clinical physiology and functional imaging 20061101

• Influence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury.

  Circulation journal : official journal of the Japanese Circulation Society 20061101

• Effect of alpha1-adrenergic receptors in cardiac pathophysiology.

  American heart journal 20061101

• Enantioselective and highly sensitive determination of carvedilol in human plasma and whole blood after administration of the racemate using normal-phase high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061020

• Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.

  The American journal of cardiology 20061015

• [The effectiveness of carvedilol in heart failure].

  Orvosi hetilap 20061008

• Design of a novel controlled-release formulation of carvedilol: pharmacology and clinical aspects. Introduction.

  The American journal of cardiology 20061002

• Pharmacokinetic properties of a new controlled-release formulation of carvedilol.

  The American journal of cardiology 20061002

• Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.

  The American journal of cardiology 20061002

• Development of a pharmacokinetic/pharmacodynamic model for carvedilol to predict beta1-blockade in patients with congestive heart failure.

  The American journal of cardiology 20061002

• Controlled-release carvedilol in the treatment of essential hypertension.

  The American journal of cardiology 20061002

• Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.

  The American journal of cardiology 20061002

• Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile.

  The American journal of cardiology 20061002

• COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure.

  The American journal of cardiology 20061002

• Rationale and design of CASPER: compliance and quality of life study comparing once-daily carvedilol CR and twice-daily carvedilol IR in patients with heart failure.

  The American journal of cardiology 20061002

• Controlled-release carvedilol: a concluding perspective.

  The American journal of cardiology 20061002

• Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study.

  European journal of heart failure 20061001

• Carvedilol reduces aldosterone release in systolic heart failure.

  Heart, lung & circulation 20061001

• Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.

  Hypertension (Dallas, Tex. : 1979) 20061001

• Echocardiography in the diagnosis and management of isolated left ventricular noncompaction: case reports and review of the literature.

  Journal of clinical ultrasound : JCU 20061001

• Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure.

  European journal of clinical investigation 20061001

• Effect of combination therapy with simvastatin and carvedilol in patients with left ventricular dysfunction complicated with acute myocardial infarction who underwent percutaneous coronary intervention.

  Circulation journal : official journal of the Japanese Circulation Society 20061001

• Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.

  Pharmacotherapy 20061001

• Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate.

  Current drug delivery 20061001

• Improving the management of patients after myocardial infarction, from admission to discharge.

  Clinical therapeutics 20061001

• Carvedilol's actions are largely mediated by endogenous nitric oxide.

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20061001

• Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells.

  Pharmacological research 20060901

• Carvedilol protected diabetic rat hearts via reducing oxidative stress.

  Journal of Zhejiang University. Science. B 20060901

• Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.

  Anesthesia and analgesia 20060901

• Upregulated neurohumoral factors are associated with left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension.

  Circulation journal : official journal of the Japanese Circulation Society 20060901

• Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients.

  Journal of clinical hypertension (Greenwich, Conn.) 20060901

• Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.

  Urology 20060901

• Stability indicating ultraviolet spectroscopic method for the estimation of ezetimibe and carvedilol.

  Die Pharmazie 20060901

• Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation.

  Vascular health and risk management 20060901

• ENOS is not activated by nebivolol in human failing myocardium.

  Life sciences 20060822

• Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system.

  International journal of pharmaceutics 20060817

• Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction.

  International journal of cardiology 20060810

• Attenuated cardioprotection by ischemic preconditioning in coronary stenosed heart and its restoration by carvedilol.

  Cardiovascular research 20060801

• Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy.

  Circulation journal : official journal of the Japanese Circulation Society 20060801

• Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20060801

• In vivo chronic carvedilol treatment in rats attenuates ex vivo regional infarction of the heart.

  Scandinavian cardiovascular journal : SCJ 20060801

• [Alpha beta-blockers for patients with hypertension].

  Nihon rinsho. Japanese journal of clinical medicine 20060801

• Fosinopril and carvedilol reverse hypertrophy and change the levels of protein kinase C epsilon and components of its signaling complex.

  Cardiovascular drugs and therapy 20060801

• Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.

  Circulation 20060711

• Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species?

  Bioorganic & medicinal chemistry 20060701

• Adrenoceptor blockade alters plasma gelatinase activity in patients with heart failure and MMP-9 promoter activity in a human cell line (ECV304).

  Pharmacological research 20060701

• Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes.

  The Journal of pharmacology and experimental therapeutics 20060701

• Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia.

  Pflugers Archiv : European journal of physiology 20060701

• Influence of carvedilol on serum digoxin levels in heart failure: is there any gender difference?

  European journal of clinical pharmacology 20060701

• Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade.

  Journal of hypertension 20060701

• Management of cardiovascular risk in patients receiving calcineurin inhibitors--a case report.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060701

• Oxidative stress: a potentially important new marker in renal transplantation.

  The Journal of pediatrics 20060701

• Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure.

  International heart journal 20060701

• Carvedilol prevents myocardial fibrosis in hamsters.

  International heart journal 20060701

• Radical scavenging and NO-releasing properties of selected beta-adrenoreceptor antagonists.

  Free radical research 20060701

• Beneficial effects of high doses of growth hormone in the introduction and optimization of medical treatment in decompensated congestive heart failure.

  International journal of cardiology 20060628

• Cardiac function and heart failure.

  Journal of the American College of Cardiology 20060606

• Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial.

  Patient education and counseling 20060601

• Getting it right: being smarter about clinical trials.

  PLoS medicine 20060601

• Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein.

  Fundamental & clinical pharmacology 20060601

• The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.

  European heart journal 20060601

• Carvedilol inhibits platelet-derived growth factor-induced extracellular matrix synthesis by inhibiting cellular reactive oxygen species and mitogen-activated protein kinase activation.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20060601

• Carvedilol versus Metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: rationale and design of the Carvedilol or Metoprolol Post-Revascularization Atrial Fibrillation Controlled Trial (COMPACT).

  Cardiovascular drugs and therapy 20060601

• [Efficacy of additional low-dose carvedilol in maintenance hemodialysis patients with asymptomatic left ventricular systolic dysfunction].

  Journal of cardiology 20060601

• Ventricular hypertrophy and hypertension: prognostic elements and implications for management.

  Herz 20060601

• Cardiovascular effects of a phosphodiesterase III inhibitor in the presence of carvedilol in dogs.

  The Journal of veterinary medical science 20060601

• [Estimation of effectiveness of the prevention of sudden cardiac death in patients with myocardial infarction].

  Georgian medical news 20060601

• The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.

  Vascular health and risk management 20060601

• The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.

  Journal of the American College of Cardiology 20060502

• Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study.

  European journal of heart failure 20060501

• Therapeutic potential of iron chelators in diseases associated with iron mismanagement.

  The Journal of pharmacy and pharmacology 20060501

• The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.

  Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20060501

• Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?

  Journal of clinical hypertension (Greenwich, Conn.) 20060501

• [Future perspectives of beta-blockers in chronic heart failure].

  Nihon rinsho. Japanese journal of clinical medicine 20060501

• Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND.

  European journal of heart failure 20060501

• [Long-term outcome and tolerability of carvedilol therapy in Japanese patients with chronic heart failure].

  Journal of cardiology 20060501

• The effect of carvedilol on metabolic parameters in patients with metabolic syndrome.

  International heart journal 20060501

• Factors that can affect the external validity of randomised controlled trials.

  PLoS clinical trials 20060501

• A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the 'patient journey') in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).

  Journal of the American College of Cardiology 20060418

• Mapping the journey.

  Journal of the American College of Cardiology 20060418

• Assessment of quality of life in patients with chronic heart failure secondary to Chagas' cardiomyopathy.

  International journal of cardiology 20060414

• [Beneficial effects of carvedilol on cardiomyocyte apoptosis and bcl-2/bax expression after acute myocardial infarction an experiment with rats].

  Zhonghua yi xue za zhi 20060404

• Evidences for prevention of nitroglycerin tolerance by carvedilol.

  Pharmacological research 20060401

• Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.

  American heart journal 20060401

• Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits.

  American heart journal 20060401

• Carvedilol action is dependent on endogenous production of nitric oxide.

  American journal of hypertension 20060401

• Multiple regression analysis of pharmacogenetic variability of carvedilol disposition in 54 healthy Japanese volunteers.

  Biological & pharmaceutical bulletin 20060401

• Pharmacokinetic and pharmacodynamic characteristics of beta-blockers: when differences may matter.

  Journal of cardiac failure 20060401

• Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation?

  Current medical research and opinion 20060401

• [Elderly heart failure patients and the role of beta-blocker therapy].

  Tijdschrift voor gerontologie en geriatrie 20060401

• Hemodynamic effects of one week of carvedilol administration on cirrhotic rats.

  Journal of gastroenterology 20060401

• Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.

  British journal of pharmacology 20060301

• Carvedilol inhibits mitochondrial oxygen consumption and superoxide production during calcium overload in isolated heart mitochondria.

  Circulation journal : official journal of the Japanese Circulation Society 20060301

• Effect of matrine and carvedilol on collagen and MMPs activity of hypertrophy myocardium induced by pressure overload.

  Journal of Zhejiang University. Science. B 20060301

• Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells.

  Biological & pharmaceutical bulletin 20060301

• [Sudden cardiac death: prevention when is right! From evidence-based medicine to family-based medicine].

  Giornale italiano di cardiologia (2006) 20060301

• The use of carvedilol in pediatric heart failure.

  Cardiovascular & hematological disorders drug targets 20060301

• [Use of betablockers in elderly patients with congestive heart failure].

  Medicina clinica 20060218

• Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase.

  Cardiovascular research 20060215

• Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?

  International journal of cardiology 20060215

• Perturbing effects of carvedilol on a model membrane system: role of lipophilicity and chemical structure.

  Biophysical chemistry 20060201

• Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosis.

  Nature clinical practice. Cardiovascular medicine 20060201

• Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment.

  American journal of hypertension 20060201

• The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.

  Current medical research and opinion 20060201

• Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.

  Journal of cardiovascular pharmacology 20060201

• After myocardial infarction carvedilol improves insulin resistance compared to metoprolol.

  Clinical research in cardiology : official journal of the German Cardiac Society 20060201

• Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients.

  Transplantation 20060115

• The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.

  International journal of cardiology 20060104

• Carvedilol blocks cardiac KATP and KG but not IK1 channels by acting at the bundle-crossing regions.

  European journal of pharmacology 20060104

• Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.

  Cardiovascular research 20060101

• An appropriate indication for the initiation of beta-blocker therapy in dilated cardiomyopathy.

  Cardiology 20060101

• Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.

  American heart journal 20060101

• Suppression of hyperglycemia-induced superoxide formation and endothelin-1 gene expression by carvedilol.

  American journal of therapeutics 20060101

• Significance of combined angiotensin II receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant.

  Journal of cardiology 20060101

• Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.

  Annals of clinical microbiology and antimicrobials 20060101

• [Identification of blockers of adrenergic beta-receptors by thin layer chromatography].

  Soudni lekarstvi 20060101

• Beta-blockers for the post-myocardial infarction patient: current clinical evidence and practical considerations.

  Reviews in cardiovascular medicine 20060101

• Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.

  Drugs & aging 20060101

• Pharmacodynamics of carvedilol in conscious, healthy dogs.

  Journal of veterinary internal medicine 20060101

• Prospective single-arm protocol of carvedilol in children with ventricular dysfunction.

  Pediatric cardiology 20060101

• Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention--the PASSAT Study.

  Clinical research in cardiology : official journal of the German Cardiac Society 20060101

• [Efficiency and safety of carvedilol treatment in high risk hypertensive patients].

  Zhonghua nei ke za zhi 20060101

• Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care.

  BMC cardiovascular disorders 20060101

• Scintigraphic evaluation of cardiac metabolism and sympathetic nerve function in alcoholic cardiomyopathy.

  Internal medicine (Tokyo, Japan) 20060101

• Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.

  Cardiology 20060101

• [Use of carvidilol in patients with hypertensive disease associated with ischemic heart disease].

  Likars'ka sprava 20060101

• Complete atrioventricular canal.

  Orphanet journal of rare diseases 20060101

• Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective, cross-sectional study.

  BMC cardiovascular disorders 20060101

• CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973].

  Trials 20060101

• Loss of lag-response curvilinearity of indices of heart rate variability in congestive heart failure.

  BMC cardiovascular disorders 20060101

• Effects of autologous bone marrow stem cell transplantation on beta-adrenoceptor density and electrical activation pattern in a rabbit model of non-ischemic heart failure.

  Journal of cardiothoracic surgery 20060101

• Carvedilol suppresses intractable hiccups.

  Journal of the American Board of Family Medicine : JABFM 20060101

• Treatment of heart failure in Dutch general practice.

  BMC family practice 20060101

• Cardiomyopathy, familial dilated.

  Orphanet journal of rare diseases 20060101

• Effectiveness of carvedilol for congestive heart failure that developed long after modified Fontan operation.

  Pediatric cardiology 20060101

• [Studying the effect of the new beta-adrenoreceptor blocker proxodolol on the ischemic model of cardiac insufficiency].

  Eksperimental'naia i klinicheskaia farmakologiia 20060101

• Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20060101

• [Chronic heart failure treatment in uremic patients with beta-blockers].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20060101

• [Evaluation of the effectivenes of treatment of patients with renal arterial hypertension with carvedilol].

  Klinicheskaia meditsina 20060101

• Beta-blocker therapy for heart failure: should the therapeutic target be dose or heart rate reduction?

  Congestive heart failure (Greenwich, Conn.) 20060101

• Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20060101

• Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20060101

• Randomized, double-blind comparison of acute beta1-blockade with 50 mg metoprolol tartrate vs 25 mg carvedilol in normal subjects.

  Congestive heart failure (Greenwich, Conn.) 20060101

• [Comparative efficacy of carvedilol and capoten in the treatment of an uncomplicated hypertensive crisis].

  Terapevticheskii arkhiv 20060101

• Changes in heart failure medications in patients hospitalised and discharged.

  BMC family practice 20060101

• Heart failure in community practice: relationship to age and sex in a beta-blocker registry.

  Congestive heart failure (Greenwich, Conn.) 20060101

• The impact of baseline HR and BP on the tolerability of carvedilol in the elderly: the COLA (Carvedilol Open Label Assessment) II Study.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20060101

• ESR techniques for the detection of nitric oxide in vivo as an index of endothelial function.

  Pharmacological reports : PR 20060101

• Nebivovol and carvedilol induce NO-dependent coronary vasodilatation that is unlikely to be mediated by extracellular ATP in the isolated guinea pig heart.

  Pharmacological reports : PR 20060101

• [Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20060101

• Elevated serum uric acid reduce heart damage in patients undergoing opern-heart surgery.

  Acta chirurgica Iugoslavica 20060101

• Could garlic be an useful adjuvant therapy in adriamycin heart failure?

  Kathmandu University medical journal (KUMJ) 20060101

• The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.

  Biomarker insights 20060101

• Sudden death prevention in heart failure: The case of CIBIS III.

  Heart international 20060101

• Non-compaction of the ventricular myocardium.

  Heart international 20060101

• Chemiluminometric determination of carvedilol in a multi-pumping flow system.

  Talanta 20051215

• Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.

  Hypertension (Dallas, Tex. : 1979) 20051201

• Recurrence of atrial fibrillation after internal cardioversion of persistent atrial fibrillation: prognostic importance of electrophysiologic parameters.

  Circulation journal : official journal of the Japanese Circulation Society 20051201

• Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.

  Journal of cardiac failure 20051201

• Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.

  American journal of hypertension 20051201

• The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20051201

• Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs.

  American journal of veterinary research 20051201

• Stereoselective effect of amiodarone on the pharmacokinetics of racemic carvedilol.

  Drug metabolism and pharmacokinetics 20051201

• [Clinical and hemodynamic efficiency of dilatrend treatment in patients with dilatation cardiomyopathy].

  Georgian medical news 20051201

• [Effects and the mechanism of carvedilol on gap junctional intercellular communication in rat myocardium].

  Zhonghua xin xue guan bing za zhi 20051201

• Influence of carvedilol on superoxide generation and enzyme release from stimulated human neutrophils.

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20051201

• Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.

  Postgraduate medicine 20051201

• Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.

  European heart journal 20051101

• Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.

  British journal of anaesthesia 20051101

• Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance.

  Heart (British Cardiac Society) 20051101

• Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20051101

• Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.

  American heart journal 20051101

• Simultaneous determination of dopamine and carvedilol in human serum and urine by first-order derivative fluorometry.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20051101

• Practical algorithms for pharmacologic management of the post myocardial infarction patient.

  Clinical cardiology 20051101

• Real-world algorithms for the optimal use of drugs and devices in the patient post myocardial infarction and the future of post myocardial infarction management.

  Clinical cardiology 20051101

• [Effects of carvedilol on neurohormone and magnesium metabolism in patients with chronic heart failure].

  Zhonghua xin xue guan bing za zhi 20051101

• Carvedilol in chronic heart failure: past, present and future.

  Future cardiology 20051101

• Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure.

  European journal of heart failure 20051001

• Does carvedilol impair insulin sensitivity in heart failure patients without diabetes?

  Journal of cardiac failure 20051001

• Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.

  Cardiovascular drugs and therapy 20051001

• Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis.

  Biochemical and biophysical research communications 20050916

• Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.

  International journal of radiation oncology, biology, physics 20050901

• Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II).

  The American journal of cardiology 20050901

• [Experimental study of effect of carvedilol on myocardial collagen network remodeling after acute myocardial infarction in rats].

  Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20050901

• Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.

  Chest 20050901

• Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent?

  Pacing and clinical electrophysiology : PACE 20050901

• Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization.

  Journal of cardiovascular pharmacology and therapeutics 20050901

• Preparation and evaluation of SEDDS and SMEDDS containing carvedilol.

  Drug development and industrial pharmacy 20050901

• Early initiation of beta blockade in heart failure: issues and evidence.

  Journal of clinical hypertension (Greenwich, Conn.) 20050901

• Inhibition of proliferation on some neoplastic cell lines-act of carvedilol and captopril.

  Journal of experimental & clinical cancer research : CR 20050901

• Adding carvedilol to ACE inhibitors may reduce arrhythmia and ventricular tachycardia following acute myocardial infarction. Commentary.

  Evidence-based cardiovascular medicine 20050901

• Guidelines for choosing drugs in chronic heart failure.

  Vascular health and risk management 20050901

• Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral alpa1-adrenoceptor activation.

  Vascular health and risk management 20050901

• Gas chromatograph-mass spectrometric method for the determination of carvedilol and its metabolites in human urine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805

• Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to bioequivalence study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805

• New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics.

  British journal of pharmacology 20050801

• Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?

  European journal of heart failure 20050801

• Early detection by the Tei index of carvedilol-induced improved left ventricular function in patients with heart failure.

  The American journal of cardiology 20050801

• An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.

  Echocardiography (Mount Kisco, N.Y.) 20050801

• Effect of CYP2D6*10 on the pharmacokinetics of R- and S-carvedilol in healthy Japanese volunteers.

  Biological & pharmaceutical bulletin 20050801

• Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade.

  Current medical research and opinion 20050801

• Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.

  European journal of heart failure 20050801

• Vagal heart rate responses to chronic beta-blockade in human heart failure relate to cardiac norepinephrine spillover.

  European journal of heart failure 20050801

• Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.

  Minerva cardioangiologica 20050801

• [Effect of carvedilol on ryanodine receptor in heart failure].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20050801

• Researched Medicines Industry (RMI) Code of Practice complaints 2004.

  The New Zealand medical journal 20050729

• Neutrophils superoxide anion generation during carvedilol therapy in patients with stable angina.

  International journal of cardiology 20050720

• Effects of carvedilol upon intra- and interventricular synchrony in patients with chronic heart failure.

  The American journal of cardiology 20050715

• Impact of carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function.

  Journal of the American College of Cardiology 20050705

• Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.

  Journal of the American College of Cardiology 20050705

• Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

  European heart journal 20050701

• Oxidative-nitrosative stress in hypertension.

  Current vascular pharmacology 20050701

• Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart.

  Clinical and experimental pharmacology & physiology 20050701

• [Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].

  Zhonghua nei ke za zhi 20050701

• Development of novel interpenetrating network gellan gum-poly(vinyl alcohol) hydrogel microspheres for the controlled release of carvedilol.

  Drug development and industrial pharmacy 20050701

• Does carvedilol have antiarrhythmic properties?

  Nature clinical practice. Cardiovascular medicine 20050701

• Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure.

  Journal of cardiovascular pharmacology 20050601

• Clinical trials report. Metabolic effects of carvedilol versus metoprolol in patients with type 2 diabetes mellitus and hypertension.

  Current hypertension reports 20050601

• Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.

  European journal of heart failure 20050601

• The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure.

  European journal of heart failure 20050601

• Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.

  European journal of heart failure 20050601

• Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).

  European journal of heart failure 20050601

• Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model.

  Critical care medicine 20050601

• Toward directed therapy for amphetamine-mediated hyperthermia: is carvedilol worth raving about?

  Critical care medicine 20050601

• Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure.

  Journal of cardiac failure 20050601

• Influence of carvedilol on chronic renal failure progression in spontaneously hypertensive rats with adriamycin nephropathy.

  Clinical nephrology 20050601

• Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation.

  Journal of cardiovascular pharmacology and therapeutics 20050601

• Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview.

  Journal of cardiovascular pharmacology and therapeutics 20050601

• Antiadrenergic therapy in the control of atrial fibrillation.

  Journal of cardiovascular pharmacology and therapeutics 20050601

• Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era.

  Journal of cardiovascular pharmacology and therapeutics 20050601

• A review of carvedilol arrhythmia data in clinical trials.

  Journal of cardiovascular pharmacology and therapeutics 20050601

• Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study.

  Journal of alternative and complementary medicine (New York, N.Y.) 20050601

• [The effect of carvedilol on cardiac function and autoantibodies against the cardiac receptors].

  Zhonghua xin xue guan bing za zhi 20050601

• Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.

  European journal of pharmacology 20050523

• Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat.

  The Journal of clinical endocrinology and metabolism 20050501

• Carvedilol reduces plasma 8-hydroxy-2'-deoxyguanosine in mild to moderate hypertension: a pilot study.

  Hypertension (Dallas, Tex. : 1979) 20050501

• Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy.

  The American journal of cardiology 20050501

• Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol.

  Journal of molecular and cellular cardiology 20050501

• Symptoms in patients with heart failure are prognostic predictors: insights from COMET.

  Journal of cardiac failure 20050501

• Simultaneous determination of carvedilol and ampicillin sodium by first-derivative fluorometry in the presence of human serum albumin.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20050501

• Dilated cardiomyopathy relieved as a result of beta-blocker therapy: a case report--key points in assessment of prognosis based on MIBG myocardial scintigraphy and BNP levels.

  Annals of nuclear medicine 20050501

• Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.

  International journal of cardiology 20050408

• Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry.

  Journal of cardiac failure 20050401

• Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.

  Journal of cardiac failure 20050401

• Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria?

  Current vascular pharmacology 20050401

• [Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].

  Revista clinica espanola 20050401

• Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction.

  Clinical cardiology 20050401

• Hemodynamic effects of orally administered carvedilol in healthy conscious dogs.

  American journal of veterinary research 20050401

• Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.

  Italian heart journal : official journal of the Italian Federation of Cardiology 20050401

• Are there clinically important differences between beta-blockers in heart failure?

  Heart failure clinics 20050401

• Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?

  Heart failure clinics 20050401

• [The effect of carvedilol on apoptosis gene PDCD5 expression in chronic heart failure patients].

  Zhonghua yi xue za zhi 20050316

• A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.

  The Canadian journal of cardiology 20050315

• Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.

  International journal of cardiology 20050310

• Carvedilol, metoprolol, and insulin resistance.

  JAMA 20050309

• The beta-adrenergic blocker carvedilol restores L-type calcium current in a myocardial infarction model of rabbit.

  Chinese medical journal 20050305

• Carvedilol effectively blocks oxidative stress-mediated downregulation of sarcoplasmic reticulum Ca2+-ATPase 2 gene transcription through modification of Sp1 binding.

  Biochemical and biophysical research communications 20050304

• Study on fluorescence property of carvedilol and determination of carvedilol by fluorimetry.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050301

• Carvedilol modulates the expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a rat model of volume-overload heart failure.

  Journal of cardiac failure 20050301

• Emerging trends in the management of heart failure: Beta blocker therapy.

  The Nursing clinics of North America 20050301

• Influence of pretreatment systolic blood pressure on benefit from carvedilol in severe chronic heart failure patients.

  Journal of the American College of Cardiology 20050301

• Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients.

  American journal of hypertension 20050301

• The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.

  Archives des maladies du coeur et des vaisseaux 20050301

• What primary care physicians know about diagnosis and treatment of chronic heart failure.

  Kardiologia polska 20050301

• Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial.

  Transplantation proceedings 20050301

• Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.

  Pharmacogenetics and genomics 20050301

• Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.

  American heart journal 20050301

• [Electrophysiological action of carvediol on the sinus node and atrioventricular node cells].

  [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20050301

• Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experience.

  Cardiovascular drugs and therapy 20050301

• Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.

  Cardiovascular drugs and therapy 20050301

• [Effects of carvedilol on the expression of IL-1beta and collagen precipitation in myocardium in post-myocardial infarction rats ].

  Zhonghua yi xue za zhi 20050216

• Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.

  Journal of the American College of Cardiology 20050215

• Three decades of clinical trials with beta-blockers: the contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias.

  Journal of the American College of Cardiology 20050215

• [Beta blockers for therapy of chronic heart failure].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20050210

• Simultaneous determination of carvedilol and ampicillin sodium by synchronous fluorimetry.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050201

• The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

  British journal of pharmacology 20050201

• Antioxidant and antiinflammatory effect of carvedilol in mononuclear cells of hypertensive patients.

  The American journal of medicine 20050201

• Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.

  American heart journal 20050201

• [Effect of carvedilol on lipid peroxidation in patients with stable angina].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050201

• [Effect of carvedilol on antioxidative enzymatic defence in patients with stable angina].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050201

• [Knowledge of primary care physicians, cardiologists from cardiology clinics, internal and cardiology department physicians about chronic heart failure diagnosis and treatment].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050201

• Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study.

  Journal of the American College of Cardiology 20050118

• Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography/mass spectrometry with scan-to-scan polarity switching.

  Rapid communications in mass spectrometry : RCM 20050101

• Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET.

  Journal of clinical pharmacology 20050101

• Pharmacokinetic characterization of transcellular transport and drug interaction of digoxin in Caco-2 cell monolayers.

  Biological & pharmaceutical bulletin 20050101

• Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model.

  Circulation journal : official journal of the Japanese Circulation Society 20050101

• Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study.

  European journal of heart failure 20050101

• Differential pulse voltammetric determination of carvedilol in tablets dosage form using glassy carbon electrode.

  Farmaco (Societa chimica italiana : 1989) 20050101

• The role of growth hormone replacement in a growth hormone deficient patient with underlying cardiomyopathy and severe congestive heart failure.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20050101

• Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.

  Journal of clinical hypertension (Greenwich, Conn.) 20050101

• Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

  American heart journal 20050101

• Carvedilol versus metoprolol in patients undergoing direct percutaneous coronary interventions for myocardial infarction: effects on QT dynamicity.

  Pacing and clinical electrophysiology : PACE 20050101

• Carvedilol versus metoprolol in the acute phase of myocardial infarction:

  Pacing and clinical electrophysiology : PACE 20050101

• Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim report.

  International journal of clinical pharmacology and therapeutics 20050101

• The COMET trial.

  Congestive heart failure (Greenwich, Conn.) 20050101

• The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.

  Journal of diabetes and its complications 20050101

• A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.

  Cardiology 20050101

• [Effect of long-term therapy with contemporary drugs on diastolic cardiac function in patients with chronic heart failure].

  Kardiologiia 20050101

• Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects.

  Cardiovascular ultrasound 20050101

• Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.

  Drugs 20050101

• [Dynamics of postinfarction left ventricular remodeling during long term use of perindopril, amiodarone, and beta-adrenoblockers].

  Kardiologiia 20050101

• Inhibition of chemiluminescence by carvedilol in the cell-free system, whole human blood and blood cells.

  Scandinavian journal of clinical and laboratory investigation 20050101

• Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.

  Bratislavske lekarske listy 20050101

• Effects of adrenoceptor blocking drugs on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study.

  Arzneimittel-Forschung 20050101

• Bioequivalence study of two different tablet formulations of carvedilol in healthy volunteers.

  Arzneimittel-Forschung 20050101

• [Primary pulmonary hypertension: activation of sympathico-adrenal system and free radical oxidation. Positive effects of carvedilol therapy].

  Terapevticheskii arkhiv 20050101

• Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.

  Cardiology 20050101

• Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart.

  Journal of biomedical science 20050101

• Effect of carvedilol on neuronal survival and poly(ADP-ribose) polymerase activity in hippocampus after transient forebrain ischemia.

  Acta neurobiologiae experimentalis 20050101

• [Implantation of an extracardiac mesh in the treatment of dilated cardiomyopathy: the TOLK Study (Therapevticheskoe Operativnoe Lechenie Kardiomyopatye)].

  Kardiologiia 20050101

• Cytoprotective effects of carvedilol against oxygen free radical generation in rat liver.

  Redox report : communications in free radical research 20050101

• ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.

  Cancer cell international 20050101

• [Carvedilol in combined therapy of patients with Q myocardial infarction].

  Terapevticheskii arkhiv 20050101

• Protective antioxidant effects of carvedilol in a rat model of ischaemia-reperfusion injury.

  The Journal of international medical research 20050101

• Pre-clinical and clinical experience of telmisartan in cardiac remodelling.

  The Journal of international medical research 20050101

• Titration of carvedilol in elderly heart failure patients.

  The American journal of geriatric cardiology 20050101

• How FDA currently makes decisions on clinical studies.

  Clinical trials (London, England) 20050101

• Diabetes and heart failure: epidemiology, pathophysiology and management.

  Indian heart journal 20050101

• [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol].

  Kardiologiia 20050101

• Validation of UV spectrophotometric and nonaqueous titration methods for the determination of carvedilol in pharmaceutical formulations.

  Journal of AOAC International 20050101

• [Cholinergic urticaria revealed by beta-blockers: case report and therapeutic management].

  Therapie 20050101

• [Beta-adrenolytics in heart failure--are they all really equal?].

  Przeglad lekarski 20050101

• Methods of assessment and clinical relevance of QT dynamics.

  Indian pacing and electrophysiology journal 20050101

• Carvedilol Protects Early Diabetic Rat Hearts through Reducing Oxidative Stress.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20050101

• Hemodynamic effects of carvedilol infusion and the contribution of the sympathetic nervous system in rats with heart failure.

  Pharmacology 20041201

• Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats.

  Fundamental & clinical pharmacology 20041201

• Early detection by the Tei index of carvedilol-induced improved left ventricular function in patients with heart failure.

  The American journal of cardiology 20041201

• Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy.

  The American journal of cardiology 20041201

• Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients.

  Journal of cardiac failure 20041201

• Outpatient treatment of systolic heart failure.

  American family physician 20041201

• Trial finds administering carvedilol in hospital improves treatment adherence for people with heart failure.

  Evidence-based cardiovascular medicine 20041201

• Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization.

  Journal of chromatography. A 20041126

• Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization.

  Journal of pharmaceutical and biomedical analysis 20041115

• Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

  JAMA 20041110

• Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.

  Journal of the American College of Cardiology 20041102

• Dismantling mandates in the treatment of heart failure.

  Journal of the American College of Cardiology 20041102

• Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells.

  Arteriosclerosis, thrombosis, and vascular biology 20041101

• Estimating mortality reduction by comparing survival curves.

  The Journal of family practice 20041101

• Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20041101

• Management of portal hypertension.

  Postgraduate medical journal 20041101

• [Effects of carvedilol on functional capacity, left ventricular function, catecholamines and oxidative stress in patients with chronic heart failure].

  Revista espanola de cardiologia 20041101

• [Prediction of intolerance to beta blocker therapy in chronic heart failure patients using BNP].

  Annales de cardiologie et d'angeiologie 20041101

• Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol.

  Internal medicine (Tokyo, Japan) 20041101

• Carvedilol protects ischemic cardiac mitochondria by preventing oxidative stress.

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20041101

• Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.

  Toxicology and applied pharmacology 20041015

• Anti-oxidants and apoptosis: attenuation of doxorubicin induced cardiomyopathy by carvedilol.

  Journal of molecular and cellular cardiology 20041001

• Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.

  Journal of molecular and cellular cardiology 20041001

• Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.

  The American journal of gastroenterology 20041001

• Anti-inflammatory medication for atrial fibrillation.

  European heart journal 20041001

• Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.

  American heart journal 20041001

• Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20041001

• Concurrent therapies that protect against doxorubicin-induced cardiomyopathy.

  Clinical journal of oncology nursing 20041001

• Different effects of antihypertensive drugs on endothelial dysfunction.

  Acta cardiologica 20041001

• Betablockers in heart failure: Carvedilol Safety Assessment (CASA 2-trial).

  European journal of heart failure 20041001

• Advantages in the use of carvedilol versus propranolol for the protection of cardiac mitochondrial function.

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20041001

• Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.

  Circulation 20040928

• [The value of BNP determination in general practice].

  MMW Fortschritte der Medizin 20040909

• [Incomplete and delayed parallel publication].

  Ugeskrift for laeger 20040906

• Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy.

  American journal of physiology. Heart and circulatory physiology 20040901

• Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors.

  Cardiovascular research 20040901

• Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.

  Drug metabolism and disposition: the biological fate of chemicals 20040901

• Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation.

  The American journal of cardiology 20040901

• Enantioselective pharmacokinetics of carvedilol in human volunteers.

  Archives of pharmacal research 20040901

• Reversal of LPS-induced immobility in mice by green tea polyphenols: possible COX-2 mechanism.

  Phytotherapy research : PTR 20040901

• Predictors of stable outcome in treating chronic heart failure patients with carvedilol.

  Japanese heart journal 20040901

• Adrenergic receptor antagonist prevents the left ventricle with chronic pressure-overload from electrical remodeling.

  Sheng li xue bao : [Acta physiologica Sinica] 20040825

• Beta-blocker-induced quadriparesis.

  Annals of internal medicine 20040817

• Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.

  The American journal of cardiology 20040815

• Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.

  Journal of the American College of Cardiology 20040804

• [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].

  Ugeskrift for laeger 20040802

• Bob Ruffolo discusses the rhythm of drug development.

  Drug discovery today 20040801

• Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy.

  European journal of heart failure 20040801

• Brain natriuretic peptide response is heterogeneous during beta-blocker therapy for congestive heart failure.

  Journal of cardiac failure 20040801

• Use of beta-blockers in older adults with chronic heart failure.

  The American journal of the medical sciences 20040801

• Effect of carvedilol on Ca2+ movement and cytotoxicity in human MG63 osteosarcoma cells.

  Basic & clinical pharmacology & toxicology 20040801

• Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.

  Archives of internal medicine 20040712

• [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].

  Der Internist 20040701

• Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.

  Heart (British Cardiac Society) 20040701

• The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter.

  Heart (British Cardiac Society) 20040701

• Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

  American heart journal 20040701

• Rationale, design, and organization of the Diastolic Heart Failure Assessment Study in Tohoku District (DIAST).

  Circulation journal : official journal of the Japanese Circulation Society 20040701

• The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.

  American journal of hypertension 20040701

• Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20040701

• Update in the management of diastolic heart failure.

  Current vascular pharmacology 20040701

• [Isolated left ventricular noncompaction in the elderly: a case report].

  Journal of cardiology 20040701

• Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.

  Italian heart journal : official journal of the Italian Federation of Cardiology 20040701

• How should COMET influence heart failure practice?

  Current heart failure reports 20040701

• Beta-blockers in heart failure: is more better?

  Current heart failure reports 20040701

• Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.

  Current heart failure reports 20040701

• Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.

  Circulation 20040629

• Carvedilol and metoprolol European trial: do the results merit challenge?

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040615

• Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.

  Circulation 20040608

• Sympathetic hyperactivity in chronic kidney disease.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040601

• Long-term oral carvedilol in chronic heart failure.

  Expert opinion on pharmacotherapy 20040601

• Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).

  European journal of heart failure 20040601

• Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure.

  European journal of heart failure 20040601

• Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).

  European journal of heart failure 20040601

• Remote titration of carvedilol for heart failure patients by advanced practice nurses.

  Journal of cardiac failure 20040601

• Chronic left ventricular failure in the community: Prevalence, prognosis, and predictors of the complete clinical recovery with return of cardiac size and function to normal in patients undergoing optimal therapy.

  Journal of cardiac failure 20040601

• Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.

  Journal of cardiovascular pharmacology and therapeutics 20040601

• Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.

  Italian heart journal : official journal of the Italian Federation of Cardiology 20040601

• Pharmacology of carvedilol.

  The American journal of cardiology 20040506

• beta-Blockers in hypertension: is carvedilol different?

  The American journal of cardiology 20040506

• Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN).

  The American journal of cardiology 20040506

• Cardiac remodeling in coronary artery disease.

  The American journal of cardiology 20040506

• Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program.

  The American journal of cardiology 20040506

• Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure.

  The American journal of cardiology 20040506

• Commentary on the Carvedilol or Metoprolol European Trial (COMET).

  The American journal of cardiology 20040506

• Ventricular remodeling in heart failure and the effect of beta-blockade.

  The American journal of cardiology 20040506

• Advantages of a third-generation beta-blocker in patients with diabetes mellitus.

  The American journal of cardiology 20040506

• Role of carvedilol in atrial fibrillation: insights from clinical trials.

  The American journal of cardiology 20040506

• Tolerability of carvedilol in heart failure: clinical trials experience.

  The American journal of cardiology 20040506

• Special considerations for carvedilol use in heart failure.

  The American journal of cardiology 20040506

• Practical guidelines to optimize effectiveness of beta-blockade in patients postinfarction and in those with chronic heart failure.

  The American journal of cardiology 20040506

• Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure.

  The American journal of cardiology 20040506

• Role of in-hospital initiation of carvedilol to improve treatment rates and clinical outcomes.

  The American journal of cardiology 20040506

• Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

  Journal of the American College of Cardiology 20040505

• Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.

  European journal of pharmacology 20040503

• Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.

  The Journal of pharmacology and experimental therapeutics 20040501

• Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers.

  Naunyn-Schmiedeberg's archives of pharmacology 20040501

• Carvedilol inhibits basal and stimulated ACE production in human endothelial cells.

  Journal of cardiovascular pharmacology 20040501

• The carvedilol or metoprolol European trial.

  Current cardiology reports 20040501

• The update on the rationale, use and selection of beta-blockers in heart failure.

  Current opinion in cardiology 20040501

• Carvedilol differentially regulates cytokine production from activated human peripheral blood mononuclear cells.

  Cardiovascular drugs and therapy 20040501

• Methods of assessing the functional status of patients with left ventricular systolic dysfunction in interventional studies: can brain natriuretic peptide measurement be used as surrogate for the traditional methods?

  Cardiovascular drugs and therapy 20040501

• Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.

  Journal of the American College of Cardiology 20040421

• Blood pressure and the therapy of advanced heart failure.

  Journal of the American College of Cardiology 20040421

• The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes.

  Archives of internal medicine 20040412

• [Genetic polymorphisms in drug metabolizing enzymes--impact on treatment with beta-blockers].

  Deutsche medizinische Wochenschrift (1946) 20040408

• Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers.

  European journal of clinical pharmacology 20040401

• Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension.

  The American journal of medicine 20040401

• Carvedilol: a new candidate for reversal of MDR1/P-glycoprotein-mediated multidrug resistance.

  Anti-cancer drugs 20040401

• Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20040401

• Heart failure management in African Americans: meeting the challenge.

  Journal of clinical hypertension (Greenwich, Conn.) 20040401

• Cardioprotective effects of carvedilol on acute autoimmune myocarditis.

  Molecular and cellular biochemistry 20040401

• Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats.

  Hypertension research : official journal of the Japanese Society of Hypertension 20040401

• Beta blocker therapy after acute myocardial infarction in patients with heart failure and systolic dysfunction.

  Heart failure reviews 20040401

• The effects of beta blockers on morbidity and mortality in heart failure.

  Heart failure reviews 20040401

• Beta-blockers in heart failure: are pharmacological differences clinically important?

  Heart failure reviews 20040401

• Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.

  Heart failure reviews 20040401

• Beta blockers as anti-arrhythmic agents.

  Heart failure reviews 20040401

• Beta blocker therapy in African American patients with heart failure.

  Heart failure reviews 20040401

• [Pharmacotherapy of chronic heart failure in clinical practice].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20040401

• [Severe heart failure: treatment optimisation and monitoring using plasma NT-proBNP levels--an useful tool in clinical practice].

  Praxis 20040317

• NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.

  European journal of heart failure 20040315

• Managing the patient with diabetes mellitus and heart failure: issues and considerations.

  The American journal of medicine 20040308

• Heart failure in a district general hospital: are target doses of beta-blockers realistic?

  QJM : monthly journal of the Association of Physicians 20040301

• Limited predictive value of cardiopulmonary exercise indices in patients with moderate chronic heart failure treated with carvedilol.

  American heart journal 20040301

• CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects.

  Clinical pharmacology and therapeutics 20040301

• Different effects of exercise on plasma concentrations of nebivolol, bisoprolol and carvedilol.

  Cardiovascular drugs and therapy 20040301

• A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET).

  Cardiovascular drugs and therapy 20040301

• The association between congestive heart failure and chronic renal disease.

  Current opinion in nephrology and hypertension 20040301

• [Benefits of a beta-blocking agent (carvedilol) on bilateral atherosclerotic renal artery stenosis. A case report].

  Annales de cardiologie et d'angeiologie 20040301

• Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?

  Cardiovascular drugs and therapy 20040301

• Pre-weaning carvedilol treatment in spontaneously hypertensive rats.

  European journal of pharmacology 20040220

• Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin.

  Journal of pharmaceutical and biomedical analysis 20040218

• Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.

  Naunyn-Schmiedeberg's archives of pharmacology 20040201

• Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol.

  Drug metabolism and disposition: the biological fate of chemicals 20040201

• Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing.

  American journal of hypertension 20040201

• Clinical trials in Japan and the United States.

  American heart journal 20040201

• Which beta-blocker for heart failure?

  American heart journal 20040201

• Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.

  American heart journal 20040201

• Comparison between a sustained administration of carvedilol versus atenolol to reduce restenosis after coronary stenting.

  American heart journal 20040201

• Pharmacological rate control of atrial fibrillation.

  Cardiology clinics 20040201

• Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.

  Circulation 20040120

• Antioxidant activity of nebivolol in the rat aorta.

  Journal of cardiovascular pharmacology 20040101

• Prevention of cold-preservation injury of cultured endothelial cells by catecholamines and related compounds.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040101

• Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?

  Expert opinion on pharmacotherapy 20040101

• Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.

  American journal of physiology. Heart and circulatory physiology 20040101

• Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic.

  American heart journal 20040101

• Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.

  American heart journal 20040101

• Cost-effectiveness analysis of carvedilol for the treatment of chronic heart failure in Japan.

  Circulation journal : official journal of the Japanese Circulation Society 20040101

• Carvedilol was more effective than metoprolol tartrate for lowering mortality in chronic heart failure.

  ACP journal club 20040101

• Evaluation of carvedilol for the treatment of portal hypertension.

  Pharmacotherapy 20040101

• The shift in the 'paradigm' of the pharmacology of hypertension.

  Current topics in medicinal chemistry 20040101

• Separation of enantiomers by capillary electrophoresis using cyclodextrins.

  Methods in molecular biology (Clifton, N.J.) 20040101

• Carvedilol therapy improved left ventricular function in a patient with arrhythmogenic right ventricular cardiomyopathy.

  Japanese heart journal 20040101

• Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism.

  Cardiovascular toxicology 20040101

• Potential interactions between exercise and drug therapy.

  Sports medicine (Auckland, N.Z.) 20040101

• The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).

  Cardiovascular drugs and therapy 20040101

• Individualising heart failure patients to beta-blocker therapy.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101

• Assessing the impact of heart failure specialist services on patient populations.

  BMC health services research 20040101

• Nonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European Trial.

  Reviews in cardiovascular medicine 20040101

• Practical considerations for switching beta-blockers in heart failure patients.

  Reviews in cardiovascular medicine 20040101

• Carvedilol: beta-blockade and beyond.

  Reviews in cardiovascular medicine 20040101

• Hemorheological methods in drug research.

  Clinical hemorheology and microcirculation 20040101

• Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.

  Cardiology 20040101

• Science review: natriuretic peptides in critical illness.

  Critical care (London, England) 20040101

• [Effect of carvedilol on blood levels of cytokines and symptoms of heart failure in patients with postinfarction cardiac dysfunction.].

  Kardiologiia 20040101

• [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].

  Kardiologiia 20040101

• Cardiovascular drug class specificity: beta-blockers.

  Progress in cardiovascular diseases 20040101

• The effectiveness and tolerance of betablockers in elderly patients (> or = 70 years) with heart failure.

  Romanian journal of internal medicine = Revue roumaine de medecine interne 20040101

• [Effects of carvedilol, atenolol and their combination with fosinopril on cardiac rhythm variability, clinicofunctional status and quality of life in patients with postinfarction left ventricular dysfunction].

  Terapevticheskii arkhiv 20040101

• A case of drug-induced pneumonitis caused by carvedilol.

  Respiration; international review of thoracic diseases 20040101

• Protective effect of carvedilol on abnormality of L-type calcium current induced by oxygen free radical in cardiomyocytes.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20040101

• [Clinical trials of beta-blockers in heart failure: history, overview and future prospects].

  Therapie 20040101

• [Carvedilol (dilatrend) treatment in cardiac failure].

  Terapevticheskii arkhiv 20040101

• Effect of Carvedilol on QT Duration in Paediatric Patients with Congestive Heart Failure.

  Clinical drug investigation 20040101

• Measurement of carvedilol in plasma by high-performance liquid chromatography with electrochemical detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031225

• Carvedilol improves energy production during acute global myocardial ischaemia.

  European journal of pharmacology 20031215

• [Beta-blocking drugs indicated in patients with heart failure].

  Nederlands tijdschrift voor geneeskunde 20031213

• [Is 'COMET' pointing in the right direction?--Pro].

  Deutsche medizinische Wochenschrift (1946) 20031212

• [Is 'COMET' pointing in the right direction?--Con].

  Deutsche medizinische Wochenschrift (1946) 20031212

• Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

  Journal of the American College of Cardiology 20031203

• Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.

  European journal of nuclear medicine and molecular imaging 20031201

• Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure.

  European journal of heart failure 20031201

• Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus.

  European journal of heart failure 20031201

• In heart failure, all beta-blockers are not necessarily equal.

  Cleveland Clinic journal of medicine 20031201

• Serum carvedilol concentration and its relation to change in plasma brain natriuretic peptide level in the treatment of heart failure: a preliminary study.

  International journal of clinical pharmacology and therapeutics 20031201

• Activation of protein kinase C and nicotinamide adenine dinucleotide phosphate oxidase in leukocytes of spontaneously hypertensive rats.

  Hypertension research : official journal of the Japanese Society of Hypertension 20031201

• Case studies in heart failure.

  Critical care nursing clinics of North America 20031201

• Contribution of sympathetic nervous system activity during administration of carvedilol in rats with dilated cardiomyopathy.

  Journal of cardiovascular pharmacology 20031201

• A comment on COMET: how to interpret a positive trial?

  Journal of cardiac failure 20031201

• Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial.

  Journal of cardiac failure 20031201

• Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?

  Journal of cardiac failure 20031201

• A clinical pharmacologist's response to Dr Milton Packer's perspective on the results of the COMET trial.

  Journal of cardiac failure 20031201

• Beta-blockers for heart failure.

  Journal of cardiac failure 20031201

• Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure.

  Journal of cardiac failure 20031201

• The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy.

  Annals of nuclear medicine 20031201

• [Beta blocker in heart failure. Dosage too low].

  MMW Fortschritte der Medizin 20031120

• Carvedilol blockade of rat myocardial alpha1-adrenoceptors.

  European journal of pharmacology 20031114

• Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20031101

• Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.

  The American journal of cardiology 20031101

• Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.

  American heart journal 20031101

• Carvedilol superior to metoprolol for preventing death from CHF.

  The Journal of family practice 20031101

• Beta-blockers for chronic heart failure: surviving longer but feeling better?

  International journal of cardiology 20031101

• Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells.

  Japanese heart journal 20031101

• Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in rats.

  Japanese heart journal 20031101

• [Clinical observation of 41 cases of senile ischemic heart disease treated by losarton, carvadilol and Shenmai Injection].

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20031101

• [A fairer comparison between carvedilol and metoprolol is still to be done].

  Lakartidningen 20031030

• Myocardial dysfunction: hibernation and remodelling.

  Lancet (London, England) 20031025

• Cardiac failure associated with G6PD deficiency.

  Circulation research 20031017

• [Comparative study in heart failure. Which beta blocker saves more life time?].

  MMW Fortschritte der Medizin 20031002

• Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.

  Clinical science (London, England : 1979) 20031001

• Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.

  Nature medicine 20031001

• Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20031001

• Antioxidant properties of carvedilol: inhibition of lipid peroxidation, protein oxidation and superoxide generation.

  Neurological research 20031001

• Nitric oxide and vascular reactivity in African American patients with hypertension.

  Journal of cardiac failure 20031001

• A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

  Journal of cardiac failure 20031001

• Beta-blockers are effective in congestive heart failure patients with atrial fibrillation.

  Journal of cardiac failure 20031001

• A COMET lost.

  Italian heart journal : official journal of the Italian Federation of Cardiology 20031001

• Carvedilol and trimetazidine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.

  Toxicology 20030930

• COMET: a proposed mechanism of action to explain the results and concerns about dose.

  Lancet (London, England) 20030927

• COMET: a proposed mechanism of action to explain the results and concerns about dose.

  Lancet (London, England) 20030927

• Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation.

  The American journal of cardiology 20030915

• [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].

  Lakartidningen 20030911

• Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).

  The American journal of cardiology 20030901

• Oxidative stress in chronic renal allograft nephropathy in rats: effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol.

  Journal of cardiovascular pharmacology 20030901

• Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity.

  Cardiovascular research 20030901

• Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.

  Journal of cardiovascular pharmacology and therapeutics 20030901

• [Comet or snoop?].

  Medizinische Monatsschrift fur Pharmazeuten 20030901

• Top heart failure drugs compared.

  Health news (Waltham, Mass.) 20030901

• Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.

  Cardiac electrophysiology review 20030901

• How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).

  Cardiac electrophysiology review 20030901

• I have been diagnosed with heart failure, and my cardiologist has prescribed a medication called Coreg. What will it do for me?

  Heart advisor 20030901

• Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.

  Circulation 20030826

• Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.

  Bioorganic & medicinal chemistry letters 20030818

• Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure.

  The American journal of cardiology 20030815

• Effect of beta-blockers on insulin resistance in patients with dilated cardiomyopathy.

  Circulation journal : official journal of the Japanese Circulation Society 20030801

• Clinical trials update from the European Society of Cardiology Heart Failure meeting: COMET, COMPANION, Tezosentan and SHAPE.

  European journal of heart failure 20030801

• Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.

  Journal of cardiac failure 20030801

• Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol.

  Cardiology in the young 20030801

• Management of drug and alcohol withdrawal.

  The New England journal of medicine 20030724

• Choosing metoprolol or carvedilol in heart failure (a pre-COMET commentary).

  The American journal of cardiology 20030715

• [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].

  MMW Fortschritte der Medizin 20030710

• Beta blockers in heart failure.

  Lancet (London, England) 20030705

• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

  Lancet (London, England) 20030705

• Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.

  Lancet (London, England) 20030705

• Carvedilol, a beta adrenoceptor blocker with chelating properties. A copper 'superdimer' based on dimetal units.

  Journal of inorganic biochemistry 20030701

• Long-term treatment with the beta-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure.

  Journal of cardiovascular pharmacology 20030701

• Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure.

  Pharmacogenetics 20030701

• [Heart failure symptoms despite normal pump function. Beta blockers also improve diastole].

  MMW Fortschritte der Medizin 20030626

• Liquid chromatographic determination of carvedilol in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030615

• QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure.

  The American journal of cardiology 20030615

• Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action.

  Circulation 20030603

• Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.

  Heart (British Cardiac Society) 20030601

• Agonist actions of 'beta-blockers' provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor.

  Molecular pharmacology 20030601

• Beta-blocker benefit according to severity of heart failure.

  European journal of heart failure 20030601

• The possible role of oxidative stress in heart failure and the potential of antioxidant intervention.

  Medical science monitor : international medical journal of experimental and clinical research 20030601

• Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.

  Circulation 20030520

• Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern.

  The American journal of cardiology 20030515

• Prevention and management of chronic heart failure in management of asymptomatic patients.

  The American journal of cardiology 20030508

• Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.

  The American journal of cardiology 20030508

• Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.

  Journal of the American College of Cardiology 20030507

• [Use of beta-blockers in heart failure].

  Nihon rinsho. Japanese journal of clinical medicine 20030501

• Digoxin-carvedilol interactions in children.

  The Journal of pediatrics 20030501

• Use of carvedilol in the treatment of heart failure.

  Hospital medicine (London, England : 1998) 20030501

• Carvedilol attenuates CPB-induced apoptosis in dog heart: regulationof Fas/FasL and caspase-3 pathway.

  Chinese medical journal 20030501

• [The changes of plasma levels of brain natriuretic peptides in evaluation of treatment responses in chronic heart failure].

  Zhonghua nei ke za zhi 20030501

• New developments in the management of heart failure: a review of the literature in 2002.

  The Netherlands journal of medicine 20030501

• A case of severe diabetes mellitus occurred during management of heart failure with carvedilol and furosemide.

  Cardiovascular drugs and therapy 20030501

• Adrenomedullin and heart failure.

  Regulatory peptides 20030415

• Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels.

  The American journal of cardiology 20030415

• [Impaired coronary flow reserve in patients with non-ischemic heart failure].

  Revista espanola de cardiologia 20030401

• Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.

  Arteriosclerosis, thrombosis, and vascular biology 20030401

• Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery.

  British journal of pharmacology 20030401

• Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.

  Minerva cardioangiologica 20030401

• Tolerability of beta-blockers in heart failure: reassurance needed, reassurance provided.

  Italian heart journal : official journal of the Italian Federation of Cardiology 20030401

• Comparison between capillary electrophoresis and high-performance liquid chromatography for the stereoselective analysis of carvedilol in serum.

  Journal of pharmaceutical and biomedical analysis 20030310

• Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study.

  Heart (British Cardiac Society) 20030301

• Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.

  Heart (British Cardiac Society) 20030301

• Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.

  European journal of heart failure 20030301

• Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.

  European journal of heart failure 20030301

• Beta-blockers for heart failure: why, which, when, and where.

  The Medical clinics of North America 20030301

• [Cardiac rehabilitation in a HIV-patient treated with protease inhibitors].

  Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 20030301

• Chenodeoxycholate induction of mitochondrial permeability transition pore is associated with increased membrane fluidity and cytochrome c release: protective role of carvedilol.

  Mitochondrion 20030301

• [Carvedilol in ischemic heart failure. Hibernating myocardium resuscitated].

  MMW Fortschritte der Medizin 20030220

• Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.

  JAMA 20030212

• Comparative effects of carvedilol and losartan alone and in combination for preventing left ventricular remodeling after acute myocardial infarction in rats.

  Circulation journal : official journal of the Japanese Circulation Society 20030201

• Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans.

  British journal of clinical pharmacology 20030201

• Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20030201

• Effect of carvedilol alone or in the presence of cyclosporine on the migration of vascular smooth muscle cell of rat.

  Transplantation proceedings 20030201

• Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study.

  American heart journal 20030201

• Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.

  American heart journal 20030201

• Improving care of chronic heart failure: advances from drugs to devices.

  Cleveland Clinic journal of medicine 20030201

• Carvedilol modulates in-vitro granulocyte-macrophage colony-stimulating factor-induced interleukin-10 production in U937 cells and human monocytes.

  Immunological investigations 20030201

• [When the left ventricle can no longer relax properly. Beta blocker improves diastolic function].

  MMW Fortschritte der Medizin 20030130

• Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies.

  European journal of pharmacology 20030126

• Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers.

  Circulation 20030121

• Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.

  Circulation 20030121

• Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure.

  The American journal of cardiology 20030115

• Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.

  Journal of the American College of Cardiology 20030115

• [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].

  Medizinische Klinik (Munich, Germany : 1983) 20030115

• Characteristic effects of alpha1-beta1,2-adrenergic blocking agent, carvedilol, on [Ca2+]i in ventricular myocytes compared with those of timolol and atenolol.

  Circulation journal : official journal of the Japanese Circulation Society 20030101

• Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality.

  BMC nephrology 20030101

• Current concepts in managing heart failure. Based on recent studies of beta-blocker therapy, treatment guidelines have been revised for patients who have mild, moderate, or severe HF.

  JAAPA : official journal of the American Academy of Physician Assistants 20030101

• Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.

  Cancer science 20030101

• Carvedilol: relation between antioxidant activity and inhibition of the mitochondrial permeability transition.

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20030101

• Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.

  Ethnicity & disease 20030101

• HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study.

  BMC nephrology 20030101

• Use of beta-blockers in congestive heart failure.

  Annals of medicine 20030101

• Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure.

  BMC physiology 20030101

• [Influence of different pharmacological agents in the ex vivo proliferation of mesothelial cells obtained from the peritoneal effluent of patients treated with peritoneal dialysis].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20030101

• Carvedilol: a review of its use in chronic heart failure.

  Drugs 20030101

• [Contribution of antioxidant properties of carvedilol in its effect on cardiac remodeling in patients with ischemic heart disease with incipient heart failure].

  Kardiologiia 20030101

• Phaeochromocytoma presenting as dilated cardiomyopathy.

  International journal of clinical practice 20030101

• Dramatic new trial results settle controversy in chronic heart failure.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20030101

• [Endothelial protection in patients with apparent cardiac failure in long-term therapy by carvedilol].

  Klinicheskaia meditsina 20030101

• Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly?

  Texas Heart Institute journal 20030101

• Effects of carvedilol on cardiomyocyte apoptosis and gene expression in vivo after ischemia-reperfusion in rats.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20030101

• Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof.

  Cardiovascular diabetology 20030101

• Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.

  Congestive heart failure (Greenwich, Conn.) 20030101

• Switching between beta blockers in heart failure patients: rationale and practical considerations.

  Congestive heart failure (Greenwich, Conn.) 20030101

• Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.

  Reviews in cardiovascular medicine 20030101

• New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.

  Reviews in cardiovascular medicine 20030101

• Diabetes, hypertension, and renal insufficiency in post-myocardial infarction cardiovascular risk.

  Reviews in cardiovascular medicine 20030101

• Carvedilol, an antihypertensive drug with antioxidant properties, protects against glycerol-induced acute renal failure.

  American journal of nephrology 20030101

• [Effect of beta-blockers metoprolol CR/XL and carvedilol on left ventricular contractility in patients with chronic low cardiac output].

  Terapevticheskii arkhiv 20030101

• Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.

  Cardiovascular ultrasound 20030101

• AVID and COMET.

  Preventive cardiology 20030101

• COMET challenges paradigm of ACE inhibition in mild heart failure.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20030101

• Drug-drug interactions of beta-adrenoceptor blockers.

  Arzneimittel-Forschung 20030101

• [The modern view on the role of inflammatory factors in chronic heart failure and possibilities of pharmacological modification].

  Przeglad lekarski 20030101

• The European Society of Cardiology working group on heart failure: Heart Failure Update 2003.

  Heart failure monitor 20030101

• The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.

  Romanian journal of internal medicine = Revue roumaine de medecine interne 20030101

• [Beta blockers in the treatment of heart failure due to left ventricular systolic dysfunction].

  Dakar medical 20030101

• Trends and treatment of heart failure developing after acute myocardial infarction.

  The American heart hospital journal 20030101

• Heart rate variability analysis in general medicine.

  Indian pacing and electrophysiology journal 20030101

• Novel effect of carvedilol on Ca2+ movement in renal tubular cells.

  Biochemical pharmacology 20021215

• Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.

  Toxicology and applied pharmacology 20021215

• Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment.

  Journal of the American College of Cardiology 20021204

• Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.

  Hepatology (Baltimore, Md.) 20021201

• Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.

  European journal of heart failure 20021201

• Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients.

  Chest 20021201

• Antiplatelet activity of carvedilol in comparison to propranolol.

  Platelets 20021201

• Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20021201

• Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.

  Circulation journal : official journal of the Japanese Circulation Society 20021201

• Normalization of left ventricular parameters following combined pimobendan and carvedilol treatment in a case of unclassified cardiomyopathy with longstanding refractory status.

  Internal medicine (Tokyo, Japan) 20021201

• Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.

  Journal of cardiac failure 20021201

• beta-blockers in heart failure--much more than heart rate reduction.

  Journal of cardiac failure 20021201

• Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.

  Herz 20021201

• [Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone. From physiopathology to diagnosis].

  Archives des maladies du coeur et des vaisseaux 20021201

• Impact of carvedilol on the mitochondrial damage induced by hypoxanthine and xantine oxidase--what role in myocardial ischemia and reperfusion?

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20021201

• Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy.

  The American journal of cardiology 20021115

• [Beta blockers and ACE inhibitors In heart failure to be combined at the beginning!].

  MMW Fortschritte der Medizin 20021107

• Nightmares and panic disorder associated with carvedilol overdose.

  The Annals of pharmacotherapy 20021101

• Beta-blockers in chronic heart failure: considerations for selecting an agent.

  Mayo Clinic proceedings 20021101

• Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype.

  Molecular medicine (Cambridge, Mass.) 20021101

• Role of antioxidants in chronic fatigue syndrome in mice.

  Indian journal of experimental biology 20021101

• Beta-blockers in heart failure: how far have we progressed?

  Postgraduate medicine 20021101

• Consistency of ss-blocker effect across various subgroups with heart failure: insights from the MERIT-HF trial.

  Postgraduate medicine 20021101

• Use of beta-blockers for heart failure in patients with diabetes mellitus.

  Postgraduate medicine 20021101

• Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?

  Circulation 20021022

• Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

  Circulation 20021022

• Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.

  Journal of the American College of Cardiology 20021002

• [Prevention and treatment of congestive heart failure in diabetic patients].

  Revista espanola de cardiologia 20021001

• The contractility enhancing effect of the calcium sensitiser levosimendan is not attenuated by carvedilol in healthy subjects.

  European journal of clinical pharmacology 20021001

• Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decreases elevated protein kinase A activity in transgenic mice with cardiac-specific overexpression of human beta 2-adrenoceptor.

  Journal of cardiovascular pharmacology 20020901

• The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design.

  American heart journal 20020901

• Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol.

  Methods and findings in experimental and clinical pharmacology 20020901

• Gateways to Clinical Trials.

  Methods and findings in experimental and clinical pharmacology 20020901

• Down-regulation of sodium current in chronic heart failure: effect of long-term therapy with carvedilol.

  Cellular and molecular life sciences : CMLS 20020901

• Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20020801

• Current research on carvedilol in heart failure.

  Critical care nurse 20020801

• Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure.

  European journal of heart failure 20020801

• Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials.

  European journal of heart failure 20020801

• The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?

  European journal of heart failure 20020801

• Beta-blockers have beneficial effects even on unclassified cardiomyopathy such as isolated ventricular noncompaction.

  Internal medicine (Tokyo, Japan) 20020801

• Carvedilol-induced changes in cardiac diastolic performance in a patient with isolated noncompaction of the myocardium.

  Internal medicine (Tokyo, Japan) 20020801

• Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine.

  Clinical nephrology 20020801

• [Pharmacology of beta blockers and their significance for therapy of hypertension].

  Herz 20020801

• [Beta blockers in post-infarction state].

  Herz 20020801

• [Beta blockers in heart failure therapy with special reference to the COPERNICUS Study].

  Herz 20020801

• [Urban & Vogel Robert Koch Award for carvedilol].

  Herz 20020801

• [Hormonal hyperactivity in heart failure. Differences in beta blockers].

  Herz 20020801

• The antihypertensive drug carvedilol inhibits the activity of mitochondrial NADH-ubiquinone oxidoreductase.

  Journal of bioenergetics and biomembranes 20020801

• Differential effects of short and prolonged exposure to carvedilol on voltage-dependent Na(+) channels in cultured bovine adrenal medullary cells.

  The Journal of pharmacology and experimental therapeutics 20020701

• Present and future pharmacotherapy for heart failure.

  Expert opinion on pharmacotherapy 20020701

• Effect of beta blockers on new congestive heart failure in older persons with healed myocardial infarcts.

  The American journal of cardiology 20020701

• [Treatment of heart failure: an update].

  Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20020701

• Prevention of and medical therapy for atrial arrhythmias in heart failure.

  Heart failure reviews 20020701

• Carvedilol decreases elevated oxidative stress in human failing myocardium.

  Circulation 20020618

• Effect of carvedilol on microcirculatory and glucose metabolic regulation in patients with congestive heart failure secondary to ischemic cardiomyopathy.

  The American journal of cardiology 20020615

• Dual chamber pacing in patients with severe heart failure on beta blocker and amiodarone treatment: preliminary results of a randomised study.

  Heart (British Cardiac Society) 20020601

• Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol.

  European journal of heart failure 20020601

• The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy.

  European journal of heart failure 20020601

• Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.

  European journal of heart failure 20020601

• Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol.

  European journal of heart failure 20020601

• Influence of nicardipine and nifedipine on plasma carvedilol disposition after oral administration in rats.

  The Journal of pharmacy and pharmacology 20020601

• Cardiovascular and renal effects of carvedilol in dogs with heart failure.

  The Journal of veterinary medical science 20020601

• [Hypertension and endothelial dysfunction].

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20020601

• Cost effectiveness of beta blocker therapy for patients with chronic severe heart failure in Ireland.

  Irish medical journal 20020601

• Effects of carvedilol and BL-443 on kidney of rats with cyclosporine nephropathy.

  General physiology and biophysics 20020601

• Bucindolol displays intrinsic sympathomimetic activity in human myocardium.

  Circulation 20020521

• Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.

  The New England journal of medicine 20020502

• Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.

  British journal of pharmacology 20020501

• Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure.

  Clinical cardiology 20020501

• Carvedilol does not modulate moderate exercise-induced hyperkalemia in hemodialysis patients.

  Clinical nephrology 20020501

• Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters.

  American heart journal 20020501

• Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy.

  Journal of cardiology 20020501

• Carvedilol inhibits pressure-induced increase in oxidative stress in coronary smooth muscle cells.

  Hypertension research : official journal of the Japanese Society of Hypertension 20020501

• Cellular mechanisms for the treatment of chronic heart failure: the nitric oxide- and adenosine-dependent pathways.

  Expert opinion on emerging drugs 20020501

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy.

  The American journal of cardiology 20020415

• [Beta blockers in severe heart failure. Prognosis improves already after a short time].

  MMW Fortschritte der Medizin 20020411

• Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).

  Circulation 20020402

• Carvedilol inhibits platelet-derived growth factor-induced signal transduction in human cardiac fibroblasts.

  Journal of cardiovascular pharmacology 20020401

• Differential effects of bucindolol and carvedilol on noradenaline-induced hypertrophic response in ventricular cardiomyocytes of adult rats.

  The Journal of pharmacology and experimental therapeutics 20020401

• Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging.

  American heart journal 20020401

• Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20020401

• Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020401

• Myocardial adrenergic dysinnervation in dilated cardiomyopathy: cornerstone or epiphenomenon?

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020401

• Using carvedilol to treat heart failure.

  Critical care nurse 20020401

• Effects of carvedilol on heart rate dynamics in patients with congestive heart failure.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20020401

• Beta-blockers in chronic heart failure.

  European heart journal 20020301

• Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension.

  Alimentary pharmacology & therapeutics 20020301

• Reimbursement claims analysis of outcomes with carvedilol and metoprolol.

  The Annals of pharmacotherapy 20020301

• Effect of vasodilatory beta-adrenoceptor blockers on cardiovascular haemodynamics in anaesthetized rats.

  Clinical and experimental pharmacology & physiology 20020301

• [Effect of Consupren, Carvedilol and BL-443 on the composition of lactate dehydrogenase in tissues of rats with cyclosporin nephropathy].

  Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20020301

• Unique effects of carvedilol on noradrenaline release in the human heart.

  European journal of heart failure 20020301

• Recovery of cardiac autonomic responsiveness with low-intensity physical training in patients with chronic heart failure.

  European journal of heart failure 20020301

• [Effects of carvedilol on the hemodynamics and its tolerance in elderly patients].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20020301

• Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats.

  Journal of the renin-angiotensin-aldosterone system : JRAAS 20020301

• [Beta blockers in therapy of chronic heart failure].

  Herz 20020301

• Exercise does not affect plasma concentrations of (R)- and (S)-carvedilol.

  Cardiovascular drugs and therapy 20020301

• Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.

  Circulation 20020226

• beta-Blocker therapy in heart failure: scientific review.

  JAMA 20020220

• Interaction of digoxin with antihypertensive drugs via MDR1.

  Life sciences 20020215

• Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET.

  Neurochemistry international 20020201

• [New and old beta-blockers in the treatment of heart failure].

  Recenti progressi in medicina 20020201

• Coreg. New indication for heart failure drug.

  Nursing 20020201

• [CAPRICORN and COPERINUS studies].

  Archives des maladies du coeur et des vaisseaux 20020201

• Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction.

  Transplantation proceedings 20020201

• [Severe heart failure--effects of carvedilol therapy. The Copernicus Study].

  Der Internist 20020201

• Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.

  Journal of gastroenterology and hepatology 20020201

• Substantial evidence of effect.

  Journal of biopharmaceutical statistics 20020201

• New series of aryloxypropanolamines with both human beta(3)-adrenoceptor agonistic activity and free radical scavenging properties.

  Bioorganic & medicinal chemistry letters 20020121

• [Therapy relevant differences in beta blockers and ACE inhibitors. Innovation or plagiarism?].

  MMW Fortschritte der Medizin 20020117

• Unpredicted lack of effect of exercise on plasma concentrations of carvedilol.

  Journal of cardiovascular pharmacology 20020101

• Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat.

  Journal of cardiovascular pharmacology 20020101

• Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.

  British journal of pharmacology 20020101

• Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

  Drugs 20020101

• Carvedilol reduced mortality and morbidity caused by myocardial infarction in patients with left ventricular dysfunction.

  ACP journal club 20020101

• Higher expectations for management of heart failure: current recommendations.

  The Journal of the American Board of Family Practice 20020101

• [Comparison beta-blockers and their relevance to pharmacologic therapy of cardiovascular diseases].

  Arzneimittel-Forschung 20020101

• [Stress ultrasonography under low doses of dobutamine, contractile reserve and dilated cardiomyopathy].

  Archives des maladies du coeur et des vaisseaux 20020101

• Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy.

  Pediatric cardiology 20020101

• Medical resource use and costs of congestive heart failure after carvedilol use.

  Heart disease (Hagerstown, Md.) 20020101

• [A comparative study of anapriline and carvedilol effectiveness in patients with thyrotoxicosis in pre- and postoperative periods].

  Klinicheskaia meditsina 20020101

• Effects of carvedilol alone and in the presence of cyclosporine A on the DNA synthesis of cultured vascular smooth muscle cells.

  Surgery today 20020101

• Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.

  Scandinavian journal of clinical and laboratory investigation 20020101

• Carvedilol: a nonselective beta blocking agent with antioxidant properties.

  Congestive heart failure (Greenwich, Conn.) 20020101

• Experimental diabetes and left ventricular hypertrophy: effects of beta-receptor blockade.

  Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 20020101

• Carvedilol offers women with heart problems the same clinical benefits as men.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20020101

• Acid-base state in patients after cardiac transplantation.

  American journal of nephrology 20020101

• [Combined alpha and beta blockers in the therapy of cardiovascular diseases].

  Vojnosanitetski pregled 20020101

• [Carvedilol in treating primary pulmonary hypertension patients: effect on severity of cardiac failure, degree of pulmonary hypertension, concentration of catecholamines in blood plasma and dependence of cyclic AMP synthesis in lymphocytes on beta-adrenergic receptors].

  Terapevticheskii arkhiv 20020101

• Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol.

  Nephron 20020101

• Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?

  Paediatric drugs 20020101

• Beta-blocker therapy for heart failure: the standard of care.

  Reviews in cardiovascular medicine 20020101

• Beta-adrenergic blocking drugs in severe heart failure.

  Reviews in cardiovascular medicine 20020101

• The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications.

  Reviews in cardiovascular medicine 20020101

• Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker.

  Clinical hemorheology and microcirculation 20020101

• Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.

  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20020101

• [Long term use of a non-selective beta-blocker with vasodilating properties carvedilol in patients with severe heart failure].

  Kardiologiia 20020101

• [Status of microcirculation and cardiodynamics in ischemic heart disease patients with decreased left ventricular fraction and their response to carvedilol].

  Terapevticheskii arkhiv 20020101

• [Congestive heart failure and acute myocardial infarction: latest trials with beta-blocking agents].

  Annales de cardiologie et d'angeiologie 20020101

• Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction.

  Blood pressure 20020101

• Major heart failure news from 2001.

  Heart failure monitor 20020101

• Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome.

  Journal of medicinal food 20020101

• Carvedilol: something else than a simple betablocker?

  European review for medical and pharmacological sciences 20020101

• Racial differences in responses to drug treatment: implications for pharmacotherapy of heart failure.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20020101

• Effects of nebivolol on human platelet aggregation.

  Journal of cardiovascular pharmacology 20011201

• Comparing methods to identify general internal medicine clinic patients with chronic heart failure.

  American heart journal 20011201

• The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.

  European journal of heart failure 20011201

• Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers.

  Journal of the American College of Cardiology 20011201

• Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.

  International journal of cardiology 20011201

• Carvedilol in the failing heart.

  Clinical cardiology 20011201

• Digoxin withdrawal in patients with dilated cardiomyopathy following normalization of ejection fraction with beta blockers.

  Clinical cardiology 20011201

• Aminoglycoside nephrotoxicity: do time and frequency of administration matter?

  Current opinion in critical care 20011201

• [Tolerability and clinical effects of carvedilol in patients over 70 years of age with chronic heart failure due to left ventricular dysfunction].

  Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20011201

• [Progress in heart failure during the year 2001].

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20011201

• Known by the society he keeps: an interview with Robert Ruffolo.

  Molecular interventions 20011201

• [Comparative effects of carvedilol, losartan and their combination in preventing left ventricular remodeling after acute myocardial infarction in rats].

  Zhonghua nei ke za zhi 20011201

• Echo-Doppler mitral flow monitoring: an operative tool to evaluate day-to-day tolerance to and effectiveness of beta-adrenergic blocking agent therapy in patients with chronic heart failure.

  Journal of the American College of Cardiology 20011115

• Scavenger effect of experimental and clinically used cardiovascular drugs.

  Journal of cardiovascular pharmacology 20011101

• Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.

  British journal of pharmacology 20011101

• Cardiac remodeling after long term norepinephrine treatment in rats.

  Cardiovascular research 20011101

• Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.

  Journal of the American College of Cardiology 20011101

• Oxidative stress impairs the haemodynamic activity of cardiovascular agents with antioxidant properties.

  Naunyn-Schmiedeberg's archives of pharmacology 20011101

• Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.

  Japanese circulation journal 20011101

• Hepatotoxicity associated with carvedilol.

  The Annals of pharmacotherapy 20011101

• [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].

  Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20011101

• Apoptosis--new opportunities for novel therapeutics for heart diseases.

  Cardiovascular drugs and therapy 20011101

• Apoptosis in cardiac disease: from basics to clinics--an editorial commentary.

  Cardiovascular drugs and therapy 20011101

• Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity.

  Circulation 20011030

• What drug must be used to avoid the most common hypertensive complications?

  Minerva cardioangiologica 20011001

• The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals.

  Cardiovascular research 20011001

• beta-Adrenergic receptors, transgenic mice, and pharmacological model systems.

  Molecular pharmacology 20011001

• Constitutive activity of the human beta(1)-adrenergic receptor in beta(1)-receptor transgenic mice.

  Molecular pharmacology 20011001

• Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.

  American heart journal 20011001

• Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.

  Journal of the American College of Cardiology 20011001

• Optimization of left ventricular function with carvedilol before high-risk cardiac surgery.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20011001

• [Severe pulmonary hypertensión treated with low dose carvedilol in a patient infected with the human immunodeficiency virus].

  Enfermedades infecciosas y microbiologia clinica 20011001

• [The effect of carvedilol on enhanced adp-ribosylation and red blood cell membrane damage caused by free radicals].

  Acta pharmaceutica Hungarica 20011001

• [Carvedilol effectiveness for left ventricular-insufficient patients with Duchenne muscular dystrophy].

  Rinsho shinkeigaku = Clinical neurology 20011001

• [Comparative effects of carvedilol and metoprolol in preventing from left ventricular remodeling after acute myocardial infarction in rats].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20011001

• Effects of beta-blocker therapy in severe chronic heart failure.

  The New England journal of medicine 20010927

• Effects of beta-blocker therapy in severe chronic heart failure.

  The New England journal of medicine 20010927

• [Differential therapy with beta blockers. What is their value, what are the risks?].

  MMW Fortschritte der Medizin 20010927

• [Role of beta-blockers in the treatment of chronic heart heart failure].

  Orvosi hetilap 20010916

• Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats.

  The Journal of pharmacology and experimental therapeutics 20010901

• Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program.

  American heart journal 20010901

• Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.

  American heart journal 20010901

• Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.

  American heart journal 20010901

• Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada.

  American heart journal 20010901

• Rise of defibrillation energy requirement under carvedilol therapy.

  Pacing and clinical electrophysiology : PACE 20010901

• Impact of pharmacotherapy on lymphocyte volumes and activity of the Na+/H+ exchanger in patients with congestive heart failure.

  Methods and findings in experimental and clinical pharmacology 20010901

• The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis.

  Virology 20010815

• [Comparative effects of carvediol in large, middle, and small dose in preventing left ventricular remodeling after acute myocardial infarction in rats].

  Zhonghua yi xue za zhi 20010810

• Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.

  British journal of pharmacology 20010801

• Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.

  European journal of heart failure 20010801

• Ultrasonic tissue characterization can predict beta-blocker efficacy in dilated cardiomyopathy.

  Ultrasound in medicine & biology 20010801

• Beta-adrenergic receptor blockers as therapy in pediatric chronic heart failure.

  Minerva pediatrica 20010801

• [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].

  Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20010801

• Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity.

  Biochemical pharmacology 20010715

• Stereoselective effects of (R)- and (S)-carvedilol in humans.

  Chirality 20010701

• Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts.

  American journal of physiology. Heart and circulatory physiology 20010701

• Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction.

  Heart (British Cardiac Society) 20010701

• Acute effects of a single oral dose of carvedilol on cardiac sympathovagal balance in man.

  International journal of clinical pharmacology and therapeutics 20010701

• [Female carrier of Duchenne muscular dystrophy presenting with secondary dilated cardiomyopathy: a case report].

  Journal of cardiology 20010701

• Random research.

  Circulation 20010626

• Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity.

  European journal of pharmacology 20010622

• Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy.

  Journal of the American College of Cardiology 20010615

• Beta-blockade in chronic heart failure.

  Circulation 20010612

• Beta-blocker trials seem to be in conflict.

  Circulation 20010612

• [The taboo topic of sexual activity in hypertensive patients. Pioneer study from Pavia proves: potency is not impaired].

  MMW Fortschritte der Medizin 20010607

• Protective effect of carvedilol on chenodeoxycholate induction of the permeability transition pore.

  Biochemical pharmacology 20010601

• Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.

  American heart journal 20010601

• Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.

  American heart journal 20010601

• Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure.

  European journal of heart failure 20010601

• Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure.

  European journal of heart failure 20010601

• Differing beta-blocking effects of carvedilol and metoprolol.

  European journal of heart failure 20010601

• A cost-effectiveness analysis of bisoprolol for heart failure.

  European journal of heart failure 20010601

• Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

  European journal of heart failure 20010601

• Bucindolol, a nonselective beta 1- and beta 2-adrenergic receptor antagonist, decreases beta-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes.

  Journal of cardiovascular pharmacology 20010601

• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.

  Journal of the American College of Cardiology 20010601

• Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.

  The Journal of family practice 20010601

• Using isoproterenol stress echocardiography to predict the response to carvedilol in patients with dilated cardiomyopathy.

  Japanese circulation journal 20010601

• Carvedilol in heart mitochondria: protonophore or opener of the mitochondrial K(ATP) channels?

  Life sciences 20010601

• [Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case].

  Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20010601

• [Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol. Results of a randomised study].

  Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20010601

• Effect of carvedilol on survival in severe chronic heart failure.

  The New England journal of medicine 20010531

• Expanding indications for beta-blockers in heart failure.

  The New England journal of medicine 20010531

• Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure.

  Circulation 20010522

• Economic impact of beta blockade in heart failure.

  The American journal of medicine 20010507

• Current role of beta-adrenergic blockers in the management of chronic heart failure.

  The American journal of medicine 20010507

• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  Lancet (London, England) 20010505

• Separation of carvedilol enantiomers in very small volumes of human plasma by capillary electrophoresis with laser-induced fluorescence.

  Journal of chromatography. B, Biomedical sciences and applications 20010505

• Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.

  The New England journal of medicine 20010503

• Racial differences in the response to drugs--pointers to genetic differences.

  The New England journal of medicine 20010503

• Carvedilol versus other beta-blockers in heart failure.

  Expert opinion on investigational drugs 20010501

• Carvedilol in the treatment of chronic heart failure.

  Expert opinion on pharmacotherapy 20010501

• Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.

  Journal of the American College of Cardiology 20010501

• Overview of the results of recent beta blocker trials.

  Current opinion in cardiology 20010501

• Mechanisms of carvedilol action in human congestive heart failure.

  Hypertension (Dallas, Tex. : 1979) 20010501

• Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial.

  International journal of clinical pharmacology and therapeutics 20010501

• Benefits of beta-blockers in heart failure: a class specific effect?

  Italian heart journal : official journal of the Italian Federation of Cardiology 20010501

• Reducing readmissions for congestive heart failure.

  American family physician 20010415

• 50th Annual scientific sessions of the American college of cardiology.

  Circulation 20010410

• Carvedilol--a new dimension in pediatric heart failure therapy.

  The Journal of pediatrics 20010401

• Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.

  The Journal of pediatrics 20010401

• Characterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium.

  British journal of pharmacology 20010401

• CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI.

  International journal of cardiology 20010401

• Beta-blocker treatment in heart failure.

  Fundamental & clinical pharmacology 20010401

• Are all beta-blockers the same for chronic heart failure?

  Current cardiology reports 20010301

• Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure overload: effects of beta-receptor blockade.

  Journal of molecular and cellular cardiology 20010301

• Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis.

  Journal of cardiac failure 20010301

• Determination of carvedilol in human cardiac tissue by high-performance liquid chromatography.

  Journal of chromatographic science 20010301

• [Severe heart failure. Carvedilol lowers mortality].

  MMW Fortschritte der Medizin 20010301

• [Adrenergic beta inhibitors in heart insufficiency: which and when?].

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20010301

• [Options in drug combinations].

  Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20010301

• Carvedilol and vesnarinone: new antiarrhythmic approach in heart failure therapy.

  Acta pharmacologica Sinica 20010301

• Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.

  Circulation 20010227

• Inhibitory effect of carvedilol in the high-conductance state of the mitochondrial permeability transition pore.

  European journal of pharmacology 20010202

• Antiarrhythmic drug carvedilol inhibits HERG potassium channels.

  Cardiovascular research 20010201

• Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.

  Cardiovascular research 20010201

• Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial.

  Journal of the American College of Cardiology 20010201

• [Economic study of carvedilol in heart failure. A cost effectiveness study in France].

  Archives des maladies du coeur et des vaisseaux 20010201

• Variceal bleeding and portal hypertension: still a therapeutic challenge?

  Endoscopy 20010201

• Development of a capillary electrophoresis assay for the determination of carvedilol enantiomers in serum using cyclodextrins.

  Journal of pharmaceutical and biomedical analysis 20010201

• Effect of carvedilol on atrioventricular conduction in the ischemic heart.

  European journal of pharmacology 20010126

• [Comprehensive anti-adrenergic therapy. It can save the weak heart].

  MMW Fortschritte der Medizin 20010125

• Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228.

  Biochemical pharmacology 20010115

• Current role of beta-adrenergic blockers in the treatment of chronic congestive heart failure.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010115

• Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial.

  Journal of cardiovascular pharmacology 20010101

• beta(1)-Adrenoceptors compensate for beta(3)-adrenoceptors in ileum from beta(3)-adrenoceptor knock-out mice.

  British journal of pharmacology 20010101

• Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity.

  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20010101

• Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010101

• Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study.

  American journal of hypertension 20010101

• Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patients.

  Journal of clinical pharmacology 20010101

• [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].

  Terapevticheskii arkhiv 20010101

• [Clinical efficacy of carvedilol in patients with severe cardiac insufficiency].

  Terapevticheskii arkhiv 20010101

• A placebo controlled evaluation of the antifibrillatory effects of carvedilol.

  Journal of electrocardiology 20010101

• What is the optimal medical management of ischemic heart failure?

  Progress in cardiovascular diseases 20010101

• Impressive amelioration of clinical (NYHA class) and echocardiographic parameters in heart failure patients treated with amiodarone and carvedilol.

  European journal of heart failure 20010101

• The MIBG tarot: is it possible to predict the efficacy of beta-blockers in congestive heart failure?

  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20010101

• Detection of low levels of the amorphous phase in crystalline pharmaceutical materials by thermally stimulated current spectrometry.

  Pharmaceutical research 20010101

• [Effects of carvedilol in rats with induced chronic kidney failure].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101

• Levosimendan.

  Drugs 20010101

• Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report.

  Indian heart journal 20010101

• Primary results of COPERNICUS, a pivotal landmark study (Carvedilol Prospective Randomised Cumulative Survival Trial).

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20010101

• Carvedilol outclasses the other beta-blockers.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20010101

• Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20010101

• [Beta-blockers in the treatment of systolic dysfunction after myocardial infarction. Closing the circle?].

  Medicina 20010101

• Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.

  Cardiovascular drug reviews 20010101

• Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program.

  The Annals of pharmacotherapy 20010101

• The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and design.

  Cardiovascular drugs and therapy 20010101

• [Clinical trials on heart failure].

  Revista espanola de cardiologia 20010101

• [Clinico-functional evaluation of hypotensive effect of carvedilol in elderly patients with mild and moderate arterial hypertension].

  Terapevticheskii arkhiv 20010101

• [Arterial hypertension and oxidative stress induced by cyclosporin. Effect of carvedilol].

  Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna 20010101

• Beta-blockers in heart failure.

  Bratislavske lekarske listy 20010101

• What is the optimal medical management of ischaemic heart failure?

  British medical bulletin 20010101

• [Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin].

  Terapevticheskii arkhiv 20010101

• [Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease].

  Klinicheskaia meditsina 20010101

• [Laser irradiation in the treatment of ischemic heart disease].

  Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20010101

• Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injury.

  Cardiovascular toxicology 20010101

• Beta-blockade in heart failure: selective versus nonselective agents.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20010101

• Carvedilol: a countermeasure to heart failure.

  Dimensions of critical care nursing : DCCN 20010101

• Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture.

  Cardiovascular research 20001101

• Beta-blockers of the third generation inhibit endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells.

  Journal of cardiovascular pharmacology 20001101

• Improvement in cardiac function and free fatty acid metabolism in a case of dilated cardiomyopathy with CD36 deficiency.

  Japanese circulation journal 20000901

• The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20000801

• Carvedilol affects the physiological and behavioral response to smoked cocaine in humans.

  Drug and alcohol dependence 20000701

• Beta-blockade in adriamycin-induced cardiomyopathy.

  Journal of cardiac failure 20000601

• Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites.

  International journal of clinical pharmacology and therapeutics 20000401

• Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen.

  Journal of molecular and cellular cardiology 20000201

• Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway.

  Cardiovascular research 20000201

• Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats.

  Cardiovascular drugs and therapy 20000201

• Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart.

  Journal of cardiovascular pharmacology 20000101

• Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.

  Biochemical pharmacology 19991201

• Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding.

  Hypertension (Dallas, Tex. : 1979) 19991201

• Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.

  The Annals of pharmacotherapy 19991201

• Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.

  Journal of the American College of Cardiology 19991101

• Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.

  American heart journal 19990901

• Carvedilol reduces ischaemic skeletal muscle necrosis.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 19990901

• Potent and selective human beta(3)-adrenergic receptor antagonists.

  The Journal of pharmacology and experimental therapeutics 19990801

• Effect of beta-blockers on free radical-induced cardiac contractile dysfunction.

  Circulation 19990727

• Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation.

  British journal of pharmacology 19990701

• The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency.

  European journal of clinical pharmacology 19990601

• Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.

  American heart journal 19990401

• Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors.

  Cardiovascular drugs and therapy 19990401

• Cost effectiveness of carvedilol for heart failure.

  The American journal of cardiology 19990315

• Statins and peripheral neuropathy.

  European journal of clinical pharmacology 19990101

• Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats.

  Life sciences 19990101

• Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.

  Journal of hypertension 19981201

• Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group.

  Journal of cardiac failure 19981201

• Carvedilol: the new role of beta blockers in congestive heart failure.

  American family physician 19981101

• Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade.

  Circulation 19981027

• Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group.

  The American journal of cardiology 19981015

• Doxorubicin-induced cardiomyopathy treated with carvedilol.

  Clinical cardiology 19981001

• Assuming the worst may not be bad at all. Carvedilol in heart failure treatment.

  European journal of clinical pharmacology 19980601

• Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.

  Diabetes care 19980401

• Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.

  Endocrinology 19980101

• Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells.

  Journal of molecular and cellular cardiology 19980101

• Interaction of the renin-angiotensin system and the endothelin system in cardiac hypertrophy.

  Journal of cardiovascular pharmacology 19980101

• Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure.

  Journal of cardiovascular pharmacology 19980101

• Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.

  Journal of cardiac failure 19970901

• Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.

  Circulation 19961201

• Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.

  Circulation 19961201

• Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.

  Journal of hepatology 19961201

• Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury.

  European journal of pharmacology 19961024

• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  The New England journal of medicine 19960523

• Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.

  Journal of hypertension 19960401

• Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension.

  Journal of cardiovascular pharmacology 19960401

• Quality of life in hypertensive patients treated with either carvedilol or enalapril.

  Blood pressure 19960101

• Regression of left ventricular hypertrophy in hypertensive elderly patients with carvedilol.

  Archives of gerontology and geriatrics 19960101

• Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.

  Journal of the American College of Cardiology 19950501

• Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans.

  Clinical pharmacology and therapeutics 19940301

• Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.

  Proceedings of the National Academy of Sciences of the United States of America 19930701

• Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 19930601

• Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.

  Cardiovascular drugs and therapy 19921001

• Effects of norepinephrine on the oxidative pentose phosphate pathway in the rat heart.

  Circulation research 19920801

• Receptor pharmacology of carvedilol in the human heart.

  Journal of cardiovascular pharmacology 19920101

• A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.

  Journal of cardiovascular pharmacology 19920101

• Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.

  Journal of cardiovascular pharmacology 19920101

• Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.

  European heart journal 19910601

• Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.

  Journal of cardiovascular pharmacology 19910101

• A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.

  Journal of cardiovascular pharmacology 19910101

• The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilol.

  Cardiovascular drugs and therapy 19900801

• Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.

  Japanese heart journal 19900701

• Effects of carvedilol on renal function.

  European journal of clinical pharmacology 19900101

• The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.

  Molecular pharmacology 19881201

• Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.

  Drugs 19880101

• Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.

  Journal of cardiovascular pharmacology 19870301

• Circadian antihypertensive profile of carvedilol (BM 14190).

  Journal of cardiovascular pharmacology 19870101

• Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.

  Journal of cardiovascular pharmacology 19870101

• Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.

  Journal of cardiovascular pharmacology 19870101

• Efficacy of carvedilol in exercise-induced myocardial ischemia.

  Journal of cardiovascular pharmacology 19870101

• Studies on the mode of vasodilating action of carvedilol.

  Journal of cardiovascular pharmacology 19870101

• Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.

  Journal of cardiovascular pharmacology 19870101

• Clinical pharmacology of carvedilol in normal volunteers.

  Clinical pharmacology and therapeutics 19870101

• Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.

  Journal of hypertension 19841001